TW200300069A - Anti-obesity foods and drinks - Google Patents

Anti-obesity foods and drinks Download PDF

Info

Publication number
TW200300069A
TW200300069A TW091132788A TW91132788A TW200300069A TW 200300069 A TW200300069 A TW 200300069A TW 091132788 A TW091132788 A TW 091132788A TW 91132788 A TW91132788 A TW 91132788A TW 200300069 A TW200300069 A TW 200300069A
Authority
TW
Taiwan
Prior art keywords
acid
food
derivatives
physiologically acceptable
acceptable salts
Prior art date
Application number
TW091132788A
Other languages
Chinese (zh)
Inventor
Noriyasu Kuno
Gou Shinohara
Hisami Shinohara
Original Assignee
Nisshin Oillio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oillio Ltd filed Critical Nisshin Oillio Ltd
Publication of TW200300069A publication Critical patent/TW200300069A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Anti-obesity foods and drinks containing compounds selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts thereof and derivatives of the same, in particular, anti-obesity foods and drinks containing maslinic acid and/or physiologically acceptable salts thereof.

Description

200300069 A7 B7 五、發明説明(j) 發明背景 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局肖工消費合作社印製 本發明乃藉經口攝食而顯現抗肥滿效果之抗肥滿用飮 食品有關。最近,日本人之食生活顯著歐美化而高熱量化 。其結果招來現代人所謂之文明病的肥滿現象,以致糖尿 病、高血壓症、心血管障礙症、高脂血症、動脈硬化等各 疾病之罹患率提升,成爲威脅國民健康之嚴重的社會問題 。另外,最近之日本人,特別是女性由於美感之意識形態 要求細瘦苗條之願望非常高。肥滿乃係攝取熱量高過消費 熱量,造成脂肪組織異於平常而蓄積之一種身體狀態。脂 肪組織係將身體內過剩熱量以脂肪蓄積之器官,由脂肪細 胞或其前驅細胞,巨噬細胞,血管周邊細胞,血液細胞等 所構成。脂肪細胞係由其前驅細胞受到攝取食物或運動等 環境因子所衍生很多因子而分化(分化誘導)成爲成熟型脂 肪細胞(成熟脂肪細胞),在細胞內能蓄積脂肪之細胞。 另外,也已知前驅型脂肪細胞(即脂肪前驅細胞)或脂 肪細胞本身經重複細胞分裂而增加其細胞數目(參考杉 原等人;別冊,醫學之進展,脂肪細胞,基礎與臨床, 7〜12頁,1 999年)。脂肪組織增大之主因分別有由脂肪細 胞大小增大(即肥大性肥滿),脂肪細胞數目增加(即形 成性過大肥滿),或上述二者之增加所造成(即肥大性, 形成性過大肥滿)。肥大性肥滿乃一般所謂中年肥滿而 常見於中年以後之肥胖者,形成性過大肥滿乃多見於從幼 小時就肥胖者。特別是後者之形成性過大肥滿者因成長 期肥胖,所以脂肪細胞數目增加2〜3倍成爲其主要原因, 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -5- 200300069 A7 B7 五、發明説明(2) (請先閲讀背面之注意事項再填寫本頁) 這種增加之脂肪細胞變成成人以後,體重減少時脂肪細胞 也會變小,但是脂肪細胞數目不會減少,所以稍爲過食就 由於脂肪細胞數目多,脂肪就容易蓄積而成爲易肥滿體質 之原因。 因此,針對肥滿之對策或減肥等方法,到現在爲止雖 然有各種提案,但環視現狀,僅有抽脂術等基於外科處理 方法真正可獲令人滿意之結果。然而,這種外科處理方法 使用在人體或動物體上不能說是沒有危險性的侵襲性手術, 何況,施術費用昂貴顯然有其缺點。 經濟部智慧財產局g(工消費合作社印¾ 一方面,五環性三萜烯類乃係由6個異戊二烯單位所形 成五環性構造之化合物,通常以碳數30個爲其基本構造, 但是在生含成過程中由於轉移,氧化,脫離或烷化而碳數 有增減者也包括其中。其功能已知者大槪有抗炎症功會g, 抗致癌啓動子功能#(參考日本油化學會議,49,571,2000 年)。然而五環性三萜烯類和其生理上容許之鹽類或其 衍生物,過去完全不知具有前驅型脂肪細胞增殖抑制功能 (脂肪前驅細胞增殖抑制功能),前驅型脂肪細胞分化抑 制功能(脂肪前驅細胞分化誘導功能),成熟型脂肪細胞 脂肪蓄積抑制功能(脂肪前驅細胞成熟抑制功能)等抗 肥滿功能,而且這些功效藉經口攝取該五環性三萜烯類和 其生理上容許之鹽類或其衍生物就能充分表現。 發明之揭示 本發明之目的在提供以肥大性肥滿,形成性過大肥滿 本纸張尺度適用中國國家標準(CN’S ) A4規格(210父297公釐1 " -6- 200300069 A7 B7 五、發明説明(3) (請先閲讀背面之注意事項再填寫本頁) ,肥大性,形成性過大肥滿等肥滿症之預防和/或改善用 途,以及爲必要之減肥或造成不易肥滿之體質用途上具有 繼續性且簡便而效果非常優異之抗肥滿用飮食品。 本發明者爲達成上述目的而努力硏究結果,發現五環 性三萜烯類和其生理上容許之鹽或其衍生物具有前驅型 脂肪細胞增殖抑制功能,前驅型脂肪細胞抑制功能,成熟 型脂肪細胞脂肪蓄積抑制功能等對於肥滿之改善具有優 異之功能,以及藉經口攝取該五環性三萜烯類和其生理上 容許之鹽類或其衍生物能充分達成其功能而完成了本發 明。 換言之,本發明乃含有由五環性三萜烯類和其生理上 容許之鹽類或其衍生物所構成群中選擇1種或2種以上之 抗肥滿用飮食品有關者。固其形態屬飮食品,所以能容易 且繼續攝取,其結果可期望優異地抗肥滿功能。 經濟部智慈財產局肖工消費合作社印¾ 另外,本發明也是含有由五環性三萜烯類和其生理上 容許之鹽類或其衍生物所構成群中選擇1種或2種以上之 做爲前驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化 抑制成分,成熟型脂肪細胞脂肪蓄積抑制成分之抗肥滿用 飮食品有關。固其形態屬於飮食品,所以能容易且繼續攝 取,其結果可期得優異地前驅型脂肪細胞增殖抑制效果, 前驅型脂肪細胞分代抑制效果和成熟型脂肪細胞脂肪蓄積 抑制效果。 又,本發明也是上述五環性三萜烯類係由齊墩果烷系 三萜烯類,熊果烷系三萜烯類和羽扇烷系三萜烯類中選擇1 本&張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐j " 200300069 A7 B7__ 五、發明説明(4) (請先閱讀背面之注意事項再填寫本頁) 種或2種以上之抗肥滿性飮食品有關。上述齊墩果烷系三萜 烯類以山楂酸和/或古柯二醇爲佳,尤以山楂酸爲更佳。熊 果烷系三萜烯類以熊果酸和/或熊果醇爲佳,羽扇烷系三萜 烯類以樺木酸和/或樺木醇爲佳。 本發明中之該五環性三萜烯類和其生理上容許之鹽類 或其衍生物,無論來源於天然或人工合成皆可適用,但考 本發明爲飮食品之一,以自天然原料中萃取者爲宜,其濃 縮和/或分離,精製者亦佳,尤以分離,精製者爲更佳。 本發明係含洋橄欖植物之脫脂物,洋橄欖萃取物或洋 橄欖萃取油爲有效成分之抗肥滿性飮食品有關。其中,洋 橄欖植萃取物係洋橄欖油製造工程所得脫脂物以水和/或 有機溶劑萃取而得之萃取物爲宜。 經濟部智慧財產局工消費合作社印¾ 山楂酸和/或其生理上容許之鹽類以由洋橄欖,啤酒 花,薄荷,石榴,丁香,鼠尾草或棗子等所取得者爲佳, 特別是將洋橄欖植物和/或洋橄欖油製造工程所得副產物 用水和/或有機溶劑萃取處理,再經濃縮處理和/或分離, 精製處理而得者爲佳,尤其以分離精製者爲最佳。這時候 ,考慮本發明爲飮食品時,萃取處理時所用有機溶劑以親 水性有機溶劑爲佳,其中以醇類爲更佳,尤以乙醇爲最佳 °特別是洋橄欖植物所得山渣酸和/或其生理上容許之鹽 類,本身屬天然物,後價格,製造效率等而觀,皆非常有 利。 本發明之抗肥滿用飮食品之形態,例如糖菓,加工食 品,油脂類,調味料,乳製品,飮料等,其形狀,性狀並 本纸張尺度適财賴家料(CNS )从秘(21()><297公董) " -8- 200300069 A7 _ B7 五、發明説明(5) 無特別限制,可任意爲固體狀,半固體狀,凝膠狀,液狀 ,粉狀等,又,錠劑,膠囊劑,液劑,顆粒劑等任意劑型 均可採用。 上述五環性三萜烯類和/或其特定衍生物通常爲油溶 性,因此,本發明之抗肥滿用飮食品以油脂和/或油脂加 工品爲最佳形態。更以該油脂和/或油脂加工品做爲原料 而使用,或炸或炒而成飮食品爲佳。又,本發明之抗肥滿 用飮食品也可爲飮料等之水系飮料。特別是將五環性三 萜烯類之一部分或全部做成其生理上容許之鹽類和/或其 特定衍生物可使該油溶性之五環性三萜烯類成爲水溶性 而利用。 又,本發明也有關於含有五環性三萜烯類和其生理上 容許之鹽類或其衍生物所構成群中選擇1種或2種以上之 抗肥大性肥滿用和/或抗形成過大肥滿用飮食品者。 又,本發明也含有由五環性三萜烯類和其生理上容許 之鹽或其衍生物所構成群中選擇1種或2種以上之預防肥滿 和/或治療肥滿用飮食品有關。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽或其衍生物所構成群中選擇1種或2種以上之減肥用飮 食品有關。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽或其衍生物所構成群中選擇1種或2種以上之不易肥滿 體質改善用飮食品有關。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) π裝. 訂 經濟砵智慧財產局a(工消货合作社印^ -9 - 200300069 A7 B7 五、發明説明(6) ^施本發明之最佳形態 (請先閲讀背面之注意事項再填寫本頁) 本發明乃含有五環性三萜烯類和其生理上容許之鹽 類或其衍生物中選擇1種或2種以上而成抗肥滿用飮食品有 關。本發明屬於飮食品形態,因此,可以方便且繼續攝取 而期待得優異之抗肥滿功能。該五環性三萜烯類乃指由6 個異戊二烯單位所構成三萜烯類中具備五環性之化合物, 自然界中存在於各種植物中而存在很多之物質群。這些 物質可從天然植物體中萃取而得,其中有若干已由人工合 成而供試藥等市販,皆可提供本發明用途。 經濟部智慧財產局員工消費合作社印¾ 含有上述物質乃指含有能發揮抗肥滿功能等水準之意 ,但其含量並無特別限制,隨所含有五環性三萜烯類之種 類,飮食品之種類,攝取量,攝取頻率,年齡,性別,體 重,症狀輕重,健康狀態等而可適度調整之。例如該含量 在0.00001〜9 0質量%範圍,其中以0.0 001〜80質量。/。爲適宜, 以0.001〜70質量%爲較佳,又以0.01~65質量%爲更佳,更以 0.1〜60質量%爲較佳,更以0.2〜55質量%爲較佳,更以0.4〜50 質量%爲較佳,更以0.6〜45質量%爲較佳,更以0.8〜40質 量%爲較佳,更以1.0〜35質量%爲較佳,更以2.0〜30質量% 爲較佳,但不侷限在上述範圍。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽類,其其衍生物中所選擇1種或2種以上做爲前驅型脂肪 細胞增殖抑制成分,前驅型脂肪細胞分化抑制成分,成熟 型脂肪細胞脂肪蓄積抑制成分而成抗肥滿用飮食品有關。 上述做爲前驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞 本紙乐尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -10- 200300069 A7 B7 五、發明説明(7) (請先閲讀背面之注意事項再填寫本頁) 分化抑制成分,成熟型脂肪細胞脂肪蓄積抑制成分而含有 乃指可以發揮該前驅型脂肪細胞增殖抑制功能,前驅型脂 肪細胞分化抑制功能,成熟型脂肪細胞脂肪蓄積抑制功能 等水準而含有之意,其含量並無特別限制,隨所含有五環 性三萜烯類之種類,飮食品之種類,攝取量,攝取頻率,年 齡,性別,體重,症狀輕重,健康狀態等而適度調整之。其 含量例如在0.0001〜90質量%範圍,其中以0.0001〜80質量 %爲宜,以0.001〜70質量%爲較佳,又以〇.〇1〜65質量%爲 更佳,更以0.1〜60質量%爲較佳,更以0.2〜55質量%爲較 佳,更以0.4〜50質量%爲較佳,更以0.6〜45質量%爲較佳, 更以0.8〜40質量%爲較佳,更以1.0〜35質量%爲較佳,更 以2.0〜30質量%爲較佳,但不侷限在上述範圍。 具有前驅型脂肪細胞增殖抑制功能,前驅型脂肪細胞 分化抑制功能,成熟型脂肪細胞脂肪蓄積抑制功能者,上 述五環性三萜烯類中,以齊墩果烷系三萜烯類,熊果烷系 三萜烯類,羽扇烷系三萜烯類爲較佳,本發明乃含有由上 述選擇1種或2種以上而成抗肥滿用飮食品有關者。 經濟部智慧財產局員工消費合作fi印¾ 上述齊墩果烷系三萜烯類以山楂酸和/或古柯二醇爲 較佳,尤以山楂酸爲最佳。熊果烷系三萜烯類以熊果酸和 /或熊果醇爲較佳。羽扇烷系三萜烯類以樺木酸和/或樺木 醇爲較佳。 上述化合物具有前驅型脂肪細胞增殖抑制功能,前驅 型脂肪細胞分化抑制功能,成熟型脂肪細胞脂肪蓄積抑制 功能之抗肥滿功能,該功能可藉培養細胞試驗法而評估之 本紙張尺度適用中國國家樣準(CNS ) A4現格(210X297公釐) -11- 200300069 A7 _ _B7_ 五、發明説明(8) (請先閲讀背面之注意事項再填寫本頁) 。依據該評估方法,和其有強力抗肥滿功能之已知物質之 共軛性亞油酸 (CLA)比較結果,可知具有2〜60倍之抗肥 滿功能。又,就繼續攝取之功能而言,藉動物實驗經口攝 取時,也發現充分表現其抗肥滿功能。 本發明中之五環性三萜烯類和其生理上容許之鹽類或 其衍生物可由自然界而獲得,也能由人工合成而得,二者 皆可適用,但考慮本發明係屬於飮食品之形態而言,以由 自然界之原料萃取爲宜,其中以濃縮和/或分離,精製者 爲更佳,尤以分離,精製者爲最佳。 經濟部智慈財產局資工消費合作社印¾ 山楂酸和/或其生理上容許之鹽類,以由洋橄欖,啤 酒花,石榴,丁香,鼠尾草或棗子而取得者爲佳,其中以 由洋橄欖植物和/或洋橄欖油製造工程所得副產物中用水 和/或有機溶劑萃取處理,再加濃縮處理和/或分離,精製 處理而得者更佳,尤以分離精製者最佳。該情況下,考慮 本發明係屬於飮食品之形態而言,上述萃取處理所使用有 機溶劑以親水性有機溶劑爲佳,其中以醇類爲更佳,尤以 乙醇爲最佳。特別是由洋橄欖植物所得山楂酸和/或其生 理上容許之鹽類,因爲屬於天然物質,就價格,製造效率 等而觀,尤其最佳。 本發明中之飮食品之形態,已如前述,例如糖栗,加 工食品,油脂類,調味料,乳製品,飮料等之各種飮食品 皆包括在內,其形狀,性狀並無特別限制,可任意爲固體 狀,半固體狀,凝膠狀,液狀,粉狀等,又,可爲錠劑,膠 囊劑,液劑,顆粒劑等任意劑型。本發明之抗肥滿用飮食 ^紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -12- 200300069 A7 B7 五、發明説明(9) (請先閲讀背面之注意事項再填寫本頁) 品,因爲上述五環性三萜烯類和/或其特定衍生物多屬油 溶性,因此,飮食品爲油脂和/或油脂加工品時,可謂係 最佳形態。例如含高量山楂酸油脂等,但非侷限在該例舉 範圍。另外,將該油脂和/或油脂加工品做爲原料使用, 或藉炸或炒製而得飮食品爲更佳。 又,本發明之抗肥滿用飮食品也可爲飮料等水系飮食 品。特別是將五環性三萜烯類之一部分或全部做成其生 理上容許之鹽和/或其特定衍生物狀態,可使本來係多爲 油溶性之五環性三萜烯類提升其水溶性而適用於水系飮 食品用途。調配本來爲油溶性之山楂酸之生理上容許之 鹽類或衍生物之水系飮食品可爲其例舉,但非侷限在本例 舉範圍。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽類或其衍生物所構成群中選擇1種或2種以上而成抗肥大 性肥滿用和/或抗形成過大性肥滿用飮食品有關。 經濟部智慧財產局,h工消費合作社印^ •又,本發明也含有五環性三萜烯類和其生理上容許之 鹽類或其衍生物所構成群中選擇1種或2種以上而成預防 肥滿和/或治療肥滿用飮食品有關。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽類或其衍生物所構成群中選擇之1種或2種以上而成之 減肥用飮食品有關。 又,本發明也含有五環性三萜烯類和其生理上容許之 鹽類或其衍生物所構成群中選擇之1或2種以上而成之不 易肥滿體質改善用飮食品有關。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) -13- 200300069 A7 B7 五、發明説明(β 本發明之抗肥滿用飮食品具有前驅型脂肪細胞增殖抑 制功能,前驅型脂肪細胞分化抑制功能,成熟型脂肪細胞 脂肪蓄積抑制功能等抗肥滿功能,可提供預防肥滿和/或治 療用途,或減肥和/或不易肥滿體質改善用途使用。上述預 防肥滿爲目的之用途,指提供抑制前驅型脂肪細胞之增殖 或成熟型脂肪細胞之分化或脂肪蓄積,使不再產生由新脂 肪細胞所構成脂肪組織而使用之用途。又,治療肥滿爲目 的之用途,乃指抑制更多前驅型脂肪細胞之增殖,或抑制 過多增生之前驅型脂肪細胞分化成爲成熟型脂肪細胞,藉 抑制已接到分化指令之前驅型脂肪細胞分化成爲成熟型脂 肪細胞脂肪,使過多增生之脂肪細胞或其前驅細胞數目減 少,而減少脂肪組織量而使用之用途。其結果,可抑制和/ 或減少皮下脂肪或內臟脂肪蓄積,而預防和/或治療肥滿。 又,減肥爲目的之用途,指減少過多增生之脂肪細胞或其 前驅細胞之數目,而減少脂肪組織量而使用之用途。又, 不易肥滿體質改善用之用途,乃指抑制成長期中之形成過 大性肥滿而使用之用途。 本發明係有關含有一種或二種以上五環性三萜烯類和 其生理上容許之鹽,或此等之衍生物所成群中選擇之抗肥 滿用飮食物,在此五環性三萜烯類係通常爲一種三萜烯類 ,由6個異戊二烯所成五環性化合物,基本上係30個碳數, 惟亦包含在生合成步驟中被轉移,氧化,脫離或烷基化而 碳數會增減者。本發明之抗肥滿用飮食物中,五環性三萜 烯類亦包含上述五環性三萜烯類,此等之生理上容許之鹽 本纸張尺度適用中國國家慄準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 一裝·200300069 A7 B7 V. Description of the invention (j) Background of the invention (please read the notes on the back before filling out this page) Printed by Xiao Gong Consumer Cooperative, Bureau of Intellectual Property, Ministry of Economic Affairs Anti-fullness is related to coriander food. Recently, the Japanese people ’s food life has become significantly higher in Europe and the United States. As a result, the so-called overcrowding phenomenon of civilization disease caused by modern people has led to an increase in the incidence of various diseases such as diabetes, hypertension, cardiovascular disease, hyperlipidemia, and arteriosclerosis, which has become a serious society threatening national health problem. In addition, recently Japanese people, especially women, have a high desire for thinness and slimness due to the aesthetic ideology. Obesity is a physical condition in which the intake of calories is higher than the calories consumed, causing fat tissue to accumulate differently than usual. Adipose tissue is an organ that accumulates excess heat in the body as fat. It is composed of fat cells or their precursor cells, macrophages, peripheral blood vessels, blood cells, and so on. Adipocytes are differentiated (differentiation induced) from their precursor cells by ingestion of many factors derived from environmental factors such as food or exercise into mature adipocytes (mature adipocytes), cells that can accumulate fat in cells. In addition, it is also known that precursor adipocytes (ie, adipocyte precursor cells) or the adipocytes themselves increase their number of cells by repeated cell division (see Sugihara et al .; separate volume, advances in medicine, adipocytes, basic and clinical, 7-12 P. 1,999). The main reasons for the increase in adipose tissue are the increase in the size of adipocytes (ie, hypertrophic hypertrophy), the increase in the number of adipocytes (ie, hypertrophic hypertrophy), or the increase of the two (ie, hypertrophy, formativeness). Too big plump). Hypertrophic obesity is usually called middle-aged obesity and is usually seen in obese people after middle age. Formal hypertrophy is more common in obese people from an early age. In particular, the latter who are over-formed and obese are obese during growth, so the increase in the number of fat cells by 2 to 3 times is the main reason. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -5- 200300069 A7 B7 V. Description of the invention (2) (Please read the notes on the back before filling out this page) After this increased fat cells become adults, the fat cells will become smaller when they lose weight, but the number of fat cells will not decrease. Therefore, a little overeating will cause the fat to accumulate easily due to the large number of fat cells, which will cause the body to become full. Therefore, although there have been various proposals for measures such as measures for obesity and weight loss, but looking at the current situation, only surgical methods such as liposuction can really achieve satisfactory results. However, the use of this surgical treatment method on human or animal body cannot be said to be a non-dangerous invasive operation. Moreover, the cost of the operation is obviously disadvantageous. On the one hand, pentacyclic triterpenes are compounds of pentacyclic structure formed by 6 isoprene units, usually with 30 carbons as the basic Structure, but the carbon number is increased or decreased due to metastasis, oxidation, detachment or alkylation during the process of biogenic formation. Those whose functions are known have anti-inflammatory function, anti-oncogenic promoter function # ( (Refer to the Japan Oil Chemistry Conference, 49, 571, 2000). However, pentacyclic triterpenes and their physiologically acceptable salts or their derivatives have been completely unknown in the past as having a precursor-type adipocyte proliferation inhibitory function (adipocytes) Antiproliferative function), precursor type adipocyte differentiation inhibition function (adipocyte differentiation induction function), mature adipocyte fat accumulation inhibition function (adipocyte maturation inhibition function) and other anti-fullness functions, and these effects are taken orally The pentacyclic triterpenes and their physiologically acceptable salts or their derivatives can be fully expressed. DISCLOSURE OF THE INVENTION The object of the present invention is to provide a hypertrophic, plump, and shaped The size of the paper that is too big and full is applicable to the Chinese National Standard (CN'S) A4 specification (210 father 297 mm 1 " -6- 200300069 A7 B7 V. Invention Description (3) (Please read the notes on the back before filling (This page), preventive and / or ameliorating hypertrophy, such as hypertrophy, hypertrophy, etc., and anti-fertility that is continuous, simple, and very effective for the purpose of reducing weight or making it difficult for obesity. Foods full of coriander. The present inventors worked hard to achieve the above-mentioned object and found out that pentacyclic triterpenes and their physiologically acceptable salts or derivatives thereof have a precursor-type adipocyte proliferation inhibiting function, a precursor-type adipocyte Inhibition function, mature fat cell fat accumulation inhibition function, etc. have excellent functions for improving plumpness, and oral penetrating of the pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof can be fully achieved In other words, the present invention contains one or two selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. Those who are related to anti-fatness are related to glutinous food. Since its form belongs to glutinous food, it can be easily and continuously ingested. As a result, excellent anti-fullness function can be expected. Printed by Xiao Gong Consumer Cooperative, Intellectual Property Bureau, Ministry of Economic Affairs ¾ In addition, The present invention also contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof as a precursor type fat cell proliferation inhibitory component, and precursor type fat cells Differentiation-inhibiting ingredients, mature fat cell fat accumulation inhibiting ingredients are related to anti-plump foods. Because their form belongs to foods, they can be easily and continuously ingested. As a result, they can be expected to have an excellent effect of inhibiting the proliferation of precursor adipocytes. The progenitor-type adipocyte generation inhibition effect and the mature-type adipocyte accumulation inhibition effect. In addition, the present invention is also the above-mentioned pentacyclic triterpene system consisting of oleanole-based triterpene and ursane-based triterpene 1 and 3 of the lupinane triterpenes are selected from the & Zhang scale applicable to the Chinese National Standard (CNS) A4 specifications (210X 297 mm j " 200300069 A7 B7__ V. The invention (4) (Please read the precautions on the back before filling out this page). The oleanolic triterpenes are preferably maslinic acid and / or cocadiol, and more particularly maslinic acid. Ursolic triterpenes are preferably ursolic acid and / or ursitol, and lupines triterpenes are betulinic acid and / or betulin. The pentacyclic triterpenes and their physiologically acceptable salts or their derivatives in the present invention can be applied regardless of whether they are derived from natural or artificial synthesis. The medium extraction is suitable, and the concentration and / or separation is also preferable, and the refinement is also preferable, especially the separation, and the refinement is more preferable. The present invention relates to a fat-reducing food containing an olive oil plant defatted product, an olive oil extract or an olive oil extract as an effective ingredient. Among them, the olive oil plant extract is preferably an extract obtained by extracting the defatted product obtained from the olive oil manufacturing process with water and / or an organic solvent. Printed by the Industrial and Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ Hawthorn acid and / or physiologically acceptable salts thereof are preferably obtained from olives, hops, mint, pomegranate, cloves, sage or dates. The byproducts of olive olive plants and / or olive oil manufacturing processes are extracted and treated with water and / or organic solvents, and then concentrated and / or separated, and refined, preferably those obtained by isolation and purification. At this time, when the present invention is a glutinous food, the organic solvent used in the extraction treatment is preferably a hydrophilic organic solvent, of which alcohols are more preferred, and ethanol is particularly preferred. Especially the slag acid and / Or its physiologically acceptable salts are natural in nature, and are very advantageous in terms of post-price and manufacturing efficiency. The form of the anti-fattiness foods for use in the present invention, such as candy, processed foods, oils and fats, seasonings, dairy products, foods, etc., whose shape and properties are in accordance with the paper standard and suitable for household materials (CNS). 21 () > < 297 public directors " -8- 200300069 A7 _ B7 V. Description of the invention (5) There is no particular limitation, and it can be any of solid, semi-solid, gel, liquid, and powder Etc. Also, any dosage form such as lozenge, capsule, liquid, granule can be used. The aforementioned pentacyclic triterpenes and / or specific derivatives thereof are generally oil-soluble. Therefore, the fat-repellent food product of the present invention is preferably in the form of fats and oils and / or processed oils. It is more preferable to use the fat and / or processed fat product as a raw material, or to deep-fry or stir-fry ravioli. In addition, the fermented food for preventing fullness of the present invention may be a water-based fermented material such as a fermented material. In particular, part or all of the pentacyclic triterpenes are made into physiologically acceptable salts and / or specific derivatives thereof, and the oil-soluble pentacyclic triterpenes can be used as water-soluble. In addition, the present invention also relates to a group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof, in which one or two or more are selected for anti-hypertrophy and / or excessive formation. Those who use plump food. In addition, the present invention also contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof, for preventing obesity and / or treating obesity foods for obesity. . In addition, the present invention also contains pentacyclic triterpenes, and one or two or more weight loss foods selected from the group consisting of physiologically acceptable salts or derivatives thereof. In addition, the present invention also contains pentacyclic triterpenes and a physiologically acceptable salt or a derivative thereof, which is selected from one or two or more types of non-fertile foods for improving physical fitness. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling out this page) π Pack. Order for Economics and Intellectual Property Bureau a (Industrial Consumer Goods Cooperatives ^ -9- 200300069 A7 B7 V. Description of the invention (6) ^ Apply the best form of the invention (please read the notes on the back before filling this page) The invention contains pentacyclic triterpenes and their physiologically acceptable salts One or two or more of these derivatives are selected to form an anti-fattiness glutinous food. The present invention belongs to the form of glutinous food, so it can be conveniently and continuously ingested with excellent anti-fullness function. The pentacyclic property Triterpenes refer to pentacyclic compounds in triterpenes composed of 6 isoprene units. They exist in various plants in nature and there are many substance groups. These substances can be obtained from natural plants. Extracted, some of which have been artificially synthesized for testing and other marketers can provide the invention. Printed by the Consumers' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ Containing the above substances means containing water that can exert anti-fullness functions, etc. Meaning, but its content is not particularly limited, and may be moderate depending on the type of pentacyclic triterpene, the type of food, intake, frequency, age, gender, weight, severity of symptoms, health status, etc. Adjust it. For example, the content is in the range of 0.00001 to 90% by mass, of which 0.0001 to 80% by mass. / Is suitable, preferably 0.001 to 70% by mass, and more preferably 0.01 to 65% by mass, more It is preferably 0.1 to 60% by mass, more preferably 0.2 to 55% by mass, more preferably 0.4 to 50% by mass, still more preferably 0.6 to 45% by mass, and still more preferably 0.8 to 40% by mass. More preferably, it is more preferably 1.0 to 35% by mass, and more preferably 2.0 to 30% by mass, but it is not limited to the above range. In addition, the present invention also contains pentacyclic triterpenes and their physiology. For permissible salts, one or two or more of its derivatives are selected as precursor-type adipocyte proliferation inhibiting ingredients, precursor-type adipocyte differentiation inhibiting ingredients, and mature adipocyte fat accumulation inhibiting ingredients for anti-puffiness.飮 Food related. The above as a precursor type of fat cell proliferation Inhibitory ingredients, precursor type fat cells. Paper scale is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) -10- 200300069 A7 B7 V. Description of invention (7) (Please read the precautions on the back before filling this page) The inclusion of differentiation inhibiting components and mature fat cell fat accumulation inhibiting components means that they can exert the precursor adipocyte proliferation inhibiting function, precursor adipocyte differentiation inhibiting function, and mature adipocyte fat accumulating inhibiting functions. Its content is not particularly limited, and it is appropriately adjusted according to the type of pentacyclic triterpene contained, the type of food, intake, frequency, age, gender, weight, severity of symptoms, and health status. Its content is, for example, in the range of 0.0001 to 90% by mass, of which 0.0001 to 80% by mass is preferable, 0.001 to 70% by mass is more preferable, and 0.001 to 65% by mass is more preferable, and 0.1 to 60% is more preferable. Mass% is better, more preferably 0.2 to 55 mass%, more preferably 0.4 to 50 mass%, still more preferably 0.6 to 45 mass%, and still more preferably 0.8 to 40 mass%, It is more preferably 1.0 to 35% by mass, and more preferably 2.0 to 30% by mass, but is not limited to the above range. Those with a precursor-type adipocyte proliferation inhibition function, a precursor-type adipocyte differentiation inhibition function, and a mature adipocyte fat accumulation inhibition function. Among the pentacyclic triterpenes, oleanolane-type triterpenes and bear fruit Alkane triterpenes and lupinane triterpenes are more preferred, and the present invention contains those selected from the above-mentioned selection of one or two or more kinds of anti-fertility foods. Consumption cooperation between employees of the Intellectual Property Bureau of the Ministry of Economic Affairs and Fibonacci ¾ The oleanolic triterpenes are preferably maslinic acid and / or cocadiol, especially maslinic acid. Ursolic acid triterpenes are preferably ursolic acid and / or arsanol. Lupinic triterpenes are preferably betulinic acid and / or betulin. The above compounds have a function of inhibiting proliferative adipocyte proliferation, inhibiting proliferative adipocyte differentiation, and inhibiting fat accumulation in mature adipocytes. This function can be evaluated by the culture cell test method. This paper is applicable to China. Sample standard (CNS) A4 is now (210X297 mm) -11- 200300069 A7 _ _B7_ V. Description of the invention (8) (Please read the precautions on the back before filling this page). According to this evaluation method, compared with the conjugated linoleic acid (CLA) of a known substance that has a strong anti-fullness function, it is known that it has an anti-fullness function of 2 to 60 times. As for the function of continuous ingestion, it was also found that when it was taken orally through animal experiments, it fully exhibited its anti-puffiness function. The pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof in the present invention can be obtained from nature, or can be artificially synthesized, both of which are applicable, but it is considered that the present invention belongs to coriander food In terms of form, it is preferable to extract from natural raw materials. Among them, it is better to concentrate and / or separate, and the refiner is the best, especially to isolate and refine. Printed by the Industrial and Commercial Consumer Cooperative of the Intellectual Property Office of the Ministry of Economic Affairs ¾ Hawthorn acid and / or physiologically acceptable salts thereof are preferably obtained from olive, hops, pomegranate, clove, sage or date The olive oil plant and / or the olive oil manufacturing process by-products obtained from the by-products are subjected to extraction treatment with water and / or organic solvents, followed by concentration treatment and / or separation, and refinement treatment is better, especially separation and purification is the best. In this case, considering that the present invention belongs to the form of glutinous food, the organic solvent used in the extraction treatment is preferably a hydrophilic organic solvent, among which alcohols are more preferred, and ethanol is particularly preferred. In particular, maslinic acid and / or physiologically acceptable salts thereof obtained from olive olive plants are natural substances, and are particularly preferable in terms of price, manufacturing efficiency, and the like. The form of the loquat food in the present invention is as described above. For example, various loquat foods such as sugar chestnuts, processed foods, oils, seasonings, dairy products, and seasonings are all included. There is no particular limitation on the shape and properties of the products. It can be solid, semi-solid, gel, liquid, powder, etc., and can be any dosage form such as lozenge, capsule, liquid, granule. The paper size for anti-fattiness for the present invention ^ The paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 mm) -12- 200300069 A7 B7 V. Description of the invention (9) (Please read the precautions on the back before filling in this Page), because the pentacyclic triterpenes and / or their specific derivatives are mostly oil-soluble. Therefore, when 飮 foods are fats and / or processed fats and oils, they can be said to be in the best form. For example, it contains high amounts of maslinic acid oil, but it is not limited to this exemplified range. In addition, it is more preferable to use the fat and / or processed fat product as a raw material, or to obtain food by frying or frying. In addition, the fermented foods for preventing fullness of the present invention may be water-based foods such as foods. In particular, making one or all of the pentacyclic triterpenes into a physiologically acceptable salt and / or a specific derivative thereof can make the pentacyclic triterpenes, which are mostly oil-soluble, enhance their water solubility. It is suitable for water and food applications. The water-based food prepared by blending physiologically acceptable salts or derivatives of oil-soluble maslinic acid can be exemplified, but is not limited to the scope of this exemplification. In addition, the present invention also contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof for anti-hypertrophy and / or excessive formation resistance Sexual obesity is related to coriander food. Bureau of Intellectual Property, Ministry of Economic Affairs, Industrial and Commercial Cooperative Cooperative Associations ^ • In addition, the present invention also contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. It may be related to preventing plumpness and / or treating plump foods. The present invention also relates to a diet food for weight loss which contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. In addition, the present invention also relates to a non-fatness-impairing coriander food product comprising one or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. This paper size applies Chinese National Standard (CNS) A4 specification (210X29 * 7 mm) -13- 200300069 A7 B7 V. Description of the invention (β The anti-fat food for use in the invention has a precursor fat cell proliferation inhibition function, Anti-fatty functions such as pro-lipid cell differentiation inhibition function, mature adipocyte fat accumulation inhibition function, etc., can be used to prevent obesity and / or therapeutic use, or to reduce weight and / or improve physical fitness. The purpose of the purpose is to provide the purpose of inhibiting the proliferation of precursor adipocytes or the differentiation or fat accumulation of mature adipocytes, so that the adipose tissue composed of new adipocytes is no longer produced and used. The purpose is to treat hypertrophy Use refers to inhibiting the proliferation of more precursor-type adipocytes, or inhibiting the differentiation of pre-adipocytes into mature adipocytes before excessive proliferation, and by inhibiting the differentiation of pre-adipocytes into mature adipocyte fat before receiving differentiation instructions, Used for reducing the number of hyperproliferative adipocytes or their precursor cells, and reducing the amount of adipose tissue As a result, it can inhibit and / or reduce the accumulation of subcutaneous fat or visceral fat, and prevent and / or treat fullness. Moreover, the purpose of weight loss refers to reducing the number of hyperproliferative fat cells or their precursor cells, and reducing The use of the amount of adipose tissue. In addition, the use for improving the body is not easy to use, refers to the use of inhibiting the formation of excessive hypertrophy in the growth period and use. The present invention relates to containing one or two or more pentacyclic triterpenes Pentenes and their physiologically acceptable salts, or anti-plump foods selected from the group of these derivatives, the pentacyclic triterpenes are usually a triterpene, consisting of 6 The pentacyclic compound formed by isoprene basically has 30 carbon numbers, but also includes those that are transferred, oxidized, detached, or alkylated during the biosynthesis step, and the carbon number will increase or decrease. The fertilizer of the present invention Pentacyclic triterpenes also include the pentacyclic triterpenes mentioned above in full-boiled foods. The physiologically acceptable salts of this paper are in accordance with China National Chestnut Standard (CNS) A4 (210X297 mm). ) (Please read the note on the back first Please fill in this page for more details)

、1T 經濟部智慧財產局ϊ貝工消黃合作社印^ -14- 200300069 A7 _ B7, 1T Printed by the Co-op Workers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ^ -14- 200300069 A7 _ B7

五、發明説明(U (請先閱讀背面之注意事項再填寫本頁) 及/或此等之羥基或羧基被取代之衍生物,又,此等之來 源並無特別限制,可爲自天然所得者,人工被合成者,市 販品等任一均可使用,通常考慮其應用於飮食物時,本發 明中係以使用天然物爲宜。 五環性三萜烯類係通常依其架構予以分類。本發明 中之五環性三萜烯類可爲例如齊墩果烷系三萜烯類,熊果 烷系三萜烯類,羽扇烷系三萜烯類,何帕烷系三萜烯類, 櫻膠烷系三萜烯類,軟木烷系三萜烯類,蒲公英賽烷系三 IS焴類,蒲公英黃院三路烧類,multifloran系三te儲類, Jarmanican系三絕燒類等。 經濟部智慈財產局貨工消費合作社印紫 在此所稱生理上可被容許之鹽係特別爲自五環性三 萜烯酸之羧基所衍生之鹽(部份構造:-C00X; X係任意 之陽離子性物質),本發明中還可包含自天然物之單離物 中原來已包含之物。本發明中係只要爲一般飮食物所用 之鹽即不予特別限制,例如可爲鈉,鉀,鋰等鹼金屬鹽, 鈣,鎂,鋇,鋅等鹼土類金屬鹽,氨,甲胺,二甲胺,三 甲胺,乙胺,二乙胺,三乙胺,丙胺,丁胺,四丁胺,戊 胺,己胺等烷基胺鹽,乙醇胺,三乙醇胺,丙醇胺,二丙 醇胺,異丙醇胺,二異丙醇胺等烷醇胺鹽,六氫吡啡,六 氫吡啶等其他之有機胺鹽,賴胺酸,精胺酸,組織胺酸, 色胺酸等鹼性胺基酸鹽等鹽。此等中以鹼金屬鹽,烷基胺 鹽,烷醇胺鹽及鹼式胺基酸鹽爲宜。此等鹽類通常比其原 來之五環性三萜烯類,有更佳之水溶性,所以本發明中尤 其適用於水系之飮食物爲宜。 本紙張尺度適用中國國家樣準(CNS ) Μ坑格(210X297公釐) " -15- 200300069 A7 B7 五、發明説明(j 又,做爲衍生物係指生化學上,或人工可形成之衍生 物而言,本發明中係只要可爲衍生物者即不必特別限制, 例如可爲具有醇酯基之衍生物,具有脂肪酯基之衍生物, 具有烷氧基之衍生物,具有烷氧甲基之衍生物,或糖苷等 。此等尤其具有醇酯基之衍生物,具有脂肪酸酯之衍生物 ,具有烷氧基衍生物,具有烷氧甲基之衍生物係比其原有 之五環性三萜烯類具有更佳之脂溶性,本發明尤其更適於 用在油系之飮食物,又,糖苷係比原來之五環性三萜烯類 有更佳之水溶性,在本發明中尤其最適宜用在水系之飮食 物。 此等衍生物係一部分存在於天然,又可人工地形成。 又可再次衍生化本發明之衍生物,使用此等之鹽。 如上述,使五環性三萜烯類成爲生理上被容許之適當 鹽或衍生物之形態,而可以提高水溶性或油溶性,因此可 成爲提高其操作性,品質,抗肥滿效果之製品。 醇酯基係指一般之羧基與醇類之脫水反應的結果所形 成之官能基(部份構造:一 COOR; R示任意之烴系官能基) 。即,本發明中五環性三萜烯類之具有醇酯基的衍生物係 尤指由其羧基與醇類可形成之衍生物而言。這時之醇類並 無特別限制,惟例如可爲甲醇,乙醇,正丙醇,異丙醇,烯 丙醇,正丁醇,第二丁醇,第三丁醇,乙二醇,三甲矽烷醇 ,三乙矽烷醇,酚,苯甲醇,糖類等。其中以自乙醇,三乙 矽烷醇,甲醇,正丙醇,異丙醇,三甲矽烷醇所形成之衍生 物爲宜。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 P. 經濟部智慧財產局8工消費合作社印製 -16- 200300069 A7 B7 五、發明説明(d (請先閲讀背面之注意事項再填寫本頁) 脂肪酸酯基係表示一般之羥基與脂肪酸類之脫水反應 之結果,所形成之官能基(部份構造:-OCOR; R示任意之 烴系官能基)。即,本發明中五環性三萜烯類之具有脂肪 酸酯基的衍生物係特別表示可以自其羥基與脂肪酸類形成 之衍生物。這時脂肪酸類雖不予特別限制,但可爲由例如 乙酸,丙酸,丁酸,異丁酸,戊酸,異戊酸,三甲基乙酸, 己酸,辛,癸酸,十一烷酸,月桂酸,肉豆蔻酸,棕櫚酸, 棕櫚烯酸,硬脂酸,油酸,異油酸,反油酸,亞油酸,反亞 油酸,亞麻酸,TV·亞麻酸,花生酸,花生浸烯酸,二十碳 五烯酸,山窬酸,廿二碳六烯,巴西棕櫚酸,蠟酸,褐煤酸 ,蜂酸等所形成者。其中以自乙酸,醋酐,己酸,辛酸,癸 酸,月桂酸,肉豆蔻酸,棕櫚酸,棕櫚烯酸,硬脂酸,油酸 ,反油酸,亞油酸,反亞油酸,亞麻酸,r -亞麻酸,花生 ,花生浸烯酸,二十碳五烯酸,山窬酸,廿二碳六烯酸所形 成衍生物爲宜。 經濟部智慈財4局5貝工消黃合作社印製 烷氧基係示一般的羥基與醇類之脫水反應結果所形成 之官能基(部分構造:-OR; R示任意之烴系官能基)。即, 本發明中五環性三萜烯類之具有烷氧基的衍生物係尤其表 示可由其羥基與醇類形成之衍生物。這時之醇類並無特別 限制,惟可爲例如甲醇,乙醇,正丙醇,異丙醇,烯丙醇, 正丁醇,第二丁醇,第三丁醇,乙二醇,三甲矽烷醇,三乙 矽烷醇,酚,苯甲醇,糖類等。其中以自乙醇,三乙矽烷醇 ,甲醇,正丙醇,異丙醇,三甲矽烷醇所形成之衍生物爲宜 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -17· 200300069 A7 B7 五、發明説明(14) (請先閲讀背面之注意事項再填寫本頁) 烷氧甲基係表示一般之羥甲基與醇類脫水反應之結果 所形成官能基(部份構造:-CH2〇R; R示任意之烴系官能基 )。本發明中五環惟三萜烯類之具有烷氧甲基之衍生物係 特別表示由其羥甲基與醇類可形成之衍生物。這時醇類 並無特別限制惟可爲例如甲醇,乙醇,正丙醇,異丙醇, 烯丙醇,正丁醇,第二丁醇,第三丁醇,乙二醇,三甲矽烷 醇,三乙矽烷醇,酚,苯甲醇,糖類等。其中以自乙醇,三 乙矽烷醇,甲醇,正丙醇,異丙醇,三甲矽烷醇所形成之衍 生物爲宜。 經濟部智慧財產局員工消費合作社印¾ 又,本發明中糖苷係上述具有醇酯基之衍生物,具有 烷氧基之衍生物,具有烷氧甲基之衍生物中,尤其表示可 自五環性三萜烯類之羧基,羥基,羥甲基,與糖類可形成 之衍生物(部份構造-COOR,- OR,- CH2〇R; R示任意之糖 類)。這時糖類並無特別限制,惟可爲例如葡萄糖,甘露 糖,半乳糖,果糖,木糖,阿拉伯糖,岩藻糖,鼠李糖,葡 萄糖胺,半乳糖胺,葡萄糖醛酸,可爲α體,石體之任一。 又,此等糖苷可爲單糖,亦可爲二糖以上組合之低聚糖。 此等中通常有存在於天然,以皂角苷之總稱被人所知者, 本發明中可用此等中之任一。 本發明中之五環性三萜烯類等係如上述,尤其就具有 高度之抑制黑色素生成效果來考量,以齊墩果烷系三®燃 類,熊果烷系三萜烯類,羽扇烷系三萜烯類及此等之生理 上容許之鹽類,或此等之衍生物爲宜。分別具有如式(1) 齊墩果烷系三萜烯類,式(Π)所示之熊果烷系三萜儲類 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) -18 - 200300069 A7 B7 五、發明説明(d (請先閱讀背面之注意事項再填寫本頁) ,式 (III)所示羽扇烷系三萜烯類之架構的五環性三萜 烯類及此等之生理上容許之鹽類,或此等之衍生物。又, 各式中之官能基係如上述者。V. Description of the invention (U (please read the notes on the back before filling this page) and / or these substituted derivatives of hydroxy or carboxyl groups, and there is no particular limitation on the source of these, which can be derived from nature Either artificially synthesized or commercially available products can be used, and in general, when it is considered to be used in glutinous food, it is advisable to use natural products in the present invention. Pentacyclic triterpenes are generally classified according to their architecture. The pentacyclic triterpenes in the present invention may be, for example, oleanol-type triterpenes, arbutin-type triterpenes, lupinane-type triterpenes, and heparane-type triterpenes , Ceracene triterpenes, corkane triterpenes, dandelion isane trisene, dandelion yellow courtyard three-way roasted, multifloran three te storage, Jarmanican three absolutely burned and so on. The “physiologically acceptable salt” of Yinzi, a cargo-worker consumer cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, is a salt derived from the carboxyl group of pentacyclic triterpene acid (partial structure: -C00X; X series) Any cationic substance), the present invention may also include a single ion from a natural substance Originally included. The present invention is not particularly limited as long as it is a salt used in general food, for example, it may be an alkali metal salt such as sodium, potassium, lithium, or an alkaline earth metal salt such as calcium, magnesium, barium, or zinc, Alkylamine salts such as ammonia, methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, butylamine, tetrabutylamine, pentylamine, hexylamine, ethanolamine, triethanolamine, propanol Amines, alkanolamine salts such as dipropanolamine, isopropanolamine, diisopropanolamine, hexahydropyridine, hexahydropyridine and other organic amine salts, lysine, arginine, histamine, Salts such as tryptophan and other basic amino acid salts. Among these, alkali metal salts, alkylamine salts, alkanolamine salts, and basic amino acid salts are preferred. These salts are usually more than the original five Cyclic triterpenes have better water solubility, so in the present invention, it is particularly suitable for water-based foods. This paper size is applicable to China National Standard (CNS) M pit (210X297 mm) " -15 -200300069 A7 B7 V. Description of the invention (j Also, as a derivative refers to a biochemical or artificially formed derivative and In the present invention, as long as it can be a derivative, there is no particular limitation. For example, it may be a derivative having an alcohol ester group, a derivative having a fatty ester group, a derivative having an alkoxy group, and a derivative having an alkoxymethyl group. Substances, or glycosides, etc. These particularly have alcohol ester groups, derivatives with fatty acid esters, alkoxy derivatives, and alkoxymethyl derivatives than their original pentacyclic tricyclic Terpenes have better fat solubility. The present invention is particularly suitable for use in oily foods. In addition, glycosides have better water solubility than the original pentacyclic triterpenes, which is especially suitable in the present invention. It is used in water-based foods. Some of these derivatives are naturally occurring and can be artificially formed. The derivatives of the present invention can be derivatized again using these salts. As mentioned above, pentacyclic triterpenes are made. It is in the form of a suitable salt or derivative that is physiologically acceptable, and can improve water solubility or oil solubility, so it can be a product that improves its operability, quality, and anti-fatty effect. Alcohol ester group refers to a functional group formed as a result of a dehydration reaction between a general carboxyl group and an alcohol (partial structure: a COOR; R represents an arbitrary hydrocarbon-based functional group). That is, the derivatives having an alcohol ester group of the pentacyclic triterpenes in the present invention are particularly derivatives which can be formed from a carboxyl group and an alcohol. The alcohols at this time are not particularly limited, but may be, for example, methanol, ethanol, n-propanol, isopropanol, allyl alcohol, n-butanol, second butanol, third butanol, ethylene glycol, and trimethylsilanol. , Triethylsilanol, phenol, benzyl alcohol, sugars, etc. Among them, derivatives derived from ethanol, triethylsilanol, methanol, n-propanol, isopropanol, and trimethylsilanol are suitable. This paper size applies to China National Standard (CNS) A4 (210X297 mm) Packing-(Please read the precautions on the back before filling out this page) Order P. Printed by the Intellectual Property Bureau of the Ministry of Economic Affairs, 8th Industrial Cooperatives-16 -200300069 A7 B7 V. Description of the invention (d (please read the precautions on the back before filling out this page) Fatty acid ester group refers to the functional group formed by the dehydration reaction of general hydroxyl and fatty acids (partial structure : -OCOR; R represents an arbitrary hydrocarbon-based functional group). That is, the derivative having a fatty acid ester group of the pentacyclic triterpenes in the present invention particularly means a derivative which can be formed from its hydroxyl group and fatty acid. In this case, fatty acids are not particularly limited, but may be, for example, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, trimethylacetic acid, hexanoic acid, caprylic acid, capric acid, and undecanoic acid. , Lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, isoleic acid, oleic acid, linoleic acid, linoleic acid, linolenic acid, TV · linolenic acid, arachidic acid, Arachidonic acid, eicosapentaenoic acid, behenic acid, arsenic Hexene, carmitic acid, wax acid, montanic acid, melonic acid, etc. Among them are acetic acid, acetic anhydride, hexanoic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitic acid, Stearic acid, oleic acid, oleic acid, linoleic acid, linoleic acid, linolenic acid, r-linolenic acid, peanut, arachidonic acid, eicosapentaenoic acid, behenic acid, arsenic acid Derivatives formed by enoic acid are suitable. The alkoxy group printed by the 5th Co., Ltd., 5th Co., Ltd. of the Ministry of Economic Affairs, Zhicicai Co., Ltd. shows functional groups formed by the dehydration reaction of general hydroxyl groups and alcohols (partial structure: -OR R represents an arbitrary hydrocarbon-based functional group). That is, the derivative having an alkoxy group of the pentacyclic triterpenes in the present invention particularly means a derivative which can be formed by its hydroxyl group and an alcohol. At this time, the alcohols are not It is not particularly limited, but may be, for example, methanol, ethanol, n-propanol, isopropanol, allyl alcohol, n-butanol, second butanol, third butanol, ethylene glycol, trimethylsilanol, and triethylsilanol. , Phenol, benzyl alcohol, sugars, etc. Among them are ethanol, triethylsilanol, methanol, n-propanol, isopropyl Derivatives formed by trimethylsilanol are suitable for this paper. Applicable to China National Standard (CNS) A4 (210X297 mm) -17 · 200300069 A7 B7 V. Description of the invention (14) (Please read the notes on the back before (Fill in this page) Alkoxymethyl is a functional group formed by the general dehydration reaction of methylol and alcohols (partial structure: -CH2OR; R is an arbitrary hydrocarbon functional group). Derivatives having cycloalkoxytriterpenes having alkoxymethyl groups are particularly derivatives which can be formed from their methylol groups and alcohols. At this time, the alcohols are not particularly limited but may be, for example, methanol, ethanol, or n-propanol. , Isopropanol, allyl alcohol, n-butanol, second butanol, third butanol, ethylene glycol, trimethylsilanol, triethylsilanol, phenol, benzyl alcohol, sugars, etc. Among them, derivatives derived from ethanol, triethylsilanol, methanol, n-propanol, isopropanol, and trimethylsilanol are suitable. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. In addition, in the present invention, the glycosides are derivatives of the alcohol ester group, derivatives of the alkoxy group, and derivatives of the alkoxymethyl group. Derivatives of triterpene carboxyl, hydroxy, methylol, and sugars (partial structure -COOR, -OR, -CH2OR; R shows any sugar). At this time, the sugar is not particularly limited, but may be, for example, glucose, mannose, galactose, fructose, xylose, arabinose, fucose, rhamnose, glucosamine, galactosamine, glucuronic acid, and may be an alpha , Any of the stones. In addition, these glycosides may be monosaccharides or oligosaccharides in combination of disaccharides or more. These are usually found in nature and known under the general name of saponin, and any of these can be used in the present invention. The pentacyclic triterpenes and the like in the present invention are as described above, and in particular, they are considered to have a high effect of inhibiting melanin production. The oleanolane tris®, ursane triterpenes, and lupinane are considered. These are triterpenes and their physiologically acceptable salts, or derivatives thereof. It has oleanolane triterpenes as shown in formula (1) and arbutane triterpenes as shown in formula (Π). The paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297 mm). ) -18-200300069 A7 B7 V. Description of the invention (d (please read the notes on the back before filling this page), the pentacyclic triterpenes of the structure of lupinane triterpenes shown in formula (III) These physiologically acceptable salts, or derivatives thereof, and the functional groups in each formula are as described above.

(式中R^Ra;示氫原子(-H),羥基(-OH),烷氧基 (· OR),醇酯基(-〇C〇R),R3示甲基 (-CH3),羥甲基 (· CH2〇H),烷氧甲基(-CH2〇R),羧基(-C00H),脂肪 酸酯基 (-COOR),羧酸鹽 (-COOX))(Wherein R ^ Ra; shows a hydrogen atom (-H), a hydroxyl group (-OH), an alkoxy group (· OR), an alcohol ester group (-OCor), R3 shows a methyl group (-CH3), a hydroxyl group Methyl (· CH2OH), alkoxymethyl (-CH2OR), carboxyl (-C00H), fatty acid ester (-COOR), carboxylate (-COOX))

經濟部智慧財凌局員工消费合作社印紫 (式中1示氫原子(-H),羥(-OH),烷氧基(-OR), 醇酯基 (-〇COR),R2示甲基 (-CH3),羥甲基 (-CH2OH),烷氧甲基(-CH2OR),羧基(-COOH),脂 肪酸酯基 (-COOR),羧酸鹽 (-COOX) 本紙張尺度適用中國國家樣準(CNS ) A4規格(210X297公釐) — _ -19- 200300069 A7 B7 五、發明説明(4Employees' Co-operative Co-operative Purple, Ministry of Economic Affairs, Ministry of Economic Affairs (where 1 shows hydrogen atom (-H), hydroxyl (-OH), alkoxy (-OR), alcohol ester group (-〇COR), R2 shows methyl (-CH3), hydroxymethyl (-CH2OH), alkoxymethyl (-CH2OR), carboxyl (-COOH), fatty acid ester (-COOR), carboxylate (-COOX) Sample standard (CNS) A4 specification (210X297 mm) — _ -19- 200300069 A7 B7 V. Description of the invention (4

(請先閱讀背面之注意事項再填寫本頁) (式中1示氫原子 (-H),羥 (-OH),烷氧基 (-OR),醇酯基(-OCOR),R2示甲基(-CH3),羥甲基 (-CH2OH),烷氧甲基(-CH2OR),羧基(-COOH),脂 肪酸酯基 (-COOR),羧酸鹽 (-COOX))。 經濟部智毯財凌笱員工消費合作钍印^ 本發明雖不特別限定,但,例如齊墩果烷系三萜烯類 可爲山楂酸,油醇,古柯二醇,沒-香樹素,常春藤苷配 置,甘草酸等,做爲熊果烷系三萜烯類可爲熊果酸,熊果 醇,香樹素,異鼠李酸,蒲公英酯醇,羥基熊果 酸等,羽扇烷系三萜烯類係可爲樺木酸,樺木醇,羽扇豆 醇等。又,此等之生理上容許之鹽類及衍生物係如上述一 樣。使用此等之生理上容許之鹽類及衍生物時,齊墩果醇 系三萜烯類,熊果烷系三萜烯類,羽扇烷系三萜烯類及此 等之生理上容許之鹽類,或此等衍生物之來源並不受限制 ,可爲自天然所得者,人工合成者,市販品等之任一均可 使用,考慮使用於飮食物時,以使用天然物較適宜。 如上述,本發明中係以五環性三萜烯類中之 齊墩果院系二結嫌類,(I)熊果院系三蔽嫌類,(II)及此等 之生理上容許之鹽,或上等之衍生物爲宜,惟就抗肥滿效 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -20- 200300069 A7 B7 五、發明説明(旮 果之強度上言,做爲齊墩果烷系三萜烯類以山楂酸,古柯 二醇爲宜,做爲熊果烷系三萜烯類以熊果酸,熊果醇爲宜 ,做爲羽扇系三萜烯類,以樺木酸,樺木醇爲宜,當然亦 以此等之生理上容許之鹽,或此等之衍生物爲宜。 山楂酸,古柯二醇均爲齊墩果烷三萜烯類的一種,已 知存在於各種植物之物質。又,此等之生理上容許之鹽及 衍生物係如上述一樣。在本發明之抗肥滿用飮食物中使用 山楂,古柯二醇,此等之生理上容許之鹽,或此等之衍生 物時,此等物質之來源並不受限制,可爲自天然所得者, 人工合成者,市販品等之任一均可使用,惟考慮本發明爲 飮食等時以使用天然物爲宜。 本發明中就抗肥滿效果之高低,安定供給面觀之,以 山楂酸及/或其生理上可被容許之鹽爲最佳。山楂酸 (maslinic acid)係齊墩果院系三IS燒的一種,不化學式 (IV)之構造,做爲作用具有抗發炎症作用或抗組織胺作 用係爲人所知者。天然者已獲知存在於洋橄欖,忽布,薄 荷,石榴,丁香,鼠尾草,棗等。本發明之抗肥滿用飮食 物中,山楂酸,其生理上可被容許之鹽及衍生物之來源並 不予限制,可爲自天然所得者,人工合成者,市販品等之 任一均可使用,惟考慮本發明係爲飮食物之形態,以例如 自洋橄欖,忽布,薄荷,石榴,丁香,鼠尾草,棗等天然 所得者爲宜,尤其洋橄欖所得山楂酸和/或其生理上容許之 鹽係就原料供給或含量上極爲理想。山楂酸和/或其生理 上容許之鹽係可自此等之原料,尤其自洋橄欖植物,藉由 ^紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐1 ~ -21- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部智慈財產局員工消費合作社印災 200300069 A7 B7 五、發明説明(4 水和/或有機溶媒經由萃取處理即可獲得,更可以經濃縮, 精製而可以簡單且大量地獲得高濃度之天然由來的山楂 酸和/或其生理上可被容許之鹽。 本發明書中指「洋橄欖」係指洋橄欖植物及/或洋橄欖 油及/或橄欖油製造步驟中所得副產物而言者。(Please read the precautions on the back before filling out this page) (where 1 represents a hydrogen atom (-H), a hydroxyl group (-OH), an alkoxy group (-OR), an alcohol ester group (-OCOR), and R2 represents a form of (-CH3), hydroxymethyl (-CH2OH), alkoxymethyl (-CH2OR), carboxy (-COOH), fatty acid ester (-COOR), carboxylate (-COOX)). Wisdom blanket of the Ministry of Economic Affairs of the People's Republic of China, and the consumption cooperation of employees ^ Although the present invention is not particularly limited, for example, oleanolic triterpenes can be maslinic acid, oleyl alcohol, cocadiol, and melanoidin , Ivy glycoside configuration, glycyrrhizic acid, etc., as ursane triterpenes can be ursolic acid, ursitol, antlerin, isorhamic acid, tartaryl alcohol, hydroxyursolic acid, etc., lupin Alkane triterpenes can be betulinic acid, betulin, lupinol and the like. The physiologically acceptable salts and derivatives are as described above. When using these physiologically acceptable salts and derivatives, oleanol-type triterpenes, arbutin-type triterpenes, lupinane-type triterpenes, and these physiologically acceptable salts The source of these derivatives is not limited, and they can be used from natural sources, artificial synthesizers, and commercial products, and it is more appropriate to use natural products when considering the use of loquat food. As mentioned above, in the present invention, the oleanders of the pentacyclic triterpenes are the second-class suspects, (I) the bear fruit hospitals are the third-class suspects, (II) and the physiologically acceptable ones Salt, or a superior derivative, is suitable, but the Chinese National Standard (CNS) A4 specification (210X297 mm) applies to the paper size for anti-fertility effect. -20- 200300069 A7 B7 V. Description of the invention In other words, as the oleanolic triterpenes, maslinic acid and cocadiol are suitable, and as the ursane triterpenes, ursolic acid and ursyl alcohol are suitable. Terpenes are preferably betulinic acid and betulin, and of course these physiologically acceptable salts or derivatives thereof are also suitable. Cratalic acid and cocadiol are both oleanol triterpenes It is a kind of substance known to exist in various plants. In addition, these physiologically acceptable salts and derivatives are as described above. Hawthorn and cocadiol are used in the anti-plumid foods of the present invention, In the case of these physiologically acceptable salts or their derivatives, the source of these substances is not limited and may be derived from nature Either artificially synthesized or commercially available products can be used, but it is advisable to use natural products when the present invention is to eat or eat. In the present invention, regarding the level of the anti-fatness effect, it is stable to supply it with maslinic acid. And / or its physiologically acceptable salt is the best. Maslinic acid is one of the three IS burners of the Oden Fruit Academy. It has no chemical formula (IV) structure and has an anti-inflammatory effect or The anti-histamine effect is known. Natural people have known that it exists in olives, hubu, mint, pomegranate, clove, sage, jujube, etc. In the anti-plump foods of the present invention, maslinic acid, The source of the physiologically acceptable salts and derivatives is not limited, and may be any one obtained from natural sources, artificial synthesizers, and commercial products, but considering that the present invention is in the form of glutinous food, For example, natural sources such as olive oil, hubu, mint, pomegranate, clove, sage, jujube and the like are suitable. In particular, maslinic acid and / or physiologically acceptable salts thereof obtained from olive olive are extremely important in terms of raw material supply or content. Ideal. Maslinic acid and / or its physiology The permissible salt is from these raw materials, especially from the olive plant. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm 1 ~ -21- (Please read the precautions on the back before (Fill in this page) Order the Consumers ’Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs to print 200300069 A7 B7 V. Description of the invention (4 Water and / or organic solvents can be obtained through extraction treatment, and can be concentrated, refined and can be simply and in large quantities Obtaining a high concentration of naturally-derived maslinic acid and / or physiologically acceptable salts thereof. In the present specification, "foreign olive" means the olive plant and / or the olive oil and / or the olive oil obtained during the manufacturing process. Product.

本發明中山楂酸之生理上可被容許之鹽及衍生物係如 上述記載一樣。即,其生理上可被容許之鹽係自化學式 (IV)中之-COOH所衍生者,其鹽之種類係通常只要爲飮 食物或醫藥組成物中所用者即不予特別限制。具體言,例 如做爲山楂酸之鹽可爲山楂酸鈉,山楂酸鉀,山楂酸銨, 山楂酸二甲銨,山楂酸鈣,山楂酸鎂等。其中,以山楂酸 鈉及山楂酸鉀爲宜。 又,山楂酸之衍生物係例如其任一部位被衍生化者, 可爲山楂酸甲酯,山楂酸乙酯,山楂酸正丙酯,山楂酸異丙 酯,山楂酸正丁酯,山楂酸三甲矽烷酯,山楂酸三乙政院 酯,山楂酸-yS-D-葡糖吡喃酯,山楂酸-泠-D-半乳吼 喃酯,3-0-乙醯基·山楂酸,3-0-丙醯基-山楂酸,3-0- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝· 訂 瞍齊郎皆慧时/1笱®工消費合itfi印¾ -22- 200300069 A7 B7 五、發明説明(1¾ (請先閱讀背面之注意事項再填寫本頁) 丁醯基-山楂酸,3- 0-戊醯基-山楂酸,3- 0-癸醯基-山楂酸,3- 0-月桂基-山楂酸,3- 0-肉豆蔻基·山楂酸, 3-0-棕櫚基-山楂酸,3-0-棕櫚醯基-山楂酸,3-0-硬 脂基-山楂酸,3-0-油基-山楂酸,3-0-異油基·山楂 酸,3· 0-亞麻基-山楂酸,3-〇-亞油基-山楂酸,3- 〇-花生基·山楂酸,3- 0-花生浸烯基·山楂酸,3- 0-山窬 基·山楂酸,2-〇-乙醯基-山楂酸,2-〇-丙醯基-山楂 酸,2-〇-丁醯基-山楂酸,2-〇·戊醯基-山楂酸,2- 〇-癸醯基-山楂酸,2- 0·月桂基-山楂酸,2- 0-肉豆蔻基-山楂酸,2- 0-棕櫚基-山楂酸,2- 0-棕櫚醯基·山楂酸, 2- 0-硬脂基-山楂酸,2- 0-油基-山楂酸,2- 0-異油 基-山楂酸,2- 0·亞麻基-山楂酸,2- 0-亞油基-山楂 酸,2- 0-花生基-山楂酸,2- 0·花生浸烯基-山楂酸,2-〇-山窬基-山楂酸,3·〇-甲基-山楂酸,3- 0-乙基-山 楂酸,3- 0-第三丁基-山楂酸,3- 0-三乙矽烷基·山楂 酸,3-〇-/9 - D-葡糖吡喃基-山楂酸,3- 0- /3-D-半乳 吡喃基·山楂酸,3-0- 葡萄糖醛酸吡喃基·山楂酸 經濟部智慧財4局員工消費合作社印製 等,其中尤以山楂酸乙酯,山楂酸三乙矽烷酯,3- 0-乙醯 基·山楂酸,2-0-乙醯基-山楂酸,2-0-三乙矽烷基-山楂酸,3-硬脂醯基-山楂酸及2- 0-硬脂醯基-山楂酸 爲宜。以上係舉出做爲衍生物只有一基被衍生化者,惟既 使此等中可衍生之位置及種類爲2基以上被衍生化者當然亦 可。例如山楂酸或上述較佳之山楂酸酯之3,3- 0-二乙醯 基,2,3· 0·三乙矽烷體,2, 3-二硬脂醯體,具體言,較佳 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) -23 - 200300069 A7 _B7_ 五、發明説明(2¾ (請先閲讀背面之注意事項再填寫本頁) 者可爲2,3- 0-二乙醯基,山楂酸,2,3- 0-三乙矽烷基· 山楂酸三乙矽烷酯及2,3- 0-二硬脂醯基-山楂酸。又, 糖苷雖只舉單糖者,惟由二種以上選各自種糖類所成群之 低聚糖當然亦可。 古柯二醇 (erythrodiol)係齊墩果院系三萜燒類之一 種,如式(V)之構造,其作用迄今已知爲具有抗發炎症 作用(Planta.Med.V0L.61,No.2,1 82- 1 8 5,1 995)等。天 然者存在於洋橄欖,向日葵,金盞花,阿拉伯橡膠樹,紫 檀,大葉饅頭果等係爲人所知者。本發明之抗肥滿用飮食 物中,古柯二醇或此等之衍生物的由來不予限制,可爲天 然所得者,人工合成者,市販品之任一均可使用,惟考慮 飮食等上之應用時係例如自洋橄欖,向日葵,金盞花,阿 拉伯橡膠樹,紫檀,大葉饅頭果等天然所得者爲宜。尤其 洋橄欖爲宜,具體言以自洋橄欖植物和/或橄欖油製造步 驟中所得副產品所得者爲宜。The physiologically acceptable salts and derivatives of maslinic acid in the present invention are as described above. That is, the physiologically acceptable salt is derived from -COOH in Chemical Formula (IV), and the type of the salt is usually not particularly limited as long as it is used in food or pharmaceutical composition. Specifically, for example, the salt of maslinic acid may be sodium maslinate, potassium maslinate, ammonium maslinate, dimethylammonium maslinate, calcium maslinate, magnesium maslinate, and the like. Among them, sodium hawate and potassium hawate are suitable. In addition, the derivatives of maslinic acid are, for example, those derived from any part thereof, and may be methyl maslinate, ethyl maslinate, n-propyl maslinate, isopropyl maslinate, n-butyl maslinate, and maslinic acid. Trimethylsilyl ester, triethyl maslinate, maslinic acid-yS-D-glucopyranyl ester, maslinic acid-Ling-D-galactopyranoate, 3-0-acetamyl maslinic acid, 3 -0-Propanyl-maslinic acid, 3-0- This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling out this page). Hour / 1 笱 ® Industrial Consumption and ITFI Printing ¾ -22- 200300069 A7 B7 V. Description of the Invention (1¾ (Please read the precautions on the back before filling out this page) Butyl-cratalic acid, 3- 0-pentyl-hawthorn Acid, 3- 0-decanoyl-maslinic acid, 3- 0-lauryl-maslinic acid, 3- 0-myristyl-maslinic acid, 3-0-palmityl-maslinic acid, 3-0-palmitine Base-maslinic acid, 3-0-stearyl-maslinic acid, 3-0-oleyl-maslinic acid, 3-0-isooleyl-maslinic acid, 3.0-linolenic-maslinic acid, 3-〇 -Linoleyl-maslinic acid, 3-〇-arachidyl maslinic acid, 3- 0-flower Alkenyl · maslinic acid, 3- 0-massyl · maslinic acid, 2-〇-ethylamyl-maslinic acid, 2-〇-propanyl-maslinic acid, 2-〇-butanyl-maslinic acid, 2-〇 · pentanoyl-maslinic acid, 2- 0-decanoyl-maslinic acid, 2- 0 · lauryl-maslinic acid, 2- 0-myristyl-maslinic acid, 2- 0-palmityl- Cratalic acid, 2- 0-palmitinyl · cratalic acid, 2- 0-stearyl-cratalic acid, 2- 0-oleyl-cratalic acid, 2- 0-isooleyl-cratalic acid, 2- 0 · Linolenic-maslinic acid, 2- 0-linoleyl-maslinic acid, 2- 0-arachidyl-maslinic acid, 2- 0 · arachidene-maslinic acid, 2-0-massyl-maslinic acid, 3.0-methyl-maslinic acid, 3- 0-ethyl-maslinic acid, 3- 0-tertiary butyl-maslinic acid, 3- 0-triethylsilyl maslinic acid, 3-〇- / 9 -D-glucopyranyl-maslinic acid, 3- 0- / 3-D-galactopyranosyl · maslinic acid, 3-0-glucuronylpyranyl · maslinic acid, employee of the Ministry of Economic Affairs Printed by consumer cooperatives, especially ethyl maslinate, triethylsilyl maslinate, 3- 0-ethylenyl maslinic acid, 2-0-ethylenyl-maslinic acid, 2-0-triethylsilyl -Cratalic acid, 3-stearyl-hawthorn And 2- 0-stearyl-maslinic acid is suitable. The above list refers to those in which only one group is derivatized as a derivative, but even if the derivatizable position and type in these are two or more groups, it is derivatized. Of course, it is also possible. For example, maslinic acid or the above-mentioned preferred maslinate, 3,3- 0-diethylfluorenyl, 2,3 · 0.0 · triethylsilane, 2,3-distearyl carbohydrate, specifically The better paper size is applicable to Chinese National Standard (CNS) A4 specification (210X29 * 7mm) -23-200300069 A7 _B7_ V. Description of the invention (2¾ (Please read the precautions on the back before filling this page). 2,3- 0-diethylfluorenyl, maslinic acid, 2,3- 0-triethylsilyl, triethylsilyl maslinate, and 2,3- 0-distearylyl-maslinic acid. In addition, although glycosides are only monosaccharides, oligosaccharides grouped by two or more kinds of saccharides can be selected. Cocadiol (erythrodiol) is one of the triterpenoids of the oleanolic system, such as the structure of formula (V), and its effect has hitherto been known to have an anti-inflammatory effect (Planta.Med.V0L.61, No. 2, 1 82- 1 8 5, 1 995) and so on. Natural beings are known in the lines of olives, sunflowers, calendula, acacia, red sandalwood, and large-leaf stolons. The origin of cocadiol or these derivatives in the anti-fattiness foods of the present invention is not limited, and may be naturally derived, artificially synthesized, or any of the commercially available products, but considering food consumption It is suitable to use natural income such as olive, sunflower, calendula, acacia, red sandalwood, big leaf bun, etc. In particular, olives are preferred, and in particular, those derived from by-products obtained from olive olive plants and / or olive oil manufacturing processes are preferred.

有關古柯二醇,其生理上可被容許之鹽或衍生物係如 上述一樣。 在此,有關衍生物雖不受以下所限制,惟例如做爲一 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公41 ----- -24 - 200300069 A7 _B7___ 五、發明説明(21) (請先閲讀背面之注意事項再填寫本頁) 經濟部智慈財4局員工消費合作社印製 個部位被衍生化者可爲3- 0-乙醯基-古柯二醇,3- 0-丙醯基-古柯二醇,3-0- 丁醯基-古柯二醇,3-0-戊醯 基-古柯二醇,3- 〇-癸醯基-古柯二醇,3- 0·月桂基-古柯二醇,3- 0-肉豆蔻基-古柯二醇,3- 0·棕櫚基-古 柯二醇,3-0-棕櫚醯基-古柯二醇,3-0-硬脂基·古柯 二醇,3-0-硬脂醯基·古柯二醇,3-0-油基-古柯二醇 ,3- 0-異油基-古柯二醇,3- 0-亞麻基-古柯二醇,3-〇-亞油基-古柯二醇,3-0-花生基-古柯二醇,3- 0-花 生浸烯基-古柯二醇,3-0-山窬基-古柯二醇,28- 0-〇-乙醯基-古柯二醇,28-0-丙醯基-古柯二醇,28-0- 丁 醯基-古柯二醇,28-0-戊醯基-古柯二醇,28-0-癸醯 基·古柯二醇,28-〇·月桂基-古柯二醇,28- 〇·肉豆蔻 基-古柯二醇,28- 0-棕櫚基-古柯二醇,28- 〇-棕櫚醯 基·古柯二醇,28- 0-硬脂基-古柯二醇,28- 〇·油基-古柯二醇,28- 0-異油基-古柯二醇,28- 0-亞麻基-古 柯二醇,28- 0-亞油基-古柯二醇,28· 0-花生基-古柯 二醇,28- 0·花生浸烯基-古柯二醇,28- 〇·山窬基-古 柯二醇,3-0-甲基·古柯二醇,3- 0-乙基-古柯二醇,3-〇-第三丁基·古柯二醇,3· 0-三乙矽烷基-古柯二醇, 28·〇-甲基-古柯二醇,28-〇·乙基-古柯二醇,28- 0-第三丁基-古柯二醇,28·〇·三乙矽烷基-古柯二醇,3-0-/3- D-葡糖吡喃基-古柯二醇,3- 0· 半乳吡喃基_ 古柯二醇,3- 0-石· D-葡萄糖醛酸吡喃基-古柯二醇,28· 〇-/3- D·葡糖吡喃基-古柯二醇,28-0-卢-D-半乳吡喃 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 200300069 A7 ____B7 五、發明説明(d 基-古柯二醇,28- 0- y3- D-葡萄糖醛酸吡喃基·古柯二 (請先閲讀背面之注意事項再填寫本頁) 醇等。其中以3- 0·乙醯基-古柯二醇,28- 0-乙醯基-古 柯二醇爲宜。以上只舉出做爲衍生物只有一基被衍生化者, 惟此等中被衍生化之位置及種類亦可爲二基以上被衍生化 者。例如可爲3,28- 0-二乙醯基-古柯二醇。又,糖苷亦 只舉單糖而已,惟亦可爲選自各種糖類所成群之二糖以上 的低聚糖。 熊果酸,熊果醇均爲熊果烷系三萜烯類的一種,已知 其爲存在於各種植物中之物質。又,此等之生理上可被容 許之鹽及衍生物係如上述一樣。本發明之抗肥滿用飮食物 中使用熊果酸,熊果醇,此等之生理上可被容許之鹽,或 此等之衍生物時,對此等物質之來源並不予特別限定,可 使用自天然所得者,人工合成者,市販品等之任一,但考 慮對飮食物等之應用時,以使用天然物爲宜。 熊果酸 (ursolic acid)係熊果烷系三萜烯類之一種, 以式(VI)所示構造之化合物,已知其作用有抗發炎症 作用,抗肥胖作用,抗糖尿病作用,抗高脂血作用(Jie Liu, Journal of Ethnopharmacology, 49,5 7- 68,1 995) 等。天然者係廣泛分佈於蘋果,櫻桃,熊莓等果實或葉爲 人所知者,本發明之抗肥滿用飮食物中對熊果酸,此等之 生理上可被容許之鹽,或此等之衍生物的來源並不特別限 制,可爲天然所得者,人工合成者,市販品之任一均可使 用,惟考慮應用於飮食等時,以自例如蘋果,櫻桃,熊莓 等天然所得者爲宜。 本纸張尺度適用中國國家標率(CNS ) A4胁(21GX297公釐) 麵 -26- 200300069 A7 B7 五、發明説明(2¾ CH,Regarding cocadiol, physiologically acceptable salts or derivatives thereof are as described above. Here, the related derivatives are not limited by the following, but for example, as a paper standard, the Chinese National Standard (CNS) A4 specification (210X297 public 41 ----- -24-200300069 A7 _B7___ V. Description of the invention ( 21) (Please read the notes on the back before filling out this page) The Ministry of Economic Affairs, the Intellectual Property and Welfare Bureau of the 4th Bureau of the Consumer Consumption Coordinator printed a derivatized part of the site, which can be 3- 0-acetyl-cocadiol, 3- 0-propanyl-cocadiol, 3-0-butanyl-cocadiol, 3-0-pentanyl-cocadiol, 3-0-decyl-cocadiol, 3- 0 · lauryl-cocadiol, 3- 0-myristoyl-cocadiol, 3- 0 · palmityl-cocadiol, 3-0-palmitinyl-cocadiol, 3- 0-stearyl-cocadiol, 3-0-stearyl-cocadiol, 3-0-oleyl-cocadiol, 3-0-isooleyl-cocadiol, 3- 0-linoleyl-cocadiol, 3-0-linoleyl-cocadiol, 3-0-arachidyl-cocadiol, 3-0-arachidene-cocadiol , 3-0-behenyl-cocadiol, 28-0-〇-ethyl-cocadiol, 28-0-propanyl-cocadiol, 28-0-butanyl-coca Diol, 28-0-pentamyl- Cocodiol, 28-0-decylenyl cocadiol, 28-0 Lauryl-cocadiol, 28-0 myristyl-cocadiol, 28-0-palmityl-gu Cocodiol, 28-0-palmitenyl cocadiol, 28-0-stearyl-cocadiol, 28-0 oil-cocadiol, 28-0-isooleyl- Cocadiol, 28-0-linoleyl-cocadiol, 28-0-linoleyl-cocadiol, 28.0-arachidyl-cocadiol, 28-0-arachidene -Cocadiol, 28-O. Behenyl-cocadiol, 3-0-methyl · cocadiol, 3-0-ethyl-cocadiol, 3-0-tertiary butane Cocadiol, 3.0-triethylsilyl-cocadiol, 28.0-methyl-cocadiol, 28-0-ethyl-cocadiol, 28-0- Tributyl-cocadiol, 28.0-triethylsilyl-cocadiol, 3-0- / 3-D-glucopyranyl-cocadiol, 3-0 · galactopyranoate Uranyl_cocadiol, 3- 0-stone · D-glucuronylpyranyl-cocadiol, 28 · 〇- / 3-D · glucopyranyl-cocadiol, 28- 0-Lu-D-galactopyrano This paper is sized for China National Standard (CNS) A4 (210X297 mm) 200300069 A 7 ____B7 V. Description of the invention (d-cocadiol, 28-0-y3-D-glucuronopyranyl coca di (Please read the notes on the back before filling this page) alcohol, etc. Among them, 3-0 · ethylfluorenyl-cocadiol and 28-0-ethylfluorenyl-cocadiol are preferable. The above list only refers to those who have only one base being derivatized as a derivative, but the position and type of derivatization in these may also be those derivatizing more than two bases. For example, it may be 3,28-0-diethylfluorenyl-cocadiol. The glycosides are only monosaccharides, but they may be oligosaccharides selected from the group consisting of disaccharides of various sugars. Ursolic acid and ursitol are both types of ursane triterpenes, and they are known to exist in various plants. The physiologically tolerable salts and derivatives are as described above. When ursolic acid, ursitol, these physiologically tolerable salts, or these derivatives are used in the food for preventing obesity in the present invention, the source of these substances is not particularly limited. Naturally derived, artificially synthesized, and commercially available products can be used, but when considering the application to food, etc., it is advisable to use natural products. Ursolic acid is one of the ursane triterpenes. The compound of formula (VI) is known to have anti-inflammatory, anti-obesity, anti-diabetic and anti-high Lipemia (Jie Liu, Journal of Ethnopharmacology, 49, 5 7-68, 1 995) and so on. Natural ones are widely known in apples, cherries, bear berries and other fruits or leaves. The fat-reducing foods of the present invention are ursolic acid, physiologically acceptable salts, or the like. The source of the derivative is not particularly limited, and it can be used naturally, artificially synthesized, or any of the commercially available products. However, when it is considered to be used for food, etc., it can be derived from natural products such as apple, cherry, and bearberry The winner is better. This paper scale is applicable to China National Standard (CNS) A4 (21GX297 mm) surface -26- 200300069 A7 B7 V. Description of the invention (2¾ CH,

對熊果酸,此等之生理上可被容許之鹽或衍生物係® 上述一樣。 在此其生理上可被容許之鹽雖不予以下限定,但例 熊果酸之鹽可爲熊果酸鈉,熊果酸鉀,熊果酸銨,熊果@ 二甲銨,熊果酸鈣,熊果酸鎂等。 又,熊果酸之衍生物係例如其任一部位被衍生化者, 可爲熊果酸甲酯,熊果酸乙酯,熊果酸正丙酯,熊果酸異 丙酯,熊果酸正丁酯,熊果酸三甲矽烷酯,熊果酸三乙矽 烷酯,熊果酸-/5 - D-葡糖吡喃酯,熊果酸· /3 - D-半乳 吡喃酯,3- 0·乙醯基-熊果酸,3- 0-丙醯基-熊果酸, 3- 0· 丁醯基·熊果酸,3· 0-戊醯基-熊果酸,3- 0-癸 醯基-熊果酸,3- 0-月桂基-熊果酸,3- 0-肉豆蔻基-熊果酸,3-0·棕櫚基-熊果酸,3-0-棕櫚醯基·熊果酸-3, - 0-硬脂基-熊果酸,3· 0-油基-熊果酸,3- 0-異油 基,熊果酸,3- 0-亞麻基·熊果酸,3- 0-亞油基-熊果 酸,3-0-花生基·熊果酸-3-0-花生浸烯基-熊果酸,3· 〇-山窬基-熊果酸,3- 0-甲基·熊果酸,3- 0·乙基-熊果酸,3- 0·第三丁基-熊果酸,3- 0-三乙矽烷基-熊 木纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) .裝.For ursolic acid, these physiologically acceptable salts or derivatives are the same as above. Although the physiologically acceptable salt is not limited here, for example, the salt of ursolic acid may be sodium ursolic acid, potassium ursolic acid, ammonium ursolic acid, ursyl @ dimethyl ammonium, ursolic acid. Calcium, magnesium ursate, etc. In addition, the derivatives of ursolic acid are, for example, those derivatized at any part thereof, and may be methyl ursolic acid, ethyl ursolic acid, n-propyl ursolic acid, isopropyl ursolic acid, and ursolic acid. N-butyl ester, trimethylsilyl ursolic acid, triethylsilyl ursolic acid, ursolic acid-/ 5-D-glucopyranyl ester, ursolic acid / 3-D-galactopyranoate, 3 -0 · Acetyl-ursolic acid, 3- 0-propanyl-ursolic acid, 3- 0 · butanyl · ursolic acid, 3.0 · pentamyl-ursolic acid, 3- 0-decyl Fluorenyl-ursolic acid, 3- 0-lauryl-ursolic acid, 3- 0-myristyl-ursolic acid, 3-0 · palmityl-ursolic acid, 3-0-palmitinyl · bear Fruit acid-3, -0-stearyl-ursolic acid, 3.0-oleyl-ursolic acid, 3-0-isooleyl, ursolic acid, 3-0-linoleyl · ursolic acid, 3- 0-linoleyl-ursolic acid, 3-0-arachisyl · ursolic acid-3-0-arachisin-alkenyl-ursolic acid, 3.0- behenyl-ursolic acid, 3- 0-methyl · ursolic acid, 3- 0 · ethyl-ursolic acid, 3- 0 · tertiary butyl-ursolic acid, 3- 0-triethylsilyl-ursin paper standards applicable to Chinese national standards (CNS) A4 size (210X297mm) (Please read the notes on the back first Then fill the page). Installed.

、1T 經濟部智慧財產局員工消资合作社印^ -27- 200300069 A7 B7 五、發明説明(2i 果酸,3-0- yS-D-葡糖吡喃基·熊果酸,3-0- 半 乳吡喃基-熊果酸,3- 0- D-葡萄糖醛酸吡喃基-熊 (請先閱讀背面之注意事項再填寫本頁) 果酸等,其中尤以熊果酸乙酯爲宜。以上只舉出做爲衍生 物只有一基被衍生化者,惟此等中被衍生化之位置及種類 亦可爲二基以上被衍生化者。又,糖苷亦只舉單糖而已, 惟亦可爲選自各種糖類所成群之二糖以上低聚糖。 熊果酸 (uraol)係熊果烷系三萜烯類之一種,具如 式 (VII)之構造式,其作用已知者有抗發炎作用 (Planta.med.V0L.61, No.2, 1 82- 1 85, 1995), 甘油磷酸脫氫酶阻斷作用(特開平9-67249)等。已知天然中 存在於洋橄欖、熊莓、鼠尾草、阿拉伯橡膠樹、白千層等 。本發明之抗肥滿用飮食物中,熊果醇或此等之衍生物的 來源並不限制,可使用自天然所得者,人工合成者,市販 品等之任一,惟考慮本發明爲飮食物之形態時,以自例如 洋橄欖、熊莓、鼠尾草、阿拉伯橡膠樹、白千層等天然物 所得者爲宜。尤其洋橄欖爲宜,具體言以自洋橄欖植物及 /或橄欖油製造步驟中所得副產物所得者爲宜。 經濟部智慧財/i局8工消Φ合作社印製 CH3, 1T Printed by the Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ^ -27- 200300069 A7 B7 V. Description of the invention (2i fruit acid, 3-0- yS-D-glucopyranyl · ursolic acid, 3-0- Galactopyranos-ursolic acid, 3- 0-D-glucuronyl-pyranyl-ursine (please read the precautions on the back before filling this page) fruit acids, etc., especially ethyl ursolic acid is It is only mentioned above that only one base is derivatized as a derivative, but the position and type of derivatization in these may also be derivatized with more than two bases. Moreover, glycosides are only monosaccharides, However, it can also be selected from oligosaccharides of disaccharides or more grouped by various sugars. Ursolic acid (urol) is one of the ursane triterpenes, which has a structural formula such as formula (VII), and its function has been The reader has anti-inflammatory effects (Planta.med.V0L.61, No.2, 1 82- 1 85, 1995), glycerol phosphate dehydrogenase blocking effect (Japanese Patent Application Laid-Open No. 9-67249), etc. It is known to exist in nature In olive oil, bear berry, sage, acacia tree, white Melaleuca, etc. In the anti-fertilization food of the present invention, the source of arsitol or these derivatives is not limited and can be used from Of course, any one of the obtained, artificially synthesized, marketed goods, etc., but when the present invention is considered to be in the form of tadpole food, it is obtained from natural objects such as olives, bear berries, sage, acacia, and melaleuca. It ’s better. Especially the olives are suitable, specifically the ones obtained from the by-products of olive olive plants and / or olive oil manufacturing process. CH3 printed by the Ministry of Economic Affairs / i Bureau 8 工 消 Φ Cooperative print CH3

熊果醇中其生理上可被容許之鹽或衍生物係與上述一 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -28- 200300069 A7 B7 _ 五、發明説明(2表 樣。 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局8工消費合作社印¾ 在此,有關衍生物雖不受以下所限制,惟例如做爲一 個部位被衍生化者則可爲3 · 〇 -乙醯基·熊果醇、3 - Ο -丙醯 基-熊果醇、3-0-丁醯基-熊果醇、3-0-戊醯基-熊果醇、3-0-癸醯基-熊果醇、3-0-月桂基-熊果醇、3-0_肉豆蔻基-熊 果醇、3-0-棕櫚基-熊果醇、3-0-棕櫚醯基-熊果醇、3-0-硬 脂基-熊果醇、3-0-油基-熊果醇、3-0-異油基-熊果醇、3-〇·亞麻基-熊果醇、3-0-亞油基-熊果醇、3_0-花生基-熊果 醇、3-0-花生浸烯基·熊果醇、3-0-山窬基-熊果醇、28-0-乙醯基-熊果醇、28-0-丙醯基-熊果醇、28-0-丁醯基-熊果 醇、28-0-戊醯基-熊果醇、28-0-癸醯基-熊果醇、28-0-月 桂基-熊果醇、28-0-肉豆蔻基·熊果醇、28-0-棕櫚基-熊果 醇、28-0-棕櫚醯基-熊果醇、28-0-硬脂基-熊果醇、28-0-油基-熊果醇、28-0-異油基-熊果醇、28-0-亞麻基-熊果醇 、28-0-亞油基-熊果醇、28-0-花生基·熊果醇、28-0-花生 浸烯基·熊果醇、28-0-山窬基·熊果醇、3-0-甲基-熊果醇、 3-0-乙基-熊果醇、3-0-第三丁基-熊果醇、3-0·三乙矽烷 基-熊果醇、28-0-甲基-熊果醇、28-0-乙基·熊果醇、28-0-第三丁基-熊果醇、28-0-三乙矽院基-熊果醇、3-0-;S-D-葡 糖吡喃基-熊果醇、3-0-冷-D-半乳吡喃基-熊果醇、3-0-石-D-葡萄糖醛酸吡喃基-熊果醇、28-0-泠-D-葡糖吡喃基-熊果 醇、28-〇· -D-半乳吡喃基-熊果醇、28-0-冷-D-葡萄糖醛 酸吡喃基-熊果醇等,其中以3-0-乙醯基-熊果醇、28-0-乙 醯基·熊果醇爲宜。以上只舉出做爲衍生物只有一基被衍生 本纸浪尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -29· 200300069 A7 _____B7_ 五、發明説明(2& (請先閱讀背面之注意事項再填寫本頁) 化者,惟此等中被衍生之位置及種類亦可爲二基以上被衍 生化者。例如可爲3,28-二乙醯基-熊果醇。又,糖苷亦只舉 單糖而已,惟亦可爲選自各種糖類所成群之二糖以上的低 聚糖。 樺木酸、樺木醇均爲羽扇烷系三萜烯類的一種,已知 其爲存在於各種植物中之物質。又,此等之生理上可被容 許之鹽及衍生物係如上述一樣。本發明之抗肥滿用飮食品 中使用樺木酸、樺木醇,此等之生理上可被容許之鹽,或 此等之衍生物時,對此等物質之來源並不予特別限定,可 使用自天然所得者,人工合成者,市販品等之任一,但考 慮對飮食等之應用時,以使用天然物爲宜。 蛵濟部智慧財產局員工消費合作社印^ 樺木酸(betulinic acid)係羽扇烷系三萜烯類之一種,如 式(VIII)的構造,已知具有制癌作用,抗發炎症作用,促進 創傷治癒作用(特公平4-26623),抑制酒精吸收作用(特開平 7-53385),促進長毛作用(特開平9- 1 57 1 39)等。天然係在當 藥、丁香、葡萄果皮、洋橄欖等中以游離狀態,竹節人參 、人參、甜菜等中以皂角苷存在於其中。本發明之抗肥滿 用飮食物中,樺木酸,此等之生理上可被容許之鹽,或此 等之衍生物的由來並不予限制,可爲自天然所得者,人工 合成者,市販品等之任一均可使用,惟考慮本發明爲飮食 物之形態,以例如自當藥、丁香、葡萄、洋橄欖,竹節人 參、人參、甜菜等天然物所得者爲宜。尤其自洋橄欖所得 者爲宜,具體言以自洋橄欖植物及/或於製造橄欖油步驟 中所得副產物得到者爲宜。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) " • 30 - 200300069 A7 B7 五、發明説明(2}The physiologically tolerable salt or derivative of arsitol is the same as the above paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -28- 200300069 A7 B7 _ V. Description of the invention (2 (Please read the precautions on the back before filling out this page) Printed by the 8th Industrial Cooperative Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ Here, the related derivatives are not restricted as follows, but for example, they are derived from a part Then it can be 3.0-ethenyl-arsitol, 3-0-propanyl-arsitol, 3-0-butanyl-arsitol, 3-0-pentyl-arsanol, 3 -0-decylmethyl-arsanol, 3-0-lauryl-arsitol, 3-0-myristyl-arsitol, 3-0-palmityl-arsitol, 3-0-palm Fluorenyl-arsanol, 3-0-stearyl-arsanol, 3-0-oleyl-arsitol, 3-0-isooleyl-arsitol, 3-〇 · linoleyl-bear Alcohol, 3-0-linoleyl-arsanol, 3_0-arachisyl-arsanol, 3-0-arachisyl arbutin, 3-0-behenyl-arsanol, 28 -0-Ethyl-arsanol, 28-0-propanyl-arsanol, 28-0-butanyl-arsanol, 28-0-pentyl-arsanol, 28-0-decyl Yen Kei- 28-0-Lauryl-Arsanol, 28-0-Myristylarsanol, 28-0-Palmyl-Arsanol, 28-0-Palmyl-Arsanol, 28 -0-stearyl-arsanol, 28-0-oleyl-arsitol, 28-0-isooleyl-arsitol, 28-0-linoleyl-arsanol, 28-0-sub Oleyl-arsanol, 28-0-arachisyl-arbutin, 28-0-arachisyl-arbutin, 28-0-behenyl-arsanol, 3-0-methyl- Arbutol, 3-0-ethyl-arsitol, 3-0-third butyl-arsitol, 3-0 · triethylsilyl-arsitol, 28-0-methyl-arsanol Alcohol, 28-0-ethyl · arsitol, 28-0-third butyl-arsanol, 28-0-triethylsilyl-arsanol, 3-0-; SD-glucopyridine Uranyl-arsanol, 3-0-cold-D-galactopyranosyl-arsanol, 3-0-stone-D-glucuronopyranyl-arsanol, 28-0-Ling- D-glucopyranyl-arsanol, 28-〇 · -D-galactopyranosyl-arsanol, 28-0-cold-D-glucuronyl-pyranyl-arsanol, etc., among which 3-0-Ethyl-arsanol, 28-0-Ethyl-arsanol are suitable. The above are just listed as derivatives, and only one base is derived. This paper applies the Chinese National Standard (CNS) ) A4 specifications (210X297 mm) -29 · 200300069 A7 _____B7_ V. Description of the invention (2 & (Please read the precautions on the back before filling this page), but the position and type derived from these can also be two Bases are derivatized. For example, it may be 3,28-diethylfluorenyl-arsanol. The glycosides are only monosaccharides, but they may be oligosaccharides selected from the group consisting of disaccharides of various sugars. Betulinic acid and betulin are both types of lupinane triterpenes, and they are known to exist in various plants. The physiologically tolerable salts and derivatives are as described above. When betulinic acid and betulin are used in the anti-fattiness foods of the present invention, the physiologically acceptable salts, or derivatives thereof, the source of these substances is not particularly limited and can be used Either from a natural source, an artificially synthesized product, or a commercial product, but when considering the use of food, etc., it is advisable to use a natural product. Printed by the Consumers ’Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ^ One of the betulinic acid-based lupinane triterpenes, such as the structure of formula (VIII), is known to have carcinogenesis, anti-inflammatory effects, and promote wound Healing effect (JP 4-26623), inhibition of alcohol absorption (JP-A 7-53385), promotion of hair growth (JP-A 9- 1 57 1 39), etc. Natural system is in free state in medicine, clove, grape peel, olive, etc., and saponin exists in bamboo ginseng, ginseng, beet and so on. The origin of betulinic acid, these physiologically acceptable salts, or these derivatives in the food for preventing obesity in the present invention is not limited, and may be naturally derived, artificially synthesized, or marketed. Any one of the products can be used, but it is considered that the present invention is in the form of coriander food, and it is preferably obtained from natural products such as medicine, cloves, grapes, olives, bamboo ginseng, ginseng, beet and the like. In particular, those obtained from olive oil are suitable, and specifically those obtained from olive oil plants and / or by-products obtained in the step of producing olive oil are suitable. This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) " • 30-200300069 A7 B7 V. Description of the invention (2)

樺木酸之其生理上可被容許之鹽或衍生物係如上述一 樣。 在此其生理上可被容許之鹽雖不一定限制如下者,但 例如做爲樺木酸可爲樺木酸鈉、樺木酸鉀、樺木酸銨、樺 木酸二甲銨、樺木酸鈣、樺木酸鎂等。其中,以樺木酸鈉 及樺木酸鉀爲宜。 又,樺木酸之衍生物係如其任一部位被衍生化者,可 爲樺木酸甲酯、樺木酸乙酯、樺木酸正丙酯、樺木酸異丙 酯、樺木酸正丁酯、樺木酸三甲矽烷酯、樺木酸三乙矽烷 酯、樺木酸-/3 -D-葡糖吡喃酯、樺木酸冷-D-半乳吡喃酯、 3-0-乙醯基-樺木酸、3-0-丙醯基-樺木酸、3-0-丁醯基-樺木 酸、3-0·戊醯基-樺木酸、3-0·癸醯基-樺木酸、3-0-月桂基-樺木酸、3-0-肉豆蔻基-樺木酸、3-0-棕櫚基-樺木酸、3-0-棕櫚醯基·樺木酸、3-0-硬脂基-樺木酸、3-0-油基-樺木酸、 3-0-異油基-樺木酸、3_0-亞麻基-樺木酸、3_0·亞油基-樺木 酸、3-0-花生基-樺木酸、3-0-花生浸烯基-樺木酸、3-0-山 窬基·樺木酸、3-0·甲基-樺木酸、3-0-乙基-樺木酸、3-0-第 三丁基-樺木酸、3-0-三乙矽烷基-樺木酸、3-0-/3 -D-葡糖吡 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 裝. 訂 經濟部智慧財4局員工消費合作社印製 -31 - 200300069 A7 _B7_ 五、發明説明(2¾ 喃基-樺木酸、3-O-yS-D-半乳吡喃基-樺木酸、3-0-/3-D-葡 (請先閱讀背面之注意事項再填寫本頁) 糖吡喃基·樺木酸等,其中尤以樺木酸乙酯爲宜。以上只舉 出做爲衍生物只有一基被衍生化者,惟此等中被衍生化之 位置及種類亦可爲二基以上被衍生化者。又,糖苷亦只舉 單糖而已,惟亦可爲選自各種糖類所成群之二糖以上的低 聚糖。 樺木醇(butulin)係羽扇烷系三萜烯之一種,具有如式 (IX)之構造,已知其作用具有抑制活體蛋白質變性之作用( 特開平9-6725 3),阻斷甘油磷酸脫氫酶作用,阻斷脂肪酶 作用(特開平1 0-265328),預防肝病作用(特開平1 1 -209275) 等。天然中已知存在於白樺之樹皮等。本發明之抗肥滿用 飮食物中樺木醇或此等之衍生物的由來並不限制,可以爲 自天然所得者人工合成者,市販品等任一均可使用,惟考 慮本發明爲飮食形態時,以例如自白樺之樹皮等天然所得 者爲宜。The physiologically acceptable salts or derivatives of betulinic acid are as described above. Although the physiologically acceptable salts are not necessarily limited to the following, for example, betulinic acid may be sodium betulinate, potassium betulinate, ammonium betulinate, dimethylammonium betulinate, calcium betulinate, and magnesium betulinate. Wait. Among them, sodium betulin and potassium betulinate are suitable. In addition, if any of the derivatives of betulinic acid is derivatized, it may be methyl betulinate, ethyl betulinate, n-propyl betulinate, isopropyl betulinate, n-butyl betulinate, or trimethyl betulinate. Silyl ester, triethylsilyl betulinate, betulinic acid- / 3-D-glucopyranyl ester, betulinic acid cold-D-galactopyranoate, 3-0-acetamido-birulinic acid, 3-0 -Propanyl-Betulinic acid, 3-0-Butyl-Betulinic acid, 3-0 · Pentyl-Betulinic acid, 3-0 · Decyl-Betulinic acid, 3-0-Lauryl-Betulinic acid, 3 -0-Myristyl-Betulinic acid, 3-0-Palmyl-Betulinic acid, 3-0-Palmitinyl-Betulinic acid, 3-0-Stearyl-Betulinic acid, 3-0-Oleyl-Birch Acid, 3-0-iso-oleyl-betulinic acid, 3_0-linoleyl-betulinic acid, 3_0 · linoleyl-betulinic acid, 3-0-arachidyl-betulinic acid, 3-0-arachidene-bienyl-birch Acid, 3-0-Behenyl-Betulinic Acid, 3-0-Methyl-Betulinic Acid, 3-0-Ethyl-Betulinic Acid, 3-0-Tertiary Butyl-Betulinic Acid, 3-0-Tri Ethylsilyl-betulinic acid, 3-0- / 3-D-glucopyranine This paper is sized for China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back first (Write this page). Order. Printed by the Consumer Cooperatives of the 4th Bureau of Wisdom and Finance of the Ministry of Economy -31-200300069 A7 _B7_ V. Description of the invention Betulinic acid, 3-0- / 3-D-glucose (please read the precautions on the back before filling out this page) sugar pyranyl betulinic acid, etc. Among them, ethyl betulinate is preferred. The above are just examples Derivatives have only one base being derivatized, but the position and type of these derivatives can also be derivatized with more than two bases. In addition, glycosides are only monosaccharides, but they can also be selected from various Oligosaccharides with more than disaccharides grouped by carbohydrates. Butulin is one of the lupinane triterpenes and has a structure like formula (IX). It is known to have the effect of inhibiting the denaturation of living proteins ( Kaiping 9-6725 3), blocking the action of glycerol phosphate dehydrogenase, blocking lipase (Japanese Patent Application No. 10-265328), preventing liver diseases (Japanese Patent Application No. 1 1-209275), etc. It is known to exist in white birch in nature The bark, etc. The origin of betulin or these derivatives in the anti-plump foods of the present invention is not limited, but Those obtained from any of a synthetic natural persons, and the like can be used commercially available products, but the present invention is considered Yin food form, for example, from the birch bark obtained by appropriate natural.

經濟部智慧財1局員工消費合作社印製 有關樺木醇其生理上可被容許之鹽係如上述一樣。 在此,有關衍生物雖不受以下所限制,惟例如做爲一 個部fiL被衍生化者則可爲3-0-乙·基-樺木醇、3-0·丙釀基· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐]" 一 '-- -32 - 200300069 A7 B7_____ 五、發明説明(d (請先閲讀背面之注意事項再填寫本頁) 絰濟部智慧財1局8工消費合作社印¾ 樺木醇、3-0-丁醯基-樺木醇、3-0-戊醯基-樺木醇、3-0-癸 醯基-樺木醇、3-0-月桂基-樺木醇、3-0-肉豆蔻基-樺木醇、 3-0-棕櫚基·樺木醇、3-0-棕櫚醯基-樺木醇、3-0-硬脂基-樺 木醇、3-0-油基-樺木醇、3-0-異油基-樺木醇、3-0-亞麻基-樺木醇、3-0-亞油基-樺木醇、3-0-花生基-樺木醇、3-0-花 生浸烯基·樺木醇、3-0-山窬基-樺木醇、28-0-乙醯基-樺木 醇、28-0-丙醯基-樺木醇、28-0-丁醯基-樺木醇、28-0-戊 醯基-樺木醇、28-0 -癸醯基-樺木醇、28-0 -月桂基-樺木醇 、28-0-肉豆蔻基-樺木醇、28-0-棕櫚基-樺木醇、28-0-棕 櫚醯基-樺木醇、28-0-硬脂基-樺木醇、28-0-油基-樺木醇 、28-0 -異油基-棒木醇、28-0 -亞麻基-棒木醇、28-0 -亞油 基-樺木醇、28-0-花生基-樺木醇、28-0-花生浸烯基-樺木 醇、28-0-山窬基-樺木醇、3-0·甲基-樺木醇、3-0-乙基·樺 木醇、3-0-第三丁基-樺木醇、3-0-三乙矽烷基·樺木醇、 28-0-甲基·樺木醇、28-0-乙基-樺木醇、28-0-第三丁基-樺 木醇、28-0-三乙矽烷基-樺木醇、3-0-/5-D-蔔糖吡喃基·樺 木醇、3-0-^S-D-半乳吡喃基-樺木醇、3-0-^S-D-葡萄糖醛 酸吡喃基-樺木醇、28-0-/3-D-葡糖吡喃基-樺木醇、28-〇· 万-D-半乳吡喃基-樺木醇、28-0-;S-D-葡萄糖醛酸吡喃基-樺木醇等,其中以3-0-乙醯基-樺木醇、28-0-乙醯基-樺木 醇爲宜。以上只舉出做爲衍生物只有一基被衍生化者,惟 此等中被衍生之位置及種類亦可爲二基以上被衍生化者。 例如可爲3,28·二乙醯基-樺木醇。又,糖苷亦只舉單糖而已 ,惟亦可爲選自各種糖類所成群之二糖以上的低聚糖。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ~ "" -33 - 200300069 A7 B7 五、發明説明(3J) (請先閲讀背面之注意事項再填寫本頁) 經濟部智慧財產局貞工消費合作社印製 本發明之抗肥滿用飲食品藉經口攝取而顯現其抗肥滿 功能。本發明中所述抗肥滿功能乃指直接而言,抑制前驅 型脂肪細胞之增殖,抑制由前驅型脂肪細胞分化成爲成熟 型脂肪細胞,以及抑制前驅型脂肪細胞成爲成熟型脂肪細 胞,據此,最後可預防,改善病態性肥滿,必要時還可減肥 或創造不易肥滿之體質爲無論去美容上或心理上都能給與 所期待功能。上述之前驅型脂肪細胞乃指存在於脂肪組織 中,藉增殖因子而能增加其數目,更由成分化因子而成爲 能蓄積體內所攝取之脂肪之成熟型脂肪細胞之前驅型細胞 而言。一般所謂肥滿乃指體內蓄積過剩脂肪之狀態而言,, 被認爲是能貯存脂肪之脂肪細胞所構成脂肪組織過多增生 所造成。因此,能抑制脂組織之形成有關前驅型脂肪細胞 之增殖,自然可以預防,改善肥滿,或減肥或成爲不易肥 滿體質。就此而言,本發明之抗肥滿用飮食品含有具備前 驅型脂肪細胞增殖抑制功能,前驅型脂肪細胞分化抑制功 能,成熟型脂肪細胞脂肪蓄積抑制功能等之抗肥滿功能之 五環性三萜烯類和其生理上容許之鹽類或其衍生物。所以 能期待得預防,改善肥滿,減肥或成爲不易肥滿體質,而 非常有用。換言之,本發明之抗肥滿用飮食品藉攝取而能 顯現其抗肥滿功能,具體言之,藉抑制皮下脂肪或內臟脂 肪之蓄積或減少所蓄積之脂肪等,而對於預防,改善肥滿, 或減肥或造成不易肥滿體質等有很大貢獻。 如同前述,肥滿乃指脂肪在體內蓄積過多之狀態,被 認爲由能蓄積脂肪之脂肪細胞所構成脂肪組織增生過多所 本纸&尺度適用中國國家標準(CNS ) A4規格(210X297公釐1 -34 - 200300069 A7 _B7_ 五、發明説明(3ί (請先閱讀背面之注意事項再填寫本頁) 造成,然而,已知這種肥滿和高脂血症,糖尿病,動脈硬化 ,冠狀動脈疾症或腦血管疾病等血管疾病有密切地關連( 參考,板倉編:脂質之科學,135〜153頁,1 999年)。因此, 能抑制脂肪細胞數目或脂肪細胞中之脂肪蓄積,就可能預 或改善肥滿或其有關連之高脂血症,糖尿病,動脈硬化, 冠狀動脈疾病或腦血管疾病等血管疾病。關於這一點,本 發明之抗肥滿用飮食品含有具備前驅型脂肪細胞抑制功倉g, 前驅型脂肪細胞分化抑制功能,成熟型脂肪細胞脂肪蓄積 抑制功能等之抗肥滿功能之五環性三萜烯類和其生理上容 許之鹽類或其衍生物,所以可期待其將肥滿或其後續之冠 狀動脈疾病或腦血管疾病等血管疾病之發生抑制到最低限 度而甚爲理想。換言之,本發明之抗肥滿性飮食品藉攝取 而顯現其抗肥滿功能,更進而能改善或防止冠狀動脈疾病 或腦血管疾病等,對於延命長壽也有很大貢獻。 上述五環性三萜烯類和其生理上容許之鹽類或其衍生 物具有前驅型脂肪細胞增殖抑制功能。 經濟部智慈財產局員工消費合作社印¾ 本發明中所謂前驅型脂肪細胞增殖抑制功能乃指可抑 制脂肪組織中之前驅型脂肪細胞在脂肪組織中增殖之功能, 就結果而言,可期待其預防脂肪組織之增生,或已存在之 脂肪組織不再肥大,甚至還會縮小之效果。本發明中用以 評估前驅型脂肪細胞增殖抑制功能之方法,乃係試管試中 篩選具有抗肥滿功能之物質用已知方法(參考Satory等人 ,J.Nntr.1 29: 92- 97,1 999年),其特徵在篩選容易,快速 且能回避犠牲很多試驗動物等。本發明中使用藉培養之前 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' " -35- 200300069 A7 B7 五、發明説明(3全 (請先閲讀背面之注意事項再填寫本頁) 驅型脂肪細胞所具有之氧化還原能力而能產生螢光物質 之試藥,將該螢光物質之產生量以螢光強度之強弱加以測 定,而探討有無增殖抑制功能。 本發明中之五環性三萜烯類和其生理上容許之鹽類 或其衍生物之前驅型脂肪細胞增殖抑制功能,可由使用前 驅型脂肪細胞之試驗法而示之。本發明中所使用前驅型脂 肪細胞爲來源於鼠之培養前驅型脂肪細胞株,該細胞按一 般方法培養的,以1 8小時爲加倍時間之增殖能力。在培養 基上形成均一之單屬細胞。相對地,該培養系中存在有具 備前驅型脂肪細胞增殖抑制功能之物質時,前驅型脂肪細 胞之增殖受到抑制,而相對地細胞之氧化還原能力也被抑 制,所產生之螢光物質量也減少而螢光強度也減弱。由這 種螢光強度之相對情形,可評估前驅型脂肪細胞增殖抑制 功能。 經濟部智慧財產局員工消費合作社印¾ 依據上述試驗法評估,將本發明中之五環性三萜烯類 和其生理上容許之鹽類或其衍生物之前驅型脂肪細胞增 殖抑制功能和周知之具有抗肥滿功能物質之CL A比較時 。例如山楂酸具有約2〜30倍,山楂酸鹽類爲約2〜28倍,古 柯二醇爲約2〜25倍,熊果酸爲約2〜60倍,熊果酸爲約2〜8 倍,樺木酸爲約2〜10倍,樺木醇爲約2〜12倍,山楂酸乙酯 爲約2〜30倍,乙醯山楂酸爲約2〜28倍,三乙基甲矽烷化山 楂酸爲約2〜2 8倍,硬脂化山楂酸乙酯爲約2〜3 2倍,乙醯化 古柯二醇爲約2〜4 4倍,熊果酸乙酯爲約2〜4 8倍,乙醯化熊 果醇爲約2〜12倍,樺木酸乙酯爲約2〜12倍,乙醯化樺木醇 本紙張>^1適财關家料(CNS ) ( 21GX297公着) -- -36 - 200300069 A7 B7_ 五、發明説明(d (請先閲讀背面之注意事項再填寫本頁) 爲約2〜12倍等之高前驅型脂肪細胞增殖抑制功能。換言 之,本發明之抗肥滿用飮食品由於含有五環性三萜烯類和 其生理上容許之鹽類或其衍生物,可獲得較之具有高抗肥 滿功能之CLA更強之前驅型脂肪細胞增殖抑制功能。 又,上述五環性三萜烯類和其生理上容許之鹽類或其 衍生物具有前驅型脂肪細胞分化抑制功能。 該前驅型脂肪細胞分化抑制功能乃指抑制分化因子 對於前驅型脂肪細胞之作用,而抑制由前驅型脂肪細胞起 分化爲成熟型脂肪細胞,結果,抑制成熟型脂肪細胞之產 生而能預防新脂肪組織之形成,或使已存在之脂肪組織中 之前驅型脂肪細胞不要成爲成熟型脂肪細胞。本發明中, 在分化時以上述物質等之作用,藉和對照群比較分化,成 熟後之成熟型脂肪細胞中所攝取中性脂肪(三甘油酯)量 而判斷有無分化抑制功能。 經濟部智慈財產局員工消費合作社印製 本發明中之五環性三萜烯類和其生理上容許之鹽類或 其衍生物之前驅型脂肪細胞分化抑制功能,可藉使用前驅 型脂肪細胞試驗法而示之。本發明中所使用前驅型脂肪細 胞乃係來源於鼠之培養前驅型脂肪細胞株,欲使該細胞分 化成爲脂肪細胞,必須用牛胎兒血淸,地塞米松(氟美松) ,3·異丁基-1·甲基黃嘌呤以及胰島素等之分化因子加 以作用,而藉該作用前驅型脂肪細胞起分化成爲脂肪細胞 。相對之,分化期存在具有抑制分化功能之物質者,成熟 型脂肪細胞數目減少,或細胞內所攝取之三甘油酯量會減 少。從和對照群比較上述三甘油酯之減少程度,可評估前 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -37 - 200300069 A7 ____ B7 五、發明説明(3)j 驅型脂肪細胞分化抑制功能。 (請先閱讀背面之注意事項再填寫本頁) 據上述試驗法評估將本發明之五環性三萜烯類和其 生理上容許之鹽或其衍生物之前驅型脂肪細胞分化抑制 功能,和周知之具有抗肥滿功能物質之CL A比較時,例如 山楂酸具備約爲2〜22倍,山楂酸鹽爲約2〜20倍,古柯二醇 爲約2〜20倍,熊果酸爲約2〜18倍,熊果醇爲約2〜16倍,樺 木酸爲約2〜18倍,樺木醇爲約2〜20倍,山楂酸乙酯爲約 2〜2 2倍,乙醯化山楂酸爲約2〜22倍,三乙基甲矽烷化山楂 酸爲約2〜20倍,硬酯化山楂酸乙酯爲約2〜22倍,乙醯化古 柯二醇爲約2〜20倍,熊果酸乙酯爲約2〜18倍,乙醯化熊果 醇爲約2〜18倍,樺木酸乙酯爲約2〜18倍,乙酸化樺木醇爲 約2〜20倍等之高前驅型脂肪細分化抑制功能。換言之,本 發明之抗肥滿用飮食品因含有五環性三萜烯類和其生理上 容許之鹽或其衍生物,具有高於CLA之強大前驅型脂肪細 胞分化抑制功能。 又,上述五環性三萜烯類和其生理上容許之鹽類或其 衍生物具有成熟型脂肪細胞脂肪蓄積抑制功能。 經濟部智慧財產局員工消費合作社印製 該成熟型脂肪細胞脂肪蓄積抑制功能乃指當前驅型脂 肪細胞受到分化因子刺激之後,抑制其成爲能蓄積體內所 攝取脂肪在細胞內之所謂成熟型脂肪細胞之情形,其結果 可抑制新成熟型脂肪細胞產生而預防進一步形成脂肪組織 ,或期待已存在之脂肪組織中之前驅型脂肪細胞受到分化 因子之刺激之後也不會成爲成熟型脂肪細胞等效果。本發 明中,藉上述物質作用在受到分化因子刺激之前驅型脂肪 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -38- 200300069 A7 ___B7___ 五、發明説明(3¾ (請先閲讀背面之注意事項再填寫本頁) 細胞,將分化成爲成型型脂肪細胞,蓄積脂肪後之細胞內 所攝取中性脂肪(即三甘油酯)量和對照群比較而評估有 無成熟型脂肪細胞脂肪蓄積抑制功能。 本發明中之五環性三萜烯類和其生理上容許之鹽類或 其衍生物之成熟型脂肪細胞脂肪蓄積抑制功能可藉使用前 驅型脂肪細胞之試驗法示之。本發明中所使用前驅型脂肪 細胞乃係來源於鼠之培養前驅型脂肪細胞株,該細胞要分 化成爲脂肪細胞,必須用牛胎兒血淸,塞地米松,3-異丁 基-1-甲基黃嘌呤和胰島素等分化因子之作用。由該作用 前驅型脂肪細胞始分化成爲脂肪細胞,然後成熟成爲成熟 型脂肪細胞。相對之,分化後之脂肪細胞成熟期,使具有 成熟型脂肪細胞脂肪蓄積抑制功能之物質共存時,成熟型 脂肪細胞數目減少,或細胞內所攝取三甘油酯量會減少。 和對照群比較上述三甘油酯量之減少情形,可評估成熟型 脂肪細胞脂肪蓄積抑制功能。 經濟部智慧財度局員工消費合作社印¾ 依據上述試驗法評估,將本發明中之五環性三萜烯類 和其生理上容許之鹽或其衍生物之成熟型脂肪細胞脂肪蓄 積抑制功能,和周知之具有抗肥滿功能物質之CLA比較時, 例如山楂酸具有約2〜20倍,山楂酸鹽爲約2〜20倍,古柯二醇 爲約2〜20倍。熊果酸爲約2〜18倍,熊果醇爲約2〜18倍,樺 木酸爲約2〜18倍,樺木醇爲約2〜18倍,山楂酸乙酯爲約 2〜20倍,乙醯化山楂酸爲約2〜20倍,三乙基甲矽烷化山楂 酸爲約2〜20倍,硬脂化山楂酸乙酯爲約2〜20倍,乙醯化古 柯二醇爲約2〜20倍,熊果酸乙酯爲約2〜20倍,乙醯化熊 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) '~' -39 - 200300069 A7 B7 五、發明説明(扁 (請先閱讀背面之注意事項再填寫本頁) 果醇爲約2〜18倍,樺木酸乙酯爲約2〜18倍,乙醯化樺木醇 爲約2〜20倍等之高成熟型脂肪細胞脂肪蓄積抑制功能。換 言之,本發明之抗肥滿用飮食品因含有五環性三萜烯類和 其生理上容許之鹽或其衍生物,而具有較之CLA更強大之成 熟型脂肪細胞脂肪蓄積抑制功能。 五環性三萜烯類和其有醇酯基之衍生物,具有脂肪酸 酯基之衍生物,具有烷氧基之衍生物,具有烷氧基甲基之 衍生物通常的脂溶性,因此,可以調配在油系或乳化系飮 食品等而使用。又,特別是以油脂或油脂加工品而攝取時, 可期得和油一起吸收,因此,從吸收性觀點而言較佳。 又,五環性三萜烯類之生理上容許之鹽類或配糖物通 常爲水溶性,因此,可藉物一溶解分散在水系或乳化系等 飮食品而使用。特別是飮食多屬水系或乳化系製品,因此, 必要時,將五環性三萜烯類製成其生理上容許之鹽類或配 糖物而調配使用。 經濟部智慧財/i局員工消費合作社印製 另外,五環性三萜烯類和/或其生理上容許之鹽類可藉 調配極微量在飮食品中就能達成通常需要之抗肥滿功能, 在成本上也有好處,同時從調配比率觀點而言,也有多餘 空間和其他成分配合,所以也能充實其他功能。 當然,也可藉增加五環性三萜烯類和/或其生理上容許 之鹽類之調配量,藉本發明也能製造具有極優異之抗肥滿 功能等之飮食品。 本發明中之五環性三萜烯類如同上述已知存在於植 物等天然物中,幾乎所有物質都經由植物而供人類飮食之 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X29*7公釐) " -40 - 200300069 A7 B7 五、發明説明(3} 經驗存在,所以祗要不過分攝食對於身體不會有不良影響 〇 就實際投與動物情形而言,例如山楂酸之LD5〇値爲 2000mg/kg體重以上,可確知其安全性極高。此結果顯示 可經口攝取具有前驅型脂肪細胞增殖抑制功能,前驅型脂 肪細胞分化抑制功能,成熟型脂肪細胞脂肪蓄積抑制功能 等抗肥滿功能之五環性三萜烯類。換言之,可經由飮食品 等形態攝取之。該情形下,不像醫藥品等之投與之際,所 伴隨麻煩或痛苦等,可繼續而簡便地攝取到體內。 又,主以減肥而使用時,本發明之五環性三萜烯類和 其生理上容許之鹽或其衍生物可直接作用在前驅型脂肪細 胞,所以可期得對其他營養成分之代謝達到最低之影響。 換言之,例如具有脂質分解作用之減肥劑等,對於人體最 低限之必須營養也會以阻礙其吸收之方向而作用,所以在 副作用方面存有不安,但本發明中之五環性三萜烯類和其 生理上容許之鹽或其衍生物係直接作用在前驅型脂肪細胞, 所以對於血中脂質,血糖等可說幾乎無影響。就這一點而 言,本發明之抗肥滿用飮食品由於充分攝取營養情形下, 尙能減肥,所以從安全上而觀,也非常理想。 本發明之抗肥滿用飮食品所適用之症狀,例如肥大性 肥滿,形成過大性肥滿,肥大性一形成過大性肥滿等之肥 滿症狀。 本發明乃含有由五環性三萜烯類和其生理上容許之鹽 或其衍生物中選擇1種或2種以上而成抗肥滿用飮食品有關 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) CII (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局貸工消費合作社印製 -41- 200300069 A7 B7 五、發明説明(3¾ (請先閲讀背面之注意事項再填寫本頁) 。上述「含有」乃指以能表現抗肥滿功能爲準而含有之意, 以及期待藉由前驅型脂肪細胞增殖抑制抑制,分化抑制, 脂肪蓄積抑制而對於脂肪組織之產生或增加發揮功能而調 配之意在內。 經濟部智慧財凌局員工消費合作社印%ί 本發明之抗肥滿用飮食品中含有五環性三萜烯類和其 生理上容許之鹽或其衍生物時,其含量隨所含有五環性三 萜烯類之種類,飮食品之種類,攝取量,攝取頻率,年齡, 性別,體重,症狀輕重,健康狀態等條件而異,不能一槪而 論。當然,該含量係藉由前驅型脂肪細胞之增殖抑制,分 化抑制,脂肪蓄積抑制而對於脂肪組織之產生或增生之預 防,治療上具有功效之含量。特別是爲獲得本發明之抗肥 滿功能,五環性三萜烯類和其生理上容許之鹽或其衍生物 之一日之攝取量,例如山楂酸而言,通常在0.001〜5g範圍, 其中以0.001〜lg爲最佳。因此,本發明之抗肥滿用飮食品中 之五環性三萜烯類和其生理上容許之鹽或其衍生物之含量, 例如在0.00001〜90質量%範圍,其中以0.0001〜80質量%爲 佳,以0.001〜70質量%爲較佳,又以0.01〜65質量%爲更佳 ,更以0.1〜60質量%爲較佳,更以0.2〜55質量%爲較佳, 更以0.4〜50 質量%爲較佳,更以0.6〜45 質量%爲較佳, 更以0.8〜40 質量%爲較佳,更以1.0〜35 質量%爲較佳, 更以2.0〜3 0 質量%爲適宜。但不侷限在上述範圍。又, 本發明之抗肥滿用飮食品之有效成分,當含有洋橄欖植物 之脫脂物,洋橄欖萃取物或洋橄欖萃取油時,其有效成分 中所含有五環性三萜烯類等之含量調整在上述規定範圍爲 本纸伕尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -42 - 200300069 A7 B7 五、發明説明(3¾ 宜。 (請先閲讀背面之注意事項再填寫本頁) 本發明之抗肥滿用飮食品中,做爲前驅型脂肪細胞增 殖抑制成分,前驅型脂肪細胞分化抑制成分,成熟型脂肪 細胞脂肪蓄積抑制成分,而含有五環性三萜烯類和其生理 上容許之鹽或其衍生物時,其含量隨所含有五環性三萜烯 類之種,飮食品之種類,攝取量,攝取頻率,年齡,性別, 體重,症狀輕重,健康狀態等條件而異,不能一槪而論。 當然,該含量係對於前驅型脂肪細胞之增殖抑制,分化抑 制,脂肪蓄積抑制上有效之含量。該含量例如在0.00001〜90 質量%範圍,其中以0.0001〜80質量%爲宜,又以0.001〜70 質量%爲較宜,又以0.01〜65質量%爲更佳,更以0.1〜60質 量%爲較佳,更以0.2〜55質量%爲較佳,更以0.4〜50質量% 爲較佳,更以0·6〜45質量%爲較佳,更以0.8〜40質量%爲 較佳,更以1.0〜35質量%爲較佳,尤以2.0〜30質量%爲適 佳,但並侷限在上述範圍。 經濟部智慧財4局員工消費合作社印製 本發明之抗肥滿用飮食品之特徵在因含有五環性三萜 烯類等而具有前驅型脂肪細胞增殖抑制功能,前驅型脂肪 細胞分化抑制功能,成熟型脂肪細胞脂肪蓄積抑制功能等 之抗肥滿功能。由於屬於飮食品之形態,所以容易且可繼 續攝取,而期得適佳效果。 又,本發明乃前述五環性三萜烯類係一般式(I)所示 齊墩果烷系三萜烯類,一般式(II)所示熊果烷系三萜烯 類,一般式 (III)所示羽扇烷系三萜烯類中選擇1種或2 種以上之抗肥滿用飮食品有關。這些由於具有抗肥滿功能 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇Χ29*7公釐) -43 - 200300069 A7 ___B7_ 五、發明説明(扃 ,而其前驅型脂肪細胞增殖抑制功能,前驅型脂肪細胞分 化抑制功能,成熟型脂肪細胞脂肪蓄積抑制功能等之高抗 肥滿功能而適佳。 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分,而含有齊墩果烷 系三萜烯類和/或其生理上容許之鹽類和/或其衍生物時,其 含有量如同前述不論一槪而論,也非侷限在下述範圍,該 含量例如在0.00001〜90質量%範圍,其中以0.0001〜80質量 %爲宜,以0.001〜70質量%爲較佳,又以0.01〜65質量%爲 更佳,更以0.1〜60質量%爲較佳,更以0.2〜55質量%爲較 佳,更以0.4〜50質量%爲較佳,更以0.6〜45質量%爲較佳, 更以0.8〜40質量%爲較佳,更以1.0〜35質量%爲較佳,尤 以2.0〜30質量%爲適宜。 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分,而含有熊果烷系 三萜烯類和/或其生理上容許之鹽和/或其衍生物時,其含 量如同前述不能一槪而論,也非侷限在下述範圍。該含量 例如在0.00001〜90 質量%範圍,其中以0.0001〜80 質量% 爲宜,以0.001〜70質量%爲較佳,又以0.01〜6 5質量%爲 更佳,更以0.1〜60質量%爲較佳,更以0.2〜55質量%爲 較佳,更以0.4〜50質量%爲較佳,更以0.6〜45 質量%爲 較佳,更以0.8〜40質量%爲較佳,更以1.0〜35質量%爲 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) •裝- 經濟部智慧財產局員工消費合作社印製 -44 - 200300069 A7 __B7_ 五、發明説明(4¾ 較佳,尤以2.0〜30質量%爲適佳。 (請先閲讀背面之注意事項再填寫本頁) 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分,而含有羽扇烷系 三萜烯類和/或其生理上容許之鹽類和/或其衍生物時,其含 量如同前述不能一槪而論,也非侷限在下述範圍。該含量 例如在0.00001〜90質量%範圍,其中以0.001〜80質量%爲 宜,以0.001〜70質量%爲較佳,又以0.01〜65質量%爲更佳, 更以0.1〜60質量%爲較佳,更以0.2〜55質量%爲較佳,更 以0.4〜50質量%爲較佳,更以0.6〜45質量%爲較佳,更以 0.8〜40質量%爲較佳,更以1.0〜35質量%爲較佳,尤以 2.0〜30質量%爲適佳。 上述齊墩烷系三萜烯類而言,以山楂酸,古柯二醇爲 較佳,尤以山楂酸爲最佳。就熊果烷系三萜烯類而言,以 熊果酸,熊果醇爲佳。羽扇烷系,三萜烯類而言,以樺木 酸,樺木醇爲佳。 經濟部智慧財產局員工消費合作社印製 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有山楂酸和/或 其生理上容許之鹽或其衍生物時,其含量如同前述不能一 槪而論,也非侷限在下述範圍。該含量例如在0.0000 1〜90 質量%範圍,其中以0.0001〜80質量%爲宜,又以0.001〜70 質量%爲較佳,又以〇.〇1〜65質量%爲更佳,更以0.1〜60 質量%爲較佳,更以0.2〜5 5質量%爲較佳,更以0.4〜50 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -45 - 200300069 A7 B7 五、發明説明(4i (請先閱讀背面之注意事項再填寫本頁) 質量%爲較佳,更以0.6〜45質量%爲較佳,更以0.8〜40 質量%爲較佳,更以1.0〜35質量%爲較佳,尤以2.0〜30質 量%爲適佳。 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有古柯二醇和/ 或其生理上容許之鹽或其衍生物時,其含量如用上述不能 一槪而論,也非侷限在下述範圍。該含量例如在0.00001〜90 質量%範圍,其中以0.0001〜70質量%爲宜,又以0.001〜60 質量%爲較佳,又以0.01〜50質量%爲更佳,更以0.1〜40質 量%爲較佳,尤以1.0〜30質量%爲適佳。 經濟部智慧財產局員工消費合作社印製 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有熊果酸和/或 或生理上容許之鹽或其衍生物時,其含量如同前述不能一 槪而論,也非侷限在下述範圍。該含量例如在0.00001〜90 質量%範圍,其中以0.0001〜70質量%爲宜,又以0.001〜60 質量%爲較佳,以0.01〜50質量%爲更佳,更以0.1〜40質 量%爲較佳,尤以1.0〜30質量%爲適佳。 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有熊果醇和/或 其生理上容許之鹽類或其衍生物時,其含量如同前述不能 一槪而論,也非侷限在下述範圍。該含量例如在 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) •46· 200300069 A7 B7 五、發明説明(扁 (請先閲讀背面之注意事項再填寫本頁) 0.00001〜90質量%範圍,其中以0.0001〜70質量%爲宜,又 以0.00卜60質量%爲較佳,又以0.01〜50質量%爲更佳,更 以0.1〜40質量%爲較佳,尤以1.0〜30質量%爲適佳。 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有樺木酸和/或 其生理上容許之鹽類或其衍生物時,其含量如同前述不能 一槪而論,也非侷限在下述範圍。該含量例如在 0.00001〜90質量%爲較佳,其中以0.0001〜70質量%爲宜, 又以0.001〜60質量%爲較佳,又以0.01〜50質量%爲更佳, 更以0.:1〜40質量%爲較佳,尤以1.0〜30質量%爲適佳。 經濟部智慧財產局員工消費合作社印製 本發明之抗肥滿用飮食品中,做爲抗肥滿成分以及前 驅型脂肪細胞增殖抑制成分,前驅型脂肪細胞分化抑制成 分,成熟型脂肪細胞脂肪蓄積抑制成分而含有樺木醇和/或 其生理上容許之鹽類或其衍生物時,其含量如同前述不能 一槪而論,也非侷限在下述範圍。該含量例如在 0.0000 1〜90質量%爲較佳,其中以0.0001〜70質量%爲宜, 又以0.001〜60質量%爲較佳,又以0.01〜50質量%爲更佳, 更以0·1〜40質量%爲較佳,尤以1.0〜30質量%爲適佳。 上述含量愈高,雖然效果愈佳,但如同前述,必要視 使用目的,使用期間,用量,使用對象年齡,性別,體重 等有關之考慮而調整其含量。 本發明之抗肥滿用飮食品,列舉具體例如下,但非侷 限在下述範圍不待說明。本發明之抗肥滿用飮食品,其形 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -47 - 200300069 A7 B7 五、發明説明(4乂 (請先閲讀背面之注意事項再填寫本頁) 瞍濟郎智慧財度局員工消費合作社印製 態並無特限制,例如一般食品,加工食品之外,他如流動 食ρα,經用營養食品,健康食品,乳幼兒用食品等形熊 皆可包括之。具體言之,例如仙貝,煎餅,爆米,含館甜 點,飴等日本式甜點;小餅乾,小甜麵包,脆餅乾,派 蛋糕,甜圈圈,布丁,海棉蛋糕,雞蛋餅,奶油,鮮奶油, 泡芙,夾克力,夾克力餅乾,牛奶,糖果,口香糖,果凍 薄餅,麵包,含餾麵包等之各歐美式甜點;馬鈴薯炸片等 速食甜點,冰淇淋,冰棒,冰霜等冰栗;乳酸飮料,乳酸 菌飮料,濃厚乳性飮料,果汁飮料,果肉飮料,機能性飮 料,碳酸飮料等之淸涼飮料;綠茶,紅茶,咖啡,可可等 嗜好品以及其飮料,發酵乳,加工乳,乳酪等乳製品;豆 漿,丑腐等黃豆加工食品;果醬,果實糖漬,花醬,花生醬 ,果膏等糊醬類;漬物類;烏龍麵,巴斯特等榖物製品; 火腿,香腸,醃燻猪肉,乾香腸,牛肉乾,漢堡等畜肉製品 ;魚肉火腿,魚肉香腸,板魚,竹輪,炸魚漿等魚貝類製品 ;魚,貝等之乾製品,鰹,鯖,鰺等魚之柴魚;海膽,小烏 魚等之_漬物;魷魚等魚之味_乾,鮭魚等之燻魚製品; 海苔;小魚,貝,山菜,香菇,昆布等之佃煑,咖哩,滷牛 肉等罐頭食品;日本豆瓣醬,醬油,醬,肉汁,沾料,咖哩 原汁,滷牛肉佐料,湯料,鮮味素等調味料;米飯類;油脂 或人造奶油,酥油,美奶滋,生菜佐料等油脂加工品,或含 油脂之各種微波食品或冷凍食品等。特別就繼續攝取之觀 點而言,以米飯類或各種調味料或調配油脂或人造奶油, 酥油,美奶滋,生菜佐料等調配油酯加工品爲較佳。又, ^紙張尺度適用中國國家標準(CNS ) A4洗格(210X297公釐) "" -48 - 200300069 A7 B7 五、發明説明(4& (請先閱讀背面之注意事項再填寫本頁) 其形狀,性狀也無特別限制。固體狀,半固體狀,凝膠狀, 液狀,粉狀等皆行,又,錠劑,膠囊劑,液劑,顆粒劑等任 何劑型均可採用。 绶濟部智慧財4局員工消費合作社印製 如同前述,本發明之抗肥滿用飮食品中之五環性三萜 烯類,其生理上容許之鹽類或其衍生物之含量,以1日之攝 取量成爲0.001〜5g,尤以能在0.001〜lg範圍爲最佳。更具體 言之,本發明之抗肥滿用飮食品爲調配油脂或人造奶油, 酥油,美奶滋,生菜佐料等調配油脂加工品時,本發明之 飮食品中所含有五環性三萜烯類,特別是山楂酸,其生理 上容許之鹽類或其衍生物之含量以製品l〇〇g計含0.001〜10g 爲宜,其中以0·01〜5g爲較佳,又以0.1〜3g爲更佳,尤以 0·2〜2g爲最佳。本發明之抗肥滿用飮食品爲錠菓,軟膠囊狀 食品,錠狀食品,粉狀食品,顆粒狀食品時,本發明中之飮 食品中所含有五環性三萜烯類,特別是山楂酸,其生理上 容許之鹽類或其衍生物之含量以製品500mg計,含1〜400mg 爲宜,其中以5〜380mg爲更佳。本發明之抗肥滿用飮食品爲 飮料,健康飮料,乳性飮料,果汁,果肉飮料,茶。咖啡類 ,酒精飮料時,本發明之飮食品中所含有五環性三萜烯類, 特別是山楂酸,其生理上容許之鹽類或其衍生物之含量以 製品200g計,以含0.002〜10g爲宜,其中以0.02〜5g爲更佳。 又,本發明之抗肥滿用飮食品,爲提升其功能,特別 是爲達成抗肥滿功能之協同效應,輔助效應,提升吸收性 等爲目的,可以調配以其他生理活性成分。上述並無特別 @制,例如被認爲對於抗肥滿功能有協同或間接性貢獻之 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -49 - 經濟部智慧財產局員工消¢合作社印¾ 200300069 A7 B7 五、發明説明(46) 抗氧化成分,提升體內吸收效率之油性成分,強化營養用 途之各種維生素。礦物質,胺基酸等可供利用。 上述抗氧化成分並無特別限制,例如生育酚類和其衍 生物,生育三烯酚類和衍生物,芝麻脂素,表芝麻脂素,芝 麻脂酚,芝麻林素,芝麻酚等之木脂素類和其配糖物,/3-胡蘿葡素等之類胡蘿葡素類和其衍生物,沒食子酸或鞣花 酸等單寧類和其衍生物,黃酮,兒茶酸,懈皮酮,無色花色 素等之類黃酮素類,泛或維生素K等之類,谷納素等之 阿魏酸衍生物,洋橄欖萃取物等。上述抗氧化劑被認爲具 有間接性抗肥滿功能,又,藉原有之抗氧化作用所帶來促 進血行功能或抗老化功能等,對於身體可期得綜合性協同 效應而適佳。 上述油性成分之例舉有芝麻油,洋橄欖油,茶油等植 物性油脂,魚油等動物性油脂之外,並無特別限制,例如 天然和化學反應或酵素反應所得MCT,MLCT,二甘油酯, 一甘油酯或由設計脂肪酸之構造而得構造油脂等。 上述強化營養用之各種維生素類,礦物質類,胺基酸 類等,雖無特別限制,以使用食品添加物標準手冊上所規 定者爲宜。 另外,本發明之抗肥滿用飮食品中,也可以調配使用 一般之飮食品中所使用材料。雖然,並無特別限制,例如 曰本豆瓣醬,醬油,西洋醬,肉汁,沾料,咖哩原汁,滷牛 肉佐抖,湯料,鮮味素等之各種調味料,猪油,牛油,乳脂 等之動物性油脂,餘油,鰛油,鰊油等水產油脂,黃豆油, 本紙張尺度適用中國國家標準(CNS ) ( 21GX297公| --— -50- (請先閲讀背面之注意事項再填寫本頁)Printed by the Employees' Cooperative of the 1st Bureau of the Ministry of Economic Affairs, Consumer Cooperatives. The physiologically acceptable salts of betulin are as described above. Here, the related derivatives are not limited as follows, but for example, as a fiL derivatized person, it can be 3-0-ethyl-betulin, 3-0 · propanol-based. This paper standard applies China National Standard (CNS) A4 Specification (210X297mm) " I '--32-200300069 A7 B7_____ V. Description of Invention (d (Please read the notes on the back before filling this page) Bureau 8 Industry Consumer Cooperative Co., Ltd. ¾ Betulin, 3-0-Butyl-Betulin, 3-0-Pentyl-Betulin, 3-0-Decyl-Betulin, 3-0-Lauryl-Betulin , 3-0-Myristyl-Betulin, 3-0-Palmityl-Betulin, 3-0-Palmityl-Betulin, 3-0-Stearyl-Betulin, 3-0-Oleol -Betulin, 3-0-Isoyl-Betulin, 3-0-Linolenyl-Betulin, 3-0-Linyl-Betulin, 3-0-Arachidyl-Betulin, 3-0- Peanut AldenylBetulin, 3-0-Behenyl-Betulin, 28-0-Ethyl-Betulin, 28-0-Propanyl-Betulin, 28-0-Butyl-Betulin, 28-0-pentamyl-betulin, 28-0-decyl-betulin, 28-0-lauryl-betulin, 28-0-myristyl-betulin, 28-0- Palmityl-bentyl alcohol, 28-0-palmitinyl-betulin, 28-0-stearyl-betulin, 28-0-oleyl-betulin, 28-0-iso-oleyl-litolol, 28-0 -Linolenyl-linol, 28-0 -linoleyl-birulin, 28-0-arachidyl-bulinol, 28-0-arachidene-benzyl alcohol, 28-0-behenlin -Betulin, 3-0 · Methyl-Betulin, 3-0-Ethyl Betulin, 3-0-Third-butyl-Betulin, 3-0-Triethylsilyl · Betulin, 28 -0-Methyl-Betulin, 28-0-Ethyl-Betulin, 28-0-Third-butyl-Betulin, 28-0-Triethylsilyl-Betulin, 3-0- / 5- D-Glucosylpyranyl-Betulin, 3-0- ^ SD-galactopyrano-Betulin, 3-0- ^ SD-glucuronyl Pyranyl-Betulin, 28-0- / 3 -D-glucopyranyl-birulinol, 28-0.0 million-D-galactopyranosyl-birulinol, 28-0-; SD-glucuronopyranyl-birulinol, etc., among which 3 -0-ethenyl-betulin and 28-0-ethenyl-betulin are suitable. The above are just examples of derivatives that have only one base being derivatized, but the positions and types of derivatization in these are also It may be derivatized with two or more radicals. For example, it may be 3,28 · diethylfluorenyl- Xylitol. In addition, the glycosides are only monosaccharides, but they can also be oligosaccharides selected from the disaccharides grouped by various sugars. This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) ) ~ &Quot; " -33-200300069 A7 B7 V. Description of the invention (3J) (Please read the notes on the back before filling out this page) The Intellectual Property Bureau of the Ministry of Economic Affairs, Zhengong Consumer Cooperative, printed this invention for anti-fullness The food and drink exhibit its anti-puffiness function when taken orally. In the present invention, the function of anti-puffiness refers to directly inhibiting the proliferation of precursor adipocytes, inhibiting the differentiation of precursor adipocytes into mature adipocytes, and inhibiting precursor adipocytes to become mature adipocytes. In the end, it can prevent and improve pathological plumpness, and if necessary, can lose weight or create a body that is not easy to plump, so that it can give the desired function whether it is cosmetic or psychological. The aforementioned prodromal adipocytes refer to the prodromal cells that are present in adipose tissue and can be increased in number by proliferation factors, and become mature adipocytes that can accumulate fats ingested by the composition factor. Generally speaking, the so-called fullness refers to the state in which excess fat is accumulated in the body, which is caused by excessive proliferation of adipose tissue composed of fat cells that can store fat. Therefore, it can inhibit the formation of adipose tissue and the proliferation of precursor-type adipocytes. Naturally, it can prevent, improve obesity, lose weight or become less obese. In this regard, the food for preventing fullness of the present invention contains a pentacyclic tri-functional anti-fullness function having a function of inhibiting the proliferation of precursor adipocytes, inhibiting the differentiation of precursor adipocytes, and inhibiting the accumulation of fat from mature adipocytes. Terpenes and their physiologically acceptable salts or derivatives thereof. Therefore, it is very useful to be able to prevent, improve plumpness, lose weight or become less fit. In other words, the anti-fatty foods of the present invention can exhibit their anti-fullness function by ingestion, specifically, by inhibiting the accumulation of subcutaneous fat or visceral fat or reducing the accumulated fat, etc., for preventing and improving the fullness , Or contribute to weight loss or make it difficult to plump body. As mentioned above, plumpness refers to the state of excessive accumulation of fat in the body. It is considered that the adipose tissue hyperplasia is composed of fat cells that can accumulate fat. The paper & standard is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm). 1 -34-200300069 A7 _B7_ V. Description of the invention (3ί (please read the precautions on the back before filling this page), however, it is known that this type of hypertrophy and hyperlipidemia, diabetes, arteriosclerosis, coronary artery disease Diseases or cerebrovascular diseases are closely related (Reference, Itakura ed .: The Science of Lipids, pp. 135 ~ 153, 1999). Therefore, it is possible to prevent the number of fat cells or the accumulation of fat in fat cells. Or improve vascular disease such as hyperlipidemia, its associated hyperlipidemia, diabetes, arteriosclerosis, coronary artery disease, or cerebrovascular disease. In this regard, the anti-fatty food product of the present invention contains a precursor-type fat cell inhibitor Gongcang g, pentacyclic triterpenes with anti-fullness function, such as precursor type adipocyte differentiation inhibition function, mature adipocyte fat accumulation inhibition function, etc. Physiologically acceptable salts or derivatives thereof, it can be expected that it will minimize the occurrence of obesity or subsequent vascular diseases such as coronary artery disease or cerebrovascular disease. In other words, the anti-fertility of the present invention Manchurian food exhibits its anti-puffiness function by ingestion, and can further improve or prevent coronary artery disease or cerebrovascular disease, etc., and also contributes significantly to longevity and longevity. The pentacyclic triterpenes mentioned above and their physiological tolerance The salts or derivatives thereof have the function of inhibiting proliferative adipocyte proliferation. Printed by the Consumer Cooperative of the Intellectual Property Office of the Ministry of Economic Affairs ¾ In the present invention, the function of inhibiting proliferative adipocyte proliferation refers to inhibiting the precursor adipocytes in adipose tissue The function of proliferation in adipose tissue, as a result, it can be expected that it can prevent the proliferation of adipose tissue, or the existing adipose tissue is no longer hypertrophic, and even the effect of shrinking. It is used in the present invention to evaluate the proliferation of precursor adipocytes The method of inhibiting function is to use known methods for screening substances with anti-hypertrophy function in test tube test (refer to Satory People, J. Nntr. 1 29: 92-97, 1999), which is characterized by easy screening, fast, and avoidance of many experimental animals. In the present invention, the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) before use. The " -35- 200300069 A7 B7 V. Description of the invention (3 full (please read the precautions on the back before filling out) (This page) A test drug that can produce fluorescent substances by the redox ability of the drive-type adipocytes. The amount of fluorescent substances produced is measured by the intensity of the fluorescent intensity, and the presence or absence of a proliferation inhibitory function is examined. The pentacyclic triterpenes and their physiologically acceptable salts or derivatives thereof have a precursor-type adipocyte proliferation inhibition function, which can be shown by a test method using a precursor-type adipocyte. The precursor-type fat used in the present invention Cells are derived from mouse-derived precursor-type adipocytes. The cells are cultured in the usual way and have a multiplier capacity of 18 hours. Double cells are formed on the culture medium. In contrast, these cells exist in this culture line. When there is a substance capable of inhibiting the proliferation of precursor adipocytes, the proliferation of precursor adipocytes is suppressed, and the cell's redox capacity is relatively Inhibited, the amount of fluorescent substance produced is also reduced and the fluorescence intensity is also weakened. From this relative situation of fluorescence intensity, the proliferative fat cell proliferation inhibition function can be evaluated. Printed by the Consumers ’Cooperative of Intellectual Property Bureau of the Ministry of Economics The above test method evaluates and compares the pentacyclic triterpenes in the present invention and their physiologically acceptable salts or their derivatives with precursor-type adipocyte proliferation inhibition function and CL A, which is a well-known substance with anti-hypertrophic function For example, maslinic acid has about 2 to 30 times, maslinate is about 2 to 28 times, cocadiol is about 2 to 25 times, ursolic acid is about 2 to 60 times, and ursolic acid is about 2 ~ 8 times, betulinic acid is about 2 ~ 10 times, betulin is about 2 ~ 12 times, ethyl maslinate is about 2 ~ 30 times, acetic acid is about 2 ~ 28 times, triethylsilylation The amount of maslinic acid is about 2 to 2 8 times, the amount of stearic ethyl maslinate is about 2 to 3 2 times, the amount of acetic cocadiol is about 2 to 4 4 times, and the amount of ethyl ursolic acid is about 2 to 4 8 times, acetic acid arbutol is about 2 to 12 times, ethyl betulinate is about 2 to 12 times, ethylated betulin paper > ^ 1 (CNS) (published by 21GX297)--36-200300069 A7 B7_ V. Description of the invention (d (Please read the precautions on the back before filling out this page) The inhibition of high precursor-type adipocyte proliferation is about 2 to 12 times In other words, since the gluten-resistant food for anti-plumbing of the present invention contains pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof, it can be stronger than CLA with a high anti-plumping function. Proliferative adipocyte proliferation inhibition function. The pentacyclic triterpenes and their physiologically acceptable salts or derivatives thereof have a precursor adipocyte differentiation inhibition function. The precursor adipocyte differentiation inhibition function refers to inhibition Differentiation factors act on precursor adipocytes, and inhibit the differentiation of precursor adipocytes into mature adipocytes. As a result, inhibiting the production of mature adipocytes can prevent the formation of new adipose tissue or make existing adipose tissue Do not become premature adipocytes. In the present invention, during the differentiation, the effect of the aforementioned substances and the like is used to compare the differentiation with the control group and determine the presence or absence of a differentiation-inhibiting function by the amount of neutral fat (triglyceride) taken up by mature adipocytes after maturation. The Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs printed the pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof of the present invention in a precursor-type adipocyte differentiation inhibiting function. The precursor-type adipocytes can be used by The test method is shown. The precursor-type adipocytes used in the present invention are derived from mouse-cultured precursor-type adipocytes. In order to differentiate the cells into adipocytes, bovine fetal blood corpuscle, dexamethasone (fluxamone), and 3 · iso Butyl-1 · methylxanthine and insulin, and other differentiation factors act, and by this effect, precursor adipocytes differentiate into adipocytes. In contrast, if there is a substance with a function of inhibiting differentiation in the differentiation stage, the number of mature adipocytes will decrease, or the amount of triglyceride in the cells will decrease. Comparing the reduction of the above triglyceride with the control group, it can be evaluated that the previous paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -37-200300069 A7 ____ B7 V. Description of the invention (3) Type adipocyte differentiation inhibition function. (Please read the notes on the back before filling this page.) Assess the pentacyclic triterpenes of the present invention and their physiologically tolerable salts or their derivatives as precursor-type adipocyte differentiation inhibitory functions according to the above test method, and When comparing CL A, which is a well-known substance with anti-pigmentation function, for example, maslinic acid has about 2 to 22 times, maslinate is about 2 to 20 times, cocadiol is about 2 to 20 times, and ursolic acid is About 2 to 18 times, arbutol is about 2 to 16 times, betulinic acid is about 2 to 18 times, betulin is about 2 to 20 times, ethyl hawate is about 2 to 2 2 times, and acetylated hawthorn The acid is about 2 to 22 times, the triethylsilylated maslinic acid is about 2 to 20 times, the hard esterified maslinic acid ethyl ester is about 2 to 22 times, and the ethyl acetate cocadiol is about 2 to 20 times. Ethyl ursolic acid is about 2 to 18 times, acetylated arsitol is about 2 to 18 times, ethyl betulinate is about 2 to 18 times, and acetated betulin is about 2 to 20 times as high. Precursor fat breakdown function. In other words, the fermented food for preventing fullness of the present invention contains a pentacyclic triterpene and a physiologically acceptable salt or a derivative thereof, and has a stronger precursor-type adipocyte differentiation inhibiting function than CLA. The pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof have the function of inhibiting fat accumulation in mature adipocytes. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, this mature fat cell fat accumulation inhibition function refers to the current type of fat cells that are stimulated by differentiation factors to inhibit them from becoming so-called mature adipocytes that can accumulate fat in the cell. In this case, as a result, it is possible to suppress the production of newly mature adipocytes and prevent the further formation of adipose tissue, or to expect that the preexisting adipocytes in the existing adipose tissue will not become mature adipocytes after being stimulated by differentiation factors. In the present invention, the above-mentioned substances are used to drive the fat before being stimulated by differentiation factors. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -38- 200300069 A7 ___B7___ V. Description of the invention (3¾ (please first Read the notes on the back and fill in this page again) Cells will differentiate into shaped adipocytes, and the amount of neutral fat (ie, triglyceride) taken up by the cells after accumulating fat is compared with the control group to evaluate whether there is mature adipocyte fat Accumulation inhibition function. The fat accumulation inhibition function of mature adipocytes of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof in the present invention can be shown by a test method using precursor adipocytes. The precursor-type adipocytes used in the invention are derived from mouse-cultured precursor-type adipocytes. To differentiate the cells into adipocytes, bovine fetal blood corpuscle, dexamethasone, and 3-isobutyl-1-methyl must be used. The role of differentiation factors such as xanthine and insulin. From this role, precursor fat cells begin to differentiate into adipocytes, and then mature into mature fat cells. On the other hand, when matured adipocytes are differentiated, if there is co-existence of substances with the function of inhibiting fat accumulation in mature adipocytes, the number of mature adipocytes will decrease, or the amount of triglyceride taken up inside the cell will decrease. Comparing the reduction of the amount of triglyceride mentioned above, the function of inhibiting fat accumulation in mature adipocytes can be evaluated. Printed by the Employees' Cooperatives of the Ministry of Economic Affairs and the Ministry of Economic Affairs ¾ According to the above test method evaluation, the pentacyclic triterpenes in the present invention are evaluated. Compared with the physiologically acceptable salts or derivatives of mature adipocytes for inhibiting fat accumulation, compared with the known CLA with anti-hypertrophic substances, for example, maslinic acid has about 2 to 20 times, and maslinate has about 2 to 20 times, cocadiol is about 2 to 20 times. Ursolic acid is about 2 to 18 times, ursitol is about 2 to 18 times, betulinic acid is about 2 to 18 times, and betulin is about 2 times. ~ 18 times, about 2 ~ 20 times of ethyl maslinate, about 2 ~ 20 times of acetylated maslinic acid, about 2 ~ 20 times of triethylsilyl maslinic acid, and about 2 ~ 20 times of stearic ethyl maslinate About 2 to 20 times 2 ~ 20 times, ethyl ursolic acid is about 2 ~ 20 times. The size of acetylated kumamoto paper is applicable to Chinese National Standard (CNS) A4 (210X297 mm) '~' -39-200300069 A7 B7 V. Description of the invention (Flat (please read the precautions on the back before filling out this page) The high maturity of fruit alcohol is about 2 to 18 times, that of ethyl betulinate is about 2 to 18 times, and that of acetated betulin is about 2 to 20 times. Function of inhibiting fat accumulation in type adipocytes. In other words, the anti-puffiness food of the present invention contains pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof, and thus has a more mature type than CLA. Inhibition of fat accumulation in adipocytes. Pentacyclic triterpenes and their derivatives with alcohol ester groups, derivatives with fatty acid ester groups, derivatives with alkoxy groups, derivatives with alkoxymethyl groups Since it is usually fat-soluble, it can be used in oil-based or emulsified foods. In addition, when ingested as an oil or fat processed product, it is expected to be absorbed together with the oil, and therefore, it is preferable from the viewpoint of absorbency. In addition, the physiologically acceptable salts or glycosides of pentacyclic triterpenes are usually water-soluble. Therefore, they can be used by dissolving and dispersing them in water-based or emulsified foods. In particular, foods are mostly water-based or emulsified products. Therefore, if necessary, pentacyclic triterpenes can be formulated and used as physiologically acceptable salts or saccharides. Printed by the Intellectual Property Department of the Ministry of Economic Affairs / I Bureau Consumer Cooperatives In addition, pentacyclic triterpenes and / or physiologically acceptable salts thereof can be formulated in trace amounts in tadpole foods to achieve the normally required anti-fullness function It is also beneficial in terms of cost. At the same time, from the point of view of the deployment ratio, there is also extra space to coordinate with other components, so it can also enrich other functions. Of course, by increasing the blending amount of pentacyclic triterpenes and / or physiologically acceptable salts thereof, the present invention can also produce loquat foods having excellent anti-puffiness functions and the like. The pentacyclic triterpenes in the present invention are known to exist in natural materials such as plants as described above. Almost all of the substances are passed through plants for human consumption. The paper size applies to the Chinese National Standard (CNS) A4 (210X29). * 7mm) " -40-200300069 A7 B7 V. Invention Description (3) Experience exists, so do n’t overdo it will not have adverse effects on the body. 0 In terms of actual animal administration, LD50 is more than 2000mg / kg body weight, it can be confirmed that it is extremely safe. This result shows that oral intake has the function of inhibiting the proliferation of precursor adipocytes, inhibiting the differentiation of precursor adipocytes, and inhibiting the accumulation of fat in mature adipocytes Pentacyclic triterpenes such as anti-puffiness function. In other words, they can be ingested through the form of glutinous food. In this case, unlike the administration of pharmaceuticals, the troubles or pains associated with them can continue. It can be easily ingested into the body. When used mainly for weight loss, the pentacyclic triterpenes of the present invention and physiologically acceptable salts or derivatives thereof can directly act on precursor lipids. Fat cells can be expected to have the lowest impact on the metabolism of other nutrients. In other words, for example, weight loss agents with lipolytic effects, the essential nutrients for the human body will also act in a direction that hinders their absorption, so in There are concerns about side effects, but the pentacyclic triterpenes and their physiologically acceptable salts or their derivatives in the present invention directly act on precursor adipocytes, so they can be said to have almost no blood lipids, blood glucose, etc. In this regard, the anti-fattiness food for foods of the present invention is also ideal from the viewpoint of safety because it can not lose weight under the condition of sufficient intake of nutrients. Symptoms, such as hypertrophy, hypertrophy, hypertrophy, hypertrophy, etc. The present invention contains pentacyclic triterpenes and their physiologically acceptable salts or their Select one or two or more of the derivatives to make a full-batter-resistant food. For this paper size, China National Standard (CNS) A4 (210X297 mm) CII (Please read first Note on the back page, please fill in this page) Order printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Loan Workers and Consumer Cooperatives-41- 200300069 A7 B7 V. Invention Description (3¾ (Please read the note on the back page before filling out this page). The above "contains "Includes the meaning based on the ability to exhibit anti-hypertrophic function, and the intention to adjust the function of the production or increase of adipose tissue through the inhibition of proliferative adipocyte proliferation inhibition, differentiation inhibition, and fat accumulation inhibition In the case of the Consumer Cooperatives Cooperative of the Intellectual Property Office of the Ministry of Economic Affairs, the content of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof contained in the anti-fattiness food of the present invention may vary with the content The types of pentacyclic triterpenes, food types, intake, frequency, age, sex, weight, severity of symptoms, health status and other conditions vary and cannot be considered in one go. Of course, this content is a therapeutically effective content for the prevention of the production or proliferation of adipose tissue through the inhibition of proliferation, differentiation, and accumulation of fat in precursor-type adipocytes. In particular, in order to obtain the anti-fertilizing function of the present invention, the daily intake of pentacyclic triterpenes and their physiologically acceptable salts or derivatives thereof, such as maslinic acid, is usually 0. 001 ~ 5g range, with 0. 001 ~ lg is the best. Therefore, the content of pentacyclic triterpenes and their physiologically acceptable salts or their derivatives in the anti-fattiness food of the present invention, for example, at 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 80 mass% is preferred, with 0. 001 ~ 70 mass% is better, and 0. 01 ~ 65 mass% is more preferable, and more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 ~ 55 mass% is better, more preferably 0. 4 ~ 50 mass% is better, more preferably 0. 6 ~ 45 mass% is better, more preferably 0. 8 ~ 40 mass% is better, more preferably 1. 0 ~ 35 mass% is better, more preferably 2. 0 to 30% by mass is suitable. But it is not limited to the above range. In addition, when the active ingredient of the anti-puffiness food of the present invention contains pentacyclic triterpenes and the like contained in the active ingredient of the olive oil plant defatted product, the olive oil extract, or the olive oil extract, The content adjustment is within the above specified range. The Chinese national standard (CNS) A4 specification (210X297 mm) is applicable to this paper. -42-200300069 A7 B7 V. Description of the invention (3¾ is appropriate. (Please read the precautions on the back before filling in this Page) The anti-puffiness foods of the present invention are used as precursor-type adipocyte proliferation inhibiting components, precursor-type adipocyte differentiation inhibiting components, mature adipocyte fat accumulation inhibiting components, and pentacyclic triterpenes and When the physiologically acceptable salt or its derivative is used, its content depends on the type of pentacyclic triterpene, the type of food, intake, frequency, age, gender, weight, severity of symptoms, health status, etc. The conditions vary, and cannot be said in a nutshell. Of course, this content is an effective content for the inhibition of proliferation, differentiation, and fat accumulation of precursor adipocytes. This content As in zero. 00001 ~ 90 mass% range, where 0. 0001 ~ 80 mass% is appropriate, and 0. 001 ~ 70 mass% is more appropriate, and 0. 01 ~ 65 mass% is more preferable, and more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 ~ 55 mass% is better, more preferably 0. 4 ~ 50 mass% is better, more preferably 0.6 ~ 45 mass%, more preferably 0. 8 ~ 40% by mass is better, more preferably 1. 0 ~ 35 mass% is better, especially 2. 0 to 30% by mass is suitable, but it is not limited to the above range. The characteristics of the anti-plumbitant glutinous food printed by the employees' cooperative of the 4th Bureau of the Ministry of Economic Affairs of the Ministry of Economic Affairs have the characteristics of inhibiting the proliferation of precursor adipocytes and inhibiting the differentiation of precursor adipocytes due to the inclusion of pentacyclic triterpenes, etc. , Anti-fatty function of mature fat cell fat accumulation inhibition function. Since it is in the form of ravioli, it is easy and can be continuously ingested, and a good effect is expected. In addition, the present invention is an oleanolane triterpene represented by the general formula (I) of the pentacyclic triterpenes, and an ursane triterpene represented by the general formula (II), III) It is related to the selection of one or two or more of the lupinane-type triterpenoids to be used for anti-fullness foods. Because of its anti-fat function, this paper standard is applicable to Chinese National Standard (CNS) A4 specification (21〇 × 29 * 7mm) -43-200300069 A7 ___B7_ V. Description of the invention (扃, and its precursor-type fat cell proliferation inhibiting function The anti-fatness function of the precursor-type adipocyte differentiation inhibition function and mature adipocyte fat accumulation inhibition function is suitable. The anti-obesity food of the present invention is used as an anti-fullness component and a precursor-type adipocyte When a proliferation-inhibiting component, a precursor-type adipocyte differentiation-inhibiting component, a mature-type adipocyte-fat accumulation-inhibiting component, and oleanolane-based triterpenes and / or physiologically acceptable salts and / or derivatives thereof are contained, Its content is the same as the foregoing regardless of the above, and is not limited to the following range, the content is, for example, 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 80% by mass is preferable to 0. 001 ~ 70 mass% is better, and 0. 01 ~ 65 mass% is more preferable, and more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 to 55% by mass is better, more preferably 0. 4 ~ 50 mass% is better, more preferably 0. 6 ~ 45 mass% is better, more preferably 0. 8 ~ 40 mass% is better, more preferably 1. 0 ~ 35 mass% is better, especially 2. 0 to 30% by mass is suitable. The anti-hypertrophic glutinous food of the present invention contains anti-hypertrophic components and precursor-type adipocyte proliferation inhibiting components, precursor-type adipocyte differentiation inhibiting components, mature adipocyte fat accumulation inhibiting components, and contains arbutane-based three In the case of terpenes and / or physiologically acceptable salts and / or derivatives thereof, the contents of terpenes and / or their physiologically acceptable salts and / or their derivatives are not limited to the foregoing, and are not limited to the following ranges. The content is e.g. 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 80% by mass is preferable to 0. 001 ~ 70 mass% is better, and 0. 01 ~ 6 5 mass% is better, more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 ~ 55 mass% is better, more preferably 0. 4 ~ 50 mass% is better, more preferably 0. 6 ~ 45 mass% is better, more preferably 0. 8 ~ 40 mass% is better, more preferably 1. 0 ~ 35 mass% is the standard of this paper. Applicable to China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling out this page) • Packing-Printed by the Intellectual Property Bureau, Ministry of Economic Affairs, Consumer Consumption Cooperative- 44-200300069 A7 __B7_ V. Description of the invention (4¾ is better, especially 2. 0 to 30% by mass is preferred. (Please read the precautions on the back before filling out this page) In the anti-puffiness food of the present invention, it is used as an anti-puffiness ingredient and a precursor fat cell proliferation inhibiting ingredient, a precursor adipocyte differentiation inhibiting ingredient, and mature fat. When the cell fat accumulation inhibiting component is contained in the lupinane triterpenes and / or physiologically acceptable salts and / or derivatives thereof, the content is as described above, and it is not limited to the following range. The content is e.g. 0. 00001 ~ 90 mass% range, where 0. 001 ~ 80% by mass is preferable to 0. 001 ~ 70 mass% is better, and 0. 01 ~ 65 mass% is more preferable, and more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 ~ 55 mass% is better, more preferably 0. 4 ~ 50 mass% is better, more preferably 0. 6 ~ 45 mass% is better, more preferably 0. 8 ~ 40 mass% is better, more preferably 1. 0 ~ 35 mass% is better, especially 2. 0 to 30% by mass is preferred. As for the oleanolic triterpenes, maslinic acid and cocadiol are preferred, and maslinic acid is most preferred. As for the ursane triterpenes, ursolic acid and arsitol are preferred. In the case of lupines and triterpenes, betulinic acid and betulin are preferred. The Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs printed the anti-plumbing foods of the present invention as an anti-puffiness component and a precursor fat cell proliferation inhibiting component, a precursor fat cell differentiation inhibiting component, and mature fat cell fat accumulation. When the inhibitory ingredient contains maslinic acid and / or a physiologically acceptable salt or derivative thereof, the content thereof is as described above, and is not limited to the following range. The content is, for example, 0. 0000 1 ~ 90 mass% range, where 0. 0001 ~ 80 mass% is appropriate, and 0. 001 ~ 70 mass% is preferred, and 〇. 〇1 ~ 65% by mass is more preferable, and more preferably 0. 1 ~ 60 mass% is better, more preferably 0. 2 ~ 5 5 mass% is better, more preferably 0. 4 ~ 50 This paper size applies Chinese National Standard (CNS) A4 specification (210X297mm) -45-200300069 A7 B7 V. Description of invention (4i (Please read the precautions on the back before filling this page) Quality% is better And more to 0. 6 ~ 45 mass% is better, more preferably 0. 8 ~ 40 mass% is better, more preferably 1. 0 ~ 35 mass% is better, especially 2. 0-30% by mass is suitable. The anti-puffiness food of the present invention contains cocadiol and / or as an anti-puffiness component and a precursor-type adipocyte proliferation inhibiting component, a precursor-type adipocyte differentiation inhibiting component, and a mature adipocyte fat accumulation inhibiting component. In the case of physiologically acceptable salts or derivatives thereof, the contents of the salts or derivatives thereof are not limited to those described above, nor are they limited to the following ranges. The content is, for example, 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 70 mass% is suitable, and 0. 001 ~ 60 mass% is better, and 0. 01 ~ 50% by mass is more preferable, and more preferably 0. 1 ~ 40 mass% is better, especially 1. 0 to 30% by mass is preferred. The Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs printed the anti-plumbing foods of the present invention as an anti-puffiness component and a precursor fat cell proliferation inhibiting component, a precursor fat cell differentiation inhibiting component, and mature fat cell fat accumulation. When the inhibitory ingredient contains ursolic acid and / or a physiologically acceptable salt or a derivative thereof, the content is not the same as that described above, nor is it limited to the following range. The content is, for example, 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 70 mass% is suitable, and 0. 001 ~ 60 mass% is better, with 0. 01 ~ 50% by mass is more preferable, and more preferably 0. 1 ~ 40 mass% is better, especially 1. 0 to 30% by mass is preferred. The gluten-resistant food for anti-fullness of the present invention contains arbutanol and / or as an anti-fullness component and a precursor-type adipocyte proliferation inhibiting component, a precursor-type adipocyte differentiation inhibiting component, and a mature adipocyte fat accumulation inhibiting component. In the case of physiologically acceptable salts or their derivatives, the content is not the same as the foregoing, nor is it limited to the following range. The content is, for example, the Chinese national standard (CNS) A4 specification (210X297 mm) applicable to this paper size. • 46 200300069 A7 B7 V. Description of the invention (flat (please read the precautions on the back before filling this page) 0. 00001 ~ 90 mass% range, where 0. 0001 ~ 70 mass% is suitable, and 0. 00 卜 60 Mass% is better, and 0. 01 to 50% by mass is more preferable, and more preferably 0. 1 ~ 40 mass% is better, especially 1. 0 to 30% by mass is preferred. The fermented food for preventing fullness of the present invention contains betulinic acid and / or it as an anti-fullness component and a precursor-type adipocyte proliferation inhibition component, a precursor-type adipocyte differentiation inhibition component, and a mature adipocyte fat accumulation inhibition component. In the case of physiologically acceptable salts or their derivatives, the content is not the same as the foregoing, nor is it limited to the following range. The content is, for example, at 0. 00001 ~ 90 mass% is preferred, with 0. 0001 ~ 70 mass% is appropriate, and 0. 001 ~ 60 mass% is better, and 0. 01 ~ 50% by mass is more preferable, and more preferably 0. : 1 ~ 40% by mass is better, especially 1. 0 to 30% by mass is preferred. The Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs printed the anti-plumbing foods of the present invention as an anti-puffiness component and a precursor fat cell proliferation inhibiting component, a precursor fat cell differentiation inhibiting component, and mature fat cell fat accumulation. When the inhibitory ingredient contains betulin and / or a physiologically acceptable salt or derivative thereof, the content is not the same as that described above, nor is it limited to the following range. The content is, for example, at 0. 0000 1 ~ 90% by mass is preferred, with 0. 0001 ~ 70 mass% is appropriate, and 0. 001 ~ 60 mass% is better, and 0. 01 to 50% by mass is more preferred, and more preferably from 0.1 to 40% by mass, especially 1. 0 to 30% by mass is preferred. The higher the above content, the better the effect, but as mentioned above, it is necessary to adjust its content according to considerations such as the purpose of use, the period of use, the amount of use, the age of the target, sex, weight, etc. The fermented foods for preventing fullness of the present invention include the following specific examples, but they are not limited to the following ranges and need not be explained. The scale-proof paper of the present invention is suitable for Chinese paper (CNS) A4 (210X297 mm) -47-200300069 A7 B7 V. Description of the invention (4 乂 (Please read the precautions on the back first) (Fill in this page again.) There is no special restriction on the printing status of the employees ’cooperatives of the Jijilang Wisdom and Finance Bureau. For example, in addition to general foods and processed foods, such as mobile food ρα, nutritional foods for health, health foods, foods for infants and young children. Isoform bears can be included. Specifically, such as senbei, pancakes, popcorn, Japanese desserts such as glutinous rice crackers, biscuits, cookies, crackers, pie cakes, donuts, puddings, Sponge cake, quiche, cream, whipped cream, puff, jacket power, jacket power biscuits, milk, candy, chewing gum, jelly wafers, bread, steamed bread and other European and American desserts; potato chips and other instant desserts , Ice cream, popsicles, frost, and other chestnuts; lactic acid sauce, lactic acid bacteria sauce, thick milky sauce, juice sauce, pulp sauce, functional sauce, carbonated sauce and other cool sauces; green tea Black tea, coffee, cocoa and other hobby products and their condiments, fermented milk, processed milk, cheese and other dairy products; soy milk, ugly and other soy processed foods; jam, fruit sugar, flower sauce, peanut butter, fruit paste and other pastes; Sauces; Udon, Buster and other meat products; ham, sausage, cured smoked pork, dry sausage, beef jerky, burger and other meat products; fish ham, fish sausage, plate fish, bamboo wheel, fried fish paste and other fish and shellfish Products; dried products such as fish, shellfish, bonito, mackerel, bonito, etc .; sea urchin, small mullet and other _ pickles; squid and other fish _ dried, salmon and other smoked fish products; nori; small Canned foods such as fish, shellfish, mountain vegetables, shiitake mushrooms, kumbu, curry, braised beef; Japanese watercress, soy sauce, sauce, gravy, dipping sauce, curry sauce, braised beef seasoning, soup, umami Seasonings; rice; oil or margarine, butter, buttermilk, lettuce sauce and other processed fats, or various microwave foods or frozen foods containing oil and fat. In terms of continued intake, rice Or various seasonings Blended with oil or margarine, butter, buttermilk, lettuce, etc. is better blended with processed oil and ester products. Also, ^ Paper size applies Chinese National Standard (CNS) A4 Washing (210X297 mm) " "- 48-200300069 A7 B7 V. Description of the invention (4 & (Please read the notes on the back before filling in this page) There is no special restriction on its shape and properties. Solid, semi-solid, gel, liquid, powder Anything can be done, and any dosage form such as tablets, capsules, liquids, granules, etc. can be used. Printed by the Consumer Cooperative of the 4th Bureau of the Ministry of Economic Affairs and the Intellectual Property Cooperative, as mentioned above, the present invention is one of Pentacyclic triterpenes, the physiologically acceptable salt or its derivative content, with a daily intake of 0. 001 ~ 5g, especially at 0. 001 ~ lg range is the best. More specifically, when the fermented foods for preventing obesity of the present invention are formulated with processed fats and oils such as oil or margarine, ghee, beauty milk, and lettuce, the pentacyclic triterpenes contained in the foods of the present invention Alkenes, especially maslinic acid, the physiologically acceptable salts or derivatives thereof contain 0. 001 ~ 10g is suitable, in which 0 · 01 ~ 5g is preferred, and 0. 1 to 3 g is more preferred, and 0.2 to 2 g is particularly preferred. When the loquat food for anti-fullness of the present invention is loquat fruit, soft capsule food, lozenge food, powdered food, granular food, the pentacyclic triterpene contained in the loquat food in the present invention, especially The content of maslinic acid, its physiologically acceptable salts or its derivatives is based on 500 mg of the product, preferably 1 to 400 mg, and more preferably 5 to 380 mg. The anti-fattiness foods used in the present invention are foods, healthy foods, milky foods, fruit juices, pulp foods, and teas. Coffee, alcoholic condiments, pentacyclic triterpenes contained in the loquat food of the present invention, especially maslinic acid, the physiologically acceptable salt or its derivative content is based on the product 200g, to contain 0. 002 ~ 10g is suitable, in which 0. 02 ~ 5g is more preferable. In addition, in order to improve the function of the fermented food for preventing fullness of the present invention, other physiologically active ingredients may be blended for the purpose of achieving the synergistic effect, auxiliary effect, and improvement of absorbency of the fullness of the function of fullness. There is no special @ system mentioned above. For example, the paper size that is considered to have a synergistic or indirect contribution to the anti-fullness function is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -49- ¢ Cooperative cooperative seal 200300069 A7 B7 V. Description of the invention (46) Antioxidant ingredients, oily ingredients that enhance the absorption efficiency in the body, and various vitamins for nutritional purposes. Minerals, amino acids, etc. are available. The above antioxidant components are not particularly limited, such as lignans such as tocopherols and derivatives thereof, tocotrienols and derivatives, sesamin, episesamin, sesamin, sesamin, sesamol, etc. And its glycosides, carotenoids and derivatives thereof such as / 3-carotene and tannins and derivatives thereof such as gallic acid or ellagic acid, flavones, catechin , Flavonoids, such as flavonoids, colorless anthocyanins, ubiquitin or vitamin K, ferulic acid derivatives such as glutenin, olive extract, etc. The above-mentioned antioxidants are considered to have indirect anti-puffiness function, and, by virtue of the original anti-oxidant effect, promote blood circulation function or anti-aging function, etc., it is expected to have a comprehensive synergistic effect on the body. Examples of the above oily ingredients include vegetable oils such as sesame oil, olive oil, tea oil, and animal oils such as fish oil, and are not particularly limited. For example, MCT, MLCT, and diglycerides obtained by natural and chemical reactions or enzyme reactions, A monoglyceride or a structured oil or fat is obtained by designing the structure of a fatty acid. Although there are no particular restrictions on the various vitamins, minerals, amino acids, etc. used in the above fortified nutrition, it is advisable to use those specified in the Standard Manual for Food Additives. In addition, the fermented foods for preventing fullness of the present invention can also be prepared by using materials used in general fermented foods. Although, there are no particular restrictions, such as Japanese bean paste, soy sauce, western sauce, gravy, dipping sauce, curry sauce, braised beef sauce, soup, umami and other seasonings, lard, butter, Animal fats such as milk fat, residual oil, amaranth oil, amaranth oil and other aquatic oils and fats, soybean oil, this paper size applies Chinese National Standards (CNS) (21GX297 male | --- -50- (Please read the precautions on the back first (Fill in this page again)

200300069 A7 __B7 _ 五、發明説明(4 (請先閱讀背面之注意事項再填寫本頁) 油菜籽油,棉籽油,米糠油,玉米油,芝麻油,花生油,向 曰葵油,紅花油,茶油,洋橄欖油,亞麻仁油,桐油,箆麻 籽油,椰子油,棕櫚油,可可脂等植物性油脂等均可採用 。其中,洋橄欖油由於含有本發明中之山楂酸等而尤爲適 宜。 本發明之抗肥滿用飮食品中之五環性三萜烯類,本來 多屬油溶性物質,因此,就溶解性而言,本發明之抗肥滿 用飮食品以油脂或油脂加工品爲較佳。上述油脂並無特別 限制,例如將天然或合成而得五環性三萜烯類溶解於一般 油脂中而成油脂等,或調整植物種子之壓榨萃取條件而使 種子之五環性三萜烯類以高濃度含在壓榨萃取油而成之油 脂,或調整精製條件而使油中所含五環性三萜烯類殘留於 油中而成之油脂等可供採用。又,該五環性三萜烯類之高 含量油脂和其油脂之混合油脂也可利用。該時,可期待上 述其他油脂所含有微量成分之生理活性功能之間之協同效 經濟部智慧財凌局員工消費合作社印製 五環性三萜烯類可由油料原料之植物而獲得,因此, 就製造面而言,該油酯可說適佳,更進之,該油脂之加工 品之人造奶油,酥油,美奶滋,生菜佐料等之油脂加工品 也可說很適佳。 據2001年之日本國民營養調查報告,食品材料本身所 含脂肪占總攝取脂肪比率之76%,而由食用油脂或人造奶油 或奶油等油脂製品所攝取脂肪比率24%。換言之,人體在— 天所攝取之總脂質量平均約爲60g中,從油脂製品所攝取油 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' ~ -51- 200300069 A7 ___B7 _____ 五、發明説明(扁 (請先閲讀背面之注意事項再填寫本頁) 脂重僅爲約14.4g。該量占人體在一天所攝取總食品量(平 均約1400g,參照日本農林水產省「食糧供需表」)之約1% 而已。考慮上項問題時,在一般食習慣中欲藉本發明之油 脂而獲得本發明之抗肥滿功能時,食用油,沙拉油,人造 奶油,奶油等油脂和油脂製品中之五環性三萜烯類和其生 理上容許之鹽類之最適合量以0.0001〜20質量%爲宜,其中 以0.0002〜18質量%爲較佳,又以0.0005〜16質量%爲更佳, 更以0.001〜14質量%爲較佳,更以0.002〜12質量%爲較佳, 更以0.005〜10質量%爲較佳,更以0.01〜8質量%爲較佳, 更以0.02〜6質量%爲較佳,更以0.05〜4質量%爲較佳,更 以0.1〜3質量%爲較佳,尤以0.2〜2質量%爲最佳。 同樣,使用上述本發明所含油脂之製品也適佳。上述 「使用」乃指做爲原料而使用,以及使用在炸或炒製品用 途之油脂而使用,皆包括其中。 經濟部智慧財產局員工消費合作社印製 上述做爲原料而使用,乃係指例如在上述各種飮食品 中,將含有上述五環性三萜烯類等之油脂做爲原料而使用, 成爲本發明之抗肥滿用飮食品。該情形下,含有五環性三 萜烯類等之油脂等可按照一般使用之油脂等同樣使用,所 以不需要特別變更飮食品之製造工程,可以簡單地獲得本 發明之飮食品而甚爲理想。 又,上述做爲油脂使用乃指一般使用油脂相同周知之 使用方法,並無特別限制,例如炒用油,炸用油,固形油脂 ,塗布油脂等。該情形下,將含有五環性三萜烯類等之上 述油脂等使用在炒製或炸製用途,所製成炒製品或炸製品 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -52 - 200300069 A7 B7 五、發明説明(扃 (請先閱讀背面之注意事項再填寫本頁) 等做爲本發明之抗肥滿飮食品。上述使用方法祗要在目的 之飮食品中藉添加,附著,含有等方法使之含有本發明之 五環性三萜烯類,並無特別限制。 上述使用五環性三萜烯類在飮食品雖無特別限制,但 油性飮食品中以使用五環性三萜烯類或其含醇酯基之衍生 物,其含脂肪酸酯基之衍生物,其含烷氧基之衍生物,其 含烷氧基甲基之衍生物爲較佳。因爲這些比較屬於油溶性, 所以很適於油系飮食品之用途。另外,當然也可以使用五 環性三萜烯類之生理上可容許之鹽類或配糖物,該時,加 用乳化劑爲較佳。 另外,一般而言,對於水系飮食品,以使用五環性三 萜烯類之生理上可容許之鹽類或配糖物爲較佳。因爲比較 屬於水溶性,所以適用於水系飮食品中。當然也可使用五 環性三萜烯類或其衍生物,該附加用乳化劑爲較佳。 上述五環性三萜烯類和其生理上可容許之鹽類,或其 衍生物,對於本發明之抗肥滿用飮食品可做爲其原料而使 用。換言之,對於上述抗肥滿用飮食品,可當做其原料之 一種而調配使用。該情形下,五環性三萜烯類和其生理上 可容許之鹽類或其衍生物之來源並無特別限制,從自然或 合成而得者皆可適用,但其純度愈高者愈佳。純度高之好 處,除可大大提升抗肥滿功能之外,還有去除不純物等之 優點。換言之,可迴避不純物所造成之無法預測之副作用 等之危險或製造抗肥滿用飮食品時無法預測之麻煩也可逃 避,操作上也較方便,對於提升製品品質也有貢獻等優點 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) • 53 - 200300069 A7 ____B7 五、發明説明(5¾ (請先閲讀背面之注意事項再填寫本頁) 甚多,所以使用純度愈高者爲較佳。又,藉分離,精製處 理等而提升純度時,本發明中之五環性三萜烯類和其生理 上可容許之鹽類或其衍生物通常以白色或無色之固體,半 固體,液體等而獲得,所以對於本發明之抗肥滿用飮食品 不需再加多餘之著色而適用之優點存在。 藉飮用或食用本發明之抗肥滿用飮食品而可以吸收具 有抗肥滿功能之五環性三萜烯類和其生理上可容許之鹽類 或其衍生物到體內而達成其效果。由於屬於飮食品之形態, 所以不需要好像使用化粧品之勞力,可以繼續攝取而非常 理想。 本發明之抗肥滿用飮食品中所含五環性三萜烯類和其 生理上容許之鹽類或其衍生物,藉攝取而期獲得適佳之抗 肥滿功能之服用量如同上述隨攝取形態,使用者性別,體 重,體況等而異,並無特別限制,例如通常爲O.OOlg/日以 上,其中以0.01 g/日以上爲較佳,又以〇.lg/日以上爲更佳, 更以0.2g/日以上爲較佳更以〇.5g/日以上爲較佳,更以0.7g/ 日以上爲較佳,尤以l.Og/日以上爲最佳。 此等之五環性三萜烯類可以自天然者,其分別記載之 植物及洋橄欖植物之脫脂物等萃取。即,以水及/或有機 溶媒自各植物體萃取,再以溶媒萃取法,利用與雜質間的 溶解度差的方法、分離沈澱法、再結晶法、離子交換樹脂 法、液體層析法等,單獨或適當地組合,或重覆使用予以 。濃縮和/或分餾•精製。再予單離者因不會讓本發明之飮 食物有多餘之顏色,味道等,所以最爲適宜。 本紙張尺度14用巾關家料(€刚八4祕(21(^297公釐) " -54 - 200300069 A7 B7 五、發明説明(5¾ (請先閲讀背面之注意事項再填寫本頁) 尤其山楂酸及/或其生理上可被容許之鹽係可自洋橄 欖植物及洋橄欖植物之脫脂物等,以水及/或有機溶媒萃 取,再單獨或適當地組合或重複使用溶媒萃取法,利用與雜 質間之溶解度差,分離沈澱法、再結晶法、離子交換樹脂 、液體層析法等單獨或適當地組合,或重覆使用予以分餾 •精製,更可以單離等自該萃取物分離精製。 洋橄欖植物(olea europaea L.)係不論爲日本產,歐洲 產等產地,食用或搾油用者均可使用。本發明之抗肥滿用 飮食品中所含山楂酸及/或此等之生理上可被容許之鹽係 以天然植物之洋橄欖植物爲主,自其果實或種子取得,更 可以自其種子皮、葉、莖、芽取得。又,可以自此等之乾 燥物、粉碎物、脫脂物適當地取得。其中以自脫脂過之果 實(含果皮)或果皮之乾燥物及粉碎物爲宜。另外可自橄欖油 製造步驟中所生成之副產物,例如壓搾殘渣、萃取殘渣、 搾油殘渣、壓搾油、萃取物、脫膠油渣、脫酸油渣、暗棕 色油、廢脫色劑、脫臭浮渣、搾油汁、廢水、過濾廢料取 得。其中以搾油殘渣及萃取殘渣爲宜。 經濟部智慧財凌局員工消費合作社印製 又,對上述洋橄欖植物之果實或其脫脂物添加水等進 行加水時,或以蒸汽蒸等加濕處理時,此等洋橄欖植物之 果實或其脫脂物等會適度膨潤,提高其萃取效率,故極適 宜。又,本說明書中所稱洋橄欖萃取物係指製造橄欖油步 驟中所得脫脂物經溶媒萃取所得萃取物而言,製造橄欖油 步驟中所得脫脂物係包含萃取殘渣與壓縮殘渣。又,本說 明書中洋橄欖萃取物油係指對於製造橄欖油步驟中所得壓 I纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐1 -55 - 200300069 A7 B7 五、發明説明(d 搾殘渣再以己烷等溶媒萃取所得萃取油而言者。 (請先閲讀背面之注意事項再填寫本頁) 尤其洋橄欖植物之脫脂物中係含高濃度之山楂酸及/ 或其生理上可被容許之鹽,並且不必自山楂酸及/或其生 理上可被容許之鹽除去油份,所以較適宜。 該脫脂物可以用食油精製步驟中產出之橄欖油搾渣, 或經由己烷萃取之殘渣做爲原料。 又,以戊烷、己烷、庚烷等烴類、乙酸乙酯等低級脂 肪酸烷基酯、二乙醚等非水溶性有機溶媒之一種或二種以 上萃取除去洋橄欖植物或該脫脂物中所含脂質成份,再視 其需要重覆此洗淨處理之脫脂物亦可以充分地利用。 以水及/或有機溶媒自上述洋橄欖植物萃取,亦可以 得本發明之抗肥滿用飮食品中所含山楂酸及/或其生理上 可被容許之鹽。 經濟部智慧財產局員工消費合作社印¾ 欲自洋橄欖植物得山楂酸及/或其生理上可被容許之 鹽時所用有機溶媒可爲親水性有機溶劑、疏水性有機溶劑 之任一。具體言親水性有機溶劑可爲甲醇、乙醇、甘油、 丙二醇、1,3-丁二醇等醇類、丙酮、四氫呋喃、乙腈、1, 4-二噁烷、吡啶、二甲亞碩、N, N-二甲基甲醯胺、乙酸等 公知之有機溶劑、疏水性有機溶劑可爲己烷、環己烷、四 氯化碳、氯仿、二氯甲烷、1,2·二氯乙烷、二乙醇、乙酸 乙酯、苯、甲苯等公知之有機溶劑。此等有機溶劑可用一 種或組合二種以上使用。 工業上言,例如就對植物組織之滲透性,萃取效率而 言,以使用親水性有機溶劑爲宜,又,使用含水親水性有 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) -56 - 200300069 A7 ___ B7_ 五、發明説明(5¾ (請先閱讀背面之注意事項再填寫本頁) 機溶劑爲宜,具體言可爲甲醇,乙醇、甘油、丙二醇、1, 3-丁二醇等醇類、丙酮、四氫呋喃、乙腈等有機溶劑及此 等之含水溶劑。可藉由一種或二種以上選自此等群,自洋 橄欖植物得本發明之抗肥滿用飮食品中所含之山楂酸及/ 或其生理上可被容許之鹽。 萃取條件並不特別限制,惟可在溫度5°C〜95°C,較佳 爲10°C〜90°C,更佳爲15°C〜85°C,常溫亦可充分萃取。溫 度高時有提高萃取效率之傾向。壓力係常壓或加壓,或吸 附等減壓亦可充分萃取。又,爲提高萃取效率,亦可用振 盪萃取,或附設有攪拌機等之萃取機,予以萃取。萃取時 間係視其他萃取條件而不同,通常爲數分鐘〜數小時,越長 時間愈能充分萃取,惟仍可依生產設備,收率等生產條件 適當地決定。 又,萃取時使用之溶劑係單獨使用水時,單獨使用有 機溶劑,混合使用水與有機溶劑均可以對原料而言用1〜100 倍量(以下均爲質量/質量),較佳係1〜20倍量。 經濟部智慧財/i局員工消費合作社印製 又,考慮對人體等之安全性等時,尤其以水、含水低 級醇類、無水低級醇類之任一萃取較爲理想。 另外,考慮所得山楂酸及/或其生理上可被容許之鹽 的收率,或抗肥滿效果的強度時,以低級醇含量爲10質量 %以上之含水低級醇萃取爲宜。更以使用低級醇含量爲10 質量%〜95質量%之含水醇爲宜,最佳係以調節爲低級醇含 量爲30質量%〜95質量%之含水低級醇爲宜。 在此,本發明使用之醇係甲醇、乙醇、1-丙醇、1-丁醇 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -57 - 200300069 A7 B7200300069 A7 __B7 _ V. Description of the invention (4 (Please read the notes on the back before filling this page) Rapeseed oil, cottonseed oil, rice bran oil, corn oil, sesame oil, peanut oil, Xiang Yue sunflower oil, safflower oil, tea oil Olive oil, linseed oil, tung oil, ramie seed oil, coconut oil, palm oil, cocoa butter, and other vegetable oils can be used. Among them, olive oil is particularly suitable because it contains maslinic acid in the present invention. The pentacyclic triterpenes in the food for preventing fullness of the present invention are mostly oil-soluble substances. Therefore, in terms of solubility, the food for preventing fullness of the present invention is processed with fat or oil The above-mentioned oils and fats are not particularly limited. For example, natural or synthetic pentacyclic triterpenes are dissolved in general oils and fats, or the extraction and extraction conditions of plant seeds are adjusted to make the pentacyclic rings of seeds. Triterpenoids can be used at high concentrations in oils extracted from extracted oil, or oils made from pentacyclic triterpenes contained in the oil can be adjusted by adjusting the refining conditions. Also, The pentacyclic triterpenes High-content olefinic fats and oils and their mixed fats can also be used. At this time, the synergy between the physiologically active functions of the trace ingredients contained in the other fats mentioned above can be expected. Sexual triterpenes can be obtained from oil-derived plants. Therefore, in terms of production, the oleyl ester can be said to be more suitable. Furthermore, the processed fats and oils such as margarine, ghee, beauty milk, and lettuce are better. According to the 2001 Japanese National Nutrition Survey report, the fat contained in food materials accounted for 76% of the total fat intake, and fat products such as edible oil or margarine or butter were used. The ratio of fat intake is 24%. In other words, the total fat mass ingested by the human body in an average of about 60g, the paper size of the oil ingested from oil and fat products applies the Chinese National Standard (CNS) A4 specification (210X297 mm) '~ -51- 200300069 A7 ___B7 _____ 5. Description of the invention (flat (please read the precautions on the back before filling out this page) The fat weight is only about 14.4g. This amount accounts for the total intake of the human body in a day The amount of food (average about 1400g, refer to the "Food and Supply Table of Food and Demand" of the Ministry of Agriculture, Forestry and Fisheries of Japan) is only about 1%. When considering the above question, in the general food habits, you want to use the oil of the present invention to obtain the anti-puffiness function of the invention At the time, the most suitable amount of pentacyclic triterpenes and physiologically acceptable salts in edible oil, salad oil, margarine, butter and other fats and oil products is 0.0001-20% by mass, of which 0.0002 ~ 18% by mass is preferred, and 0.0005 ~ 16% by mass is more preferred, 0.001 ~ 14% by mass is more preferred, 0.002 ~ 12% by mass is more preferred, and 0.005 ~ 10% by mass is more preferred. Better, more preferably 0.01 to 8% by mass, more preferably 0.02 to 6% by mass, still more preferably 0.05 to 4% by mass, still more preferably 0.1 to 3% by mass, especially 0.2 ~ 2% by mass is optimal. Similarly, products using the oils and fats contained in the present invention are also suitable. The above "use" refers to the use as raw materials and the use of fats and oils in fried or fried products, both of which are included. The above is used as a raw material for printing by the consumer cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, which refers to, for example, the use of oils containing the pentacyclic triterpenes and the like as raw materials in the above-mentioned various foods, which has become the present invention. The anti-plump foods are made with coriander. In this case, oils and fats containing pentacyclic triterpenes and the like can be used in the same way as oils and fats that are generally used. Therefore, it is not necessary to specifically change the manufacturing process of the food, and it is ideal to simply obtain the food of the present invention. . In addition, the above-mentioned use as fats and oils refers to generally known methods of using fats and oils, and is not particularly limited, such as frying oils, frying oils, solid fats and oils, and the like. In this case, the above-mentioned fats and oils containing pentacyclic triterpenes and the like are used for frying or frying, and the fried or fried products are made to this paper. The standard of this paper applies to the Chinese National Standard (CNS) A4 (210X297). -52-200300069 A7 B7 V. Description of the invention (扃 (Please read the precautions on the back before filling out this page) etc. as the anti-fat food of the present invention. The above usage method should be in the food of the purpose The pentacyclic triterpenes of the present invention are not particularly limited by adding, attaching, containing, etc. The pentacyclic triterpenes used in the above-mentioned foods are not particularly limited, but they are used in oily foods. Pentacyclic triterpenes or derivatives containing alcohol ester groups, derivatives containing fatty acid ester groups, derivatives containing alkoxy groups, derivatives containing alkoxymethyl groups are preferred Because these are relatively oil-soluble, they are very suitable for the use of oil-based foods. Of course, pentacyclic triterpenes can also use physiologically acceptable salts or glycosides. In this case, add An emulsifier is preferred. In addition, generally For water-based foods, it is better to use physiologically acceptable salts or glycosides of pentacyclic triterpenes. Because they are relatively water-soluble, they are suitable for water-based foods. Of course, five The cyclic triterpenes or their derivatives are preferably added with an emulsifier. The pentacyclic triterpenes and their physiologically acceptable salts, or their derivatives, are suitable for the anti-puffiness of the present invention. The gluten-containing food can be used as its raw material. In other words, the above-mentioned fertility-resistant glutinous food can be used as one of its raw materials. In this case, pentacyclic triterpenes and their physiologically acceptable There are no particular restrictions on the origin of salts or their derivatives. They can be obtained from natural or synthetic sources, but the higher the purity, the better. The benefits of high purity, in addition to greatly improving the anti-puffiness function, It has the advantage of removing impurities, etc. In other words, it can avoid the danger of unpredictable side effects caused by impurities or the trouble that can't be predicted when making anti-plump foods. It is also more convenient in operation. Contributes to quality and other advantages This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 mm) • 53-200300069 A7 ____B7 V. Description of the invention (5¾ (Please read the precautions on the back before filling this page) There are many Therefore, it is better to use the higher purity. In addition, when the purity is improved by separation, refining, etc., the pentacyclic triterpenes in the present invention and their physiologically acceptable salts or their derivatives are usually It is obtained by white or colorless solid, semi-solid, liquid, etc., so it has the advantage of being suitable for the anti-fattiness foods of the present invention without additional coloring.飮 Foods can absorb pentacyclic triterpenes and their physiologically tolerable salts or their derivatives into the body to achieve their effects. Since it is in the form of ravioli, it does not require labor as if using cosmetics, and it is ideal to continue ingestion. The pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof contained in the food for preventing obesity in the present invention, by ingestion, are expected to obtain an appropriate amount of anti- plumping function as described above with ingestion The form, gender of the user, weight, body condition, etc. vary, and there are no particular restrictions. For example, it is usually 0.0000 g / day or more, with 0.01 g / day or more being preferred, and 0.1 g / day or more being more preferred. More preferably, it is more preferably 0.2 g / day or more, more preferably 0.5 g / day or more, even more preferably 0.7 g / day or more, and most preferably 1.0 g / day or more. These pentacyclic triterpenes can be extracted from naturally occurring plants, degreased matter of the olive plant, and the like, respectively. That is, water and / or organic solvents are used to extract from each plant body, and then the solvent extraction method is used, which uses the difference in solubility with impurities, separation precipitation method, recrystallization method, ion exchange resin method, liquid chromatography method, etc. Or appropriate combination, or repeated use. Concentration and / or fractionation • Refining. Re-single-separators are most suitable because they do not allow foods of the invention to have extra color and taste. This paper size 14 is used for towels and household materials (€ 8 and 4 secrets (21 (^ 297 mm) " -54-200300069 A7 B7) 5. Description of the invention (5¾ (Please read the precautions on the back before filling this page) In particular, maslinic acid and / or physiologically acceptable salts thereof can be extracted from olive oil plants and degreased matter of olive oil plants with water and / or organic solvents, and the solvent extraction method can be combined or reused separately or appropriately. , Using the difference in solubility with impurities, separation precipitation method, recrystallization method, ion exchange resin, liquid chromatography, etc. alone or appropriately combined, or repeated use for fractionation and purification, and can be isolated from the extract Isolation and refinement. The olive plant (olea europaea L.) can be used by anyone who eats or squeezes oil from Japan, Europe, etc. The maslinic acid and / or this contained in the anti-plump food of the present invention The physiologically tolerable salts are mainly natural olive olive plants, obtained from their fruits or seeds, and can also be obtained from their seed bark, leaves, stems, and buds. Also, they can be obtained from such dried matter , Crushed material, degreasing Appropriately obtained. Among them, self-defatted fruits (including peels) or dried and pulverized pieces of the peels are suitable. In addition, by-products generated in the olive oil manufacturing steps, such as crushing residues, extraction residues, and oil extraction residues , Pressed oil, extracts, degummed oil residues, deacidified oil residues, dark brown oil, waste decolorant, deodorizing scum, squeezed juice, waste water, and filtration waste. Among them, oil extraction residues and extraction residues are appropriate. Ministry of Economic Affairs Printed by the Consumer Finance Cooperative of the Intellectual Property Office, when the water of the above olive oil plants or their degreased matter is added with water, or when steaming or humidification is performed, the fruits of these olive oil plants or their degreased matter It will moderately swell and increase its extraction efficiency, so it is extremely suitable. In addition, the olive extract referred to in this specification refers to the extract obtained by the solvent extraction of the defatted product obtained in the step of manufacturing olive oil, and obtained in the step of manufacturing olive oil. The degreasing system includes extraction residues and compression residues. In addition, in the present specification, the olive oil extract refers to a paper scale obtained from the pressure I obtained in the olive oil production step. Applicable to Chinese National Standard (CNS) A4 specification (210X297 mm 1 -55-200300069 A7 B7) V. Description of the invention (d. For the extraction oil obtained by squeezing the residue and then extracting it with hexane and other solvents. (Please read the precautions on the back first) (Please fill in this page again) In particular, the degreased substances of the olive plant contain high concentrations of maslinic acid and / or its physiologically acceptable salts, and it is not necessary to remove oil from maslinic acid and / or its physiologically acceptable salts. The degreased product can be made from olive oil press residue produced in the edible oil refining step, or the residue extracted through hexane as a raw material. In addition, hydrocarbons such as pentane, hexane, and heptane, and acetic acid are used as raw materials. One or two or more non-water-soluble organic solvents such as ethyl esters of lower fatty acids, diethyl ether and the like are used to extract and remove the lipid components contained in the olive oil plant or the degreased matter, and then repeat the washing and degreasing treatment as necessary. Things can also be fully utilized. Extraction from the above olive plant with water and / or organic solvent can also obtain maslinic acid and / or physiologically acceptable salts thereof contained in the anti-fattiness food of the invention. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ The organic solvent used to obtain maslinic acid and / or physiologically acceptable salts from olive plants can be either a hydrophilic organic solvent or a hydrophobic organic solvent. Specifically, the hydrophilic organic solvent may be alcohols such as methanol, ethanol, glycerin, propylene glycol, and 1,3-butanediol, acetone, tetrahydrofuran, acetonitrile, 1,4-dioxane, pyridine, dimethylasyl, N, Well-known organic solvents and hydrophobic organic solvents such as N-dimethylformamide and acetic acid may be hexane, cyclohexane, carbon tetrachloride, chloroform, dichloromethane, 1,2 · dichloroethane, and Well-known organic solvents such as ethanol, ethyl acetate, benzene, and toluene. These organic solvents may be used singly or in combination of two or more kinds. Industrially speaking, for example, in terms of permeability to plant tissues and extraction efficiency, the use of hydrophilic organic solvents is appropriate, and the use of water-containing hydrophilicity is in accordance with the Chinese National Standard (CNS) A4 specification (210X29 * 7) Mm) -56-200300069 A7 ___ B7_ 5. Description of the invention (5¾ (Please read the notes on the back before filling this page) Organic solvents are suitable, specifically methanol, ethanol, glycerol, propylene glycol, 1, 3- Alcohols such as butanediol, organic solvents such as acetone, tetrahydrofuran, and acetonitrile, and these aqueous solvents. One or two or more kinds of these solvents can be selected from the olive oil plant to obtain the fertility-resistant fermented food of the present invention The maslinic acid and / or physiologically acceptable salts thereof contained in the extract. The extraction conditions are not particularly limited, but may be at a temperature of 5 ° C to 95 ° C, preferably 10 ° C to 90 ° C, more preferably It is 15 ° C ~ 85 ° C, and can be fully extracted at normal temperature. When the temperature is high, there is a tendency to improve the extraction efficiency. The pressure is normal pressure or pressure, or reduced pressure such as adsorption can also fully extract. Also, in order to improve the extraction efficiency, Can also be extracted by shaking, or equipped with a mixer, etc. The extraction machine extracts. The extraction time varies depending on other extraction conditions, usually several minutes to several hours. The longer the time, the more sufficient the extraction can be, but it can still be appropriately determined according to production conditions such as production equipment and yield. The solvent used in the extraction is water alone, organic solvents alone, and mixed use of water and organic solvents can be 1 to 100 times the amount of the raw materials (the following are all mass / mass), preferably 1 to 20 times Printed by the Consumers ’Cooperative of the Ministry of Economic Affairs and the Bureau of the Ministry of Economic Affairs. When considering the safety of the human body, etc., it is particularly preferable to use any of water, water-containing lower alcohols, and anhydrous lower alcohols for extraction. In addition, consider When the yield of the obtained maslinic acid and / or its physiologically acceptable salt, or the strength of the anti-puffiness effect, it is preferable to extract the aqueous lower alcohol with a lower alcohol content of 10% by mass or more. It is more preferable to use a lower alcohol content The water-containing alcohol is preferably 10% by mass to 95% by mass, and most preferably, the water-containing lower alcohol having a lower alcohol content of 30% to 95% by mass is adjusted. Here, the alcohol-based methanol used in the present invention is Ethanol, 1-propanol, 1-butanol scale applies this paper China National Standard (CNS) A4 size (210X297 mm) -57 - 200300069 A7 B7

五、發明説明(A (請先閱讀背面之注意事項再填寫本頁) 等一級醇、2-丙醇、2-丁醇等之二級醇、2-甲基-2-丙醇等三 級醇、更可爲乙二醇、丙二醇、1,3-丁二醇等液狀多元醇 等溶劑,此等溶劑可用一種或組合二種以上使用。 低級醇可爲C!〜C4之公知醇類,例如上述之一、二、三 級或液狀多元醇等,此等可用一種或組合二種以上使用。 又,考慮本發明爲飮食物時做爲低級醇以乙醇爲宜, 以含量爲10質量%以上之含水乙醇萃取爲宜。更以使用10 質量%〜95質量%之含水乙醇爲宜,最佳係調製爲30質 量%〜95質量%之含水乙醇爲宜。 自如此所得粗萃取物及/或粗萃取液,除去溶劑、水 份,即可得本發明中的山楂酸及/或其生理上可被容許之 鹽。 除去溶劑、水份時可採用減壓蒸餾、減壓•真空乾燥 、冷凍乾燥、噴霧乾燥等公知之方法。 當然亦可維持包含溶劑、水份在內,並不特別限制。 自脫脂物所得萃取物因不含甘油三酯或脂醇、生育酚 等油溶性成份,所以不必將此等除去、精製、所以較佳。 經濟部智慧財產局員工消骨合作社印製 更由於脫脂物中係含有搾油後之殘渣者,可使用搾橄 欖油之壓搾殘渣(壓搾渣)及萃取殘渣(萃取渣),所以係對洋 橄欖爲極佳之有效利用方法,通常係利用廢棄或被使用於 飼料者,所以就生產成本面而言亦爲極優異之方法。 另外,爲更加強自洋橄欖植物所萃取之山楂酸及/或 其生理上可被容許之鹽之抗肥滿效果,最好係濃縮處堙等 山楂酸及/或其生理上可被容許之鹽含於本發明之抗肥滿 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -58 - 200300069 A7 B7 五、發明説明(々 用飮食品。 (請先閲讀背面之注意事項再填寫本頁) 濃縮條件並不特別限制,惟可爲利用其對水之溶解性 的方法。本發明之抗肥滿用飮食物中所含山楂酸及/或其 生理上可被容許之鹽係極性較低,爲難溶性之化合物。利 用此性質,將來自洋橄欖植物所得粗萃取物分爲難溶於水 之成份及/或不溶於水之成份,即,將其分成難溶水性等 之成份與容易溶於水之成份,藉此可更予濃縮。自洋橄欖 植物之粗萃取物中所含難溶水性等成份係與整體之自洋橄 欖植物萃取物相比,其抗肥滿效果極優者,由此可確認山 楂酸及/或其生理上可被容許之鹽己被濃縮。 難溶水性等之成份係可以將自洋橄欖粗萃取物添加水, 予攪拌後,過濾析出之部份等予以採取,即可簡單地取得 〇 經濟部智慧財1局員工消費合作社印¾ 又,本發明之抗肥滿用飮食物中所含山楂酸及/或其 生理上可被容許之鹽係可視其需要藉由組合一般之溶劑, 經由液-液分離加以濃縮。溶劑之組合很難一槪地規定,惟 可以例如組合水一疏水性有機溶劑、疏水性溶劑可爲己烷 、四氯化碳、氯仿、二氯甲烷、1,2-二氯乙烷、二乙醚、 乙酸乙酯、正丁醇、苯、甲苯等公知之溶劑。其中以己烷 、乙酸乙酯、正丁醇爲宜。 山楂酸及/或其生理上可被容許之鹽係難水溶性者, 將疏水性有機溶劑相分離時即可除不用之水溶性成份。除 去溶劑可以極容易濃縮山楂酸及/或其生理上可被容許之 鹽。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -59- 200300069 A7 B7 五、發明説明(5¾ (請先閲讀背面之注意事項再填寫本頁) 另外,本發明抗肥滿用飮食物中所含山楂酸及/或其 生理上可被容許之鹽係最好自上述萃取物及/或濃縮物予 以分餾•精製處理。藉此可以更比上述濃縮,單離出目的 之成份。 分餾•精製處理之有利處係除可以更提高黑色素生成 抑制劑還可以除去雜質。即,經分餾、精製處理時,可以 做爲白色結晶得到山楂酸及/或其生理上可被容許之鹽, 所以使用時不會對飮食物多出不用之色彩,極適於配合, 是爲其有利之處,故極理想。 經濟部智慧財產局員工消費合作社印製 分餾•精製處理之方法雖難以一槪規定,但例如可利 用再結晶法、離沈澱法、層析之方法等。尤其層析中利用 液體層析之方法以不致於分解本發明之抗肥滿用飮食物中 所含山楂酸及/或其生理上可被容許之鹽,在極佳收率下 分餾、精製、所以最爲理想。液體層析係具體言有順相液 體層析,逆相液體層析、薄層層析、紙層析、高速液體層 析(HPLC)等,分餾、精製處理本發明之抗肥滿用飮食物中 所含山楂酸及/或其生理上可被容許之鹽時可採用其任一 之方法。尤其考慮分離能力、處理量、步驟數等時係以順 相層析逆相層析、高速液體層析(HPLC)爲宜。 在此所稱順相層析係指例如以下之方法者。即,例如 以矽膠爲固定相,以己烷-乙酸乙酯混液、氯仿·甲醇混液等 移動相之管柱,以負荷率0.1〜5%(質量/體積)供予來自山楂 酸之粗萃取物或其濃縮物,藉由單一移動相之連續式溶離, 或依序增溶媒極性之階段性溶離法,使所定餾份溶離之方 本紙張尺度適用中國國家標隼(CNS ) A4規格(210X297公釐) -60 - 200300069 A7 __B7__ 五、發明説明(分 法。 (請先閲讀背面之注意事項再填寫本頁) 逆相液體層析係例如指以下之方法。即,作成例如以 十八烷基矽烷結合之矽石(ODS)爲固定相,以水-甲醇混液' 水·乙腈混液、水-丙酮混液等爲移動相之管柱,以〇·1〜50%( (質量/體積)供予來自山楂酸之粗萃取物或其濃縮物,藉由 單一溶媒之連續式溶離或依序降低溶媒極性之階段性溶離 法,溶離出所定餾份溶離之方法。 高速液體層析(HPLC)係原理上與上述順相液體層析或 逆相液體層析相同者,以較快速且高分離能力進行分餾、 精製者。 以一種或組合二種以上上述手法即可顯著濃縮山楂酸 及/或其生理上可被容許之鹽,並且以雜質被除去之狀態 下獲得,所以極爲理想。 另外,以一種或組合二種以上述手法,即可以調整山 楂酸及/或其生理上可被容許之鹽的純度,視其需要設計 出黑色素生成抑制效果之強度、特性等。 經濟部智慧財產局員工消費合作社印¾ 上述濃縮處理,較佳係重覆進行濃縮處理,更可以組 合不同之濃縮處理。同樣有關分餾、精製處理亦較佳係重 覆分餾、精製處理,更可以組合不同之分餾、精製處理。 又施予濃縮處理後可進行分餾、精製處理、或施予分餾、 精製處理後再分餾、精製處理,於濃縮處理後進行分餾、 精製處理,再予濃縮處理。當然上述組合以外之組合亦可 〇 藉由各種組合上述記載之萃取處理、濃縮處理、分餾 ^紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -61 - 200300069 A7 B7 五、發明説明(β (請先閲讀背面之注意事項再填寫本頁) 及/或精製處理等,即極適於得到山楂酸及/或其生理上 可被容許之鹽。其組合並無特別限制,惟一連之處理上具 體例可爲如以下之方法。 例如以水及/或親水性有機溶劑萃取處理洋橄欖植物 後,對所得萃取液除去一部份或全部親水性有機溶劑,視 其需要加入水攪拌,回收水層部析出之不溶水成份予以濃 縮。析出之不溶水成份可經由過濾或離心分離等回收,爲 提高此回收效率,視其需要對水溶液添加水、攪拌處理。 又,自洋橄欖植物所得除去萃取液之水及/或親水性有機 溶劑之乾固狀態的萃取物亦可以與上述一樣,進行添加水 、攪拌等處理,經由過濾等回收其不溶水成份即可濃縮處 理。依此濃縮方法時係一種水系下之處理,所以比使用溶 劑予以濃縮者更安全,可使用之機器的範圍亦較廣。又, 由於幾乎不含油份,所以濃縮、精製之效率亦極優、極理 想。 經濟部智慧財產局員工消費合作社印製 以順相及/或逆相層析及/或再結晶時施予分餾、精 製處理此等濃縮物,即可極順利地得被精製爲高純度之山 楂酸及/或其生理上可被容許之鹽更可得單離者。 在此,於液·液分離時添加之水量係只要爲可分離處理 之量即不予特別限定,惟以每一單位被乾固之萃取物的質 量,1〜100倍量爲宜,更佳係5〜50倍量,最佳係10〜30倍 量程度。 又,以水-疏水性有機溶劑之液-液分離中,水與疏水性 有機溶劑係使用水:疏水性有機溶劑1〜1:9(體積比)爲宜, 本纸張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -62- 200300069 A7 B7 五、發明説明(士 更佳係用8:2〜2:8。 (請先閱讀背面之注意事項再填寫本頁) 又,自洋橄欖植物及/或橄欖油製造步驟所得生成物 得到之山楂酸與生理上可被容許之鹽之混合物中的山楂酸 及/或生理上可被容許之鹽的合計含量係以95%以上爲宜, 更佳係95%〜99.99%。該含有率例如可用層析予以測定。 又,對於自洋橄欖所得萃取液除去親水性有機溶劑對 所剩水溶液視其需要添加水,再添加疏水性有機溶劑即可 藉由水-疏水性有機溶劑之液·液分離予以濃縮處理。又,對 乾固狀態之萃取物亦可同樣添加水,再添加疏水性有機溶 劑,即可藉水-疏水性有機溶劑之液-液分離予以濃縮處理。 以順相及/或逆相層析及/或再結晶予以分餾、精製處理, 即可得被粗製爲高純度之山楂酸及/或其生理上可被容許 之鹽更可得離者。 經濟部智慧財產局員工消費合作社印製 本發明之抗肥滿用飮食品含有山楂酸及/或其生理上 可被容許之鹽類,但做爲含有山楂酸和/或其生理上可容許 之鹽類,藉含有上述萃取物,濃縮物,分離•精製物,純離 物等也能獲得本發明之抗肥滿用飮食品。又,藉調整濃縮, 分離•精製等之程度也能調整所含山楂酸和/或其生理上 可容許之鹽類之濃度,而調適配合在飮食品中。 另外,也可以調配使用其他抗肥滿用物質,據此而能 詳細設計抗肥滿功能,又,可藉和其他抗肥滿物質之協同 效應而大幅度強化抗肥滿功能。 由於橄欖油中係含有山楂酸者,所以在本發明之抗肥 滿用飮食物中做爲油性成份使用橄欖油,即可得極適宜之 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐1 -63 - 200300069 Α7 Β7 五、發明説明(βί) 抗肥滿效果,係爲極爲理想者。 (請先閲讀背面之注意事項再填寫本頁) 又,自洋橄欖萃取山楂酸及/或其生理上可被容許之 鹽時亦同時會被萃取出油醇酸及/或其生理上可被容許之 鹽,惟此油醇酸及/或其生理上可被容許之鹽係與山楂酸 之互溶性優,所以可直接配合此等混合物於本發明之抗肥 滿用飮食物。藉此可期待分別所具有之生理上效果的相乘 效果,尤其可期山楂酸及/或其生理上可被容許之鹽在本 發明中發揮對抗肥滿效果上之相乘效果,故極爲理想。自 洋橄欖植物萃取,分離精製山楂酸及/或其生理上可被容 許之鹽時,可以調節其條件即可得與油醇酸及/或其生理 上可被容許之鹽的混合物,還可以自洋橄欖分別單離山楂 酸及/或其生理上可被容許之鹽,油醇酸及/或其生理上 可被容許之鹽,然後加以混合後獲得。還可以爲將分別不 同之原料所得之山楂酸及/或其生理上可被容許之鹽,與 油醇酸及/或其生理上可被容許之鹽的混合物。 經濟部智慧財產局員工消費合作社印製 又,本發明對象之山楂酸和/或其生理上可容許之鹽 類以外之五環性三萜烯類,也可以按照山楂酸和/或其生 理上可容許之鹽類所記載原料和方法,從天然物中分離而 得。 本發明之抗肥滿用飮食品可提供抗肥大性肥滿和/或 抗形成過大性肥滿用飮食品而使用。如同前述,由於本發 明之五環性三萜烯類和其生理上可容許之鹽類或其衍生物 具有前驅型脂肪細胞增殖抑制功能,前驅型脂肪細胞分化 抑制功能或成熟型脂肪細胞脂肪蓄積抑制功能,據此功能 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) " -64 - 200300069 A7 B7 五、發明説明(β)ι (請先閲讀背面之注意事項再填寫本頁) 而具有抗肥大性肥滿和/或抗形成過大性肥滿功能。質言之, 認爲主要可藉前驅型脂肪細胞增殖抑制功能或前驅型脂肪 細胞分化抑制功能而獲得抗肥大性肥滿功能,所以具有抗 肥大性肥滿和/或抗形成過大性肥滿效果。 蛵濟部智慧財產局®工消費合作社印¾ 本發明之抗肥滿用飮食品可提供預防肥滿和/或肥滿之 治療用飮食品使用。換言之,本發明乃含有由五環性三萜 烯類和其生理上可容許之鹽類或其衍生物所構成群中選擇1 種或2種以上而成之預防肥滿和/或肥滿治療用飮食品有關。 做爲預防肥滿爲目的而使用乃指開始擔心肥滿或當成長期 或中年期而有肥滿之掛慮時,事先爲預防肥滿而使用之情 形。該情形下,本發明之飮食品乃係含有五環性三萜烯類 和其生理上可容許之鹽類或其衍生物等具有抗肥滿功能之 物質之飮食品,所以,需要過分限制或節食之情形減少, 可以達成健康的預防肥滿之目的而很理想。又,以治療肥 滿爲目的而使用乃指已肥滿,特別是在健康上需要治療肥 滿等之際,改善肥滿之情形而言。該情形下,本發明之抗 肥滿飮食品乃係含有五環性三萜烯類和其生理上可容許之 鹽類或其衍生物等具有抗肥滿功能之物質之飮食品,所以 將需要過分節食或變更食生活習慣等對於身體有負擔情 形能抑制在最低限度下,可藉比較緩和之節食等而能進治 療肥滿,所以非常理想。 又,本發明之抗肥滿用飮食品也可以做爲減肥用飮食 品而利用。換言之,本發明乃含有五環性三萜烯類和其生 理上可容許之鹽類或其衍生物所構成群中選擇1種或2種以 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -65 - 200300069 A7 _B7_ 五、發明説明(七 (請先閱讀背面之注意事項再填寫本頁) 上而成之減肥用飮食品有關。以減肥爲目的之用途乃指對 於已屬肥滿體況者,自然包括並非特別肥滿,而因健康或 美容上需要減肥之際,應必要而進行減肥之情形。該情形 下,本發明之抗肥滿用飮食品乃係含有五環性三萜烯類和 其生理上可容許之鹽類或其衍生物等具有抗肥滿等功能之 物質之飮食品,所以不必進行伴隨痛苦或營養失調等過分 節食,而在充分之食生活和營養供應下能有效進行減肥而 甚爲理想。 經濟部智慧財1局員工消費合作社印¾ 又,本發明之抗肥滿用飮食品也可以做爲改善爲不易 肥滿體質用飮食物而利用。換言之,本發明乃含有五環性 三萜烯類和其生理上可容許之鹽類或其衍生物所構成群中 選擇1種或2種以上而成改善爲不易肥滿體質用飮食品有關 。所謂改善爲不易肥滿體質爲目的之使用乃指根本且長期 性之肥滿對策中,以改善體質本身而造成不易肥滿之體質 之性形而言。該情形下,本發明之抗肥滿用飮食品乃係含 有五環性三萜烯類和其生理上可容許之鹽類或其衍生物等 具有抗肥滿功能等之物質之飮食品,所以不會伴隨長期性 節食等痛苦,而在取得充分之營養和食生活下,改善爲不 易肥滿體質而甚爲理想。 本發明之具體之實施形態,例如可藉洋橄欖油製造工 程所得脫脂殘渣以乙醇溶液萃取處理,所得萃取物經乾而 濃縮之濃縮物,以使用GC分析而得山楂酸計,含有0.1〜5 質量%之上述所得濃縮物之食用油脂爲例舉。 又,本發明之另一具體之實施形態,例如可藉洋橄欖 ^紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) " -66 - 200300069 A7 B7 五、發明説明(6^ 油製造工程所得脫脂或殘渣以乙醇溶液萃取處理,以1〜30 質量%含量而含有上述所得萃取物之生菜用佐料爲例舉。 (請先閱讀背面之注意事項再填寫本頁) 又,本發明之另一具體之實施形態,例如可藉洋橄欖 油製造工程所得脫脂殘渣以乙醇溶液萃取處理,所得萃取 物經乾燥而濃縮成濃縮物,以含有藉GC分析計,含山楂酸 餾分0.1〜5質量%之該濃縮物而成生菜用佐料爲例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得搾油殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮成濃縮物,以含有0.1〜5質量%之該濃縮 物之飮料可爲其例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得脫脂殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 含量計,含有0.5〜25質量%之錠菓可爲例舉。 經濟部智慧財1局員工消资合作社印製 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得榨油殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 計含0.1〜5質量%之脆餅乾可爲例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得脫脂殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 含量計含0.5~5質量%之衣液和其炸製用調理品(冷凍食品 )可爲例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 I纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) " -67 - 200300069 A7 _ _ B7_ __ 五、發明説明(以 (請先閱讀背面之注意事項再填寫本頁) 欖油製造工程所得搾油殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 計,含0.05〜2.5質量%之醬可爲例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得脫脂殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 計,含0.1〜5質量%之美奶滋可爲例舉。 又,本發明之另一種具體之實施形態,例如可藉洋橄 欖油製造工程所得搾油殘渣以乙醇溶液萃取處理,所得萃 取物經乾燥而濃縮,以含有該濃縮物藉GC分析所得山楂酸 計,含〇.1〜5質量%之人造奶油可爲例舉。 經濟部智慧財1局員工消費合作社印製 本發明乃含有五環性三萜烯類和其生理上可容許之鹽 類或其衍生物所構成群中選擇1種或2種以上而成之抗肥滿 用飮食品有關。這些五環性三萜烯類具有前驅型脂肪細胞 增殖抑制功能,前驅型脂肪細胞分化抑制功能,成熟型脂 肪細胞脂肪蓄積抑制功能等之特別優異之抗肥滿功能。本 發明之抗肥滿用飮食品,不需要時間或勞力方面之特別負 擔,可以簡單且繼續享受抗肥滿功能而甚爲理想。又,本 發明之五環性三萜烯類可由天然植物而獲得,可以在日常 用途上安全使用,特別是來源於洋橄欖時,對於使用者尙 能給與精神上之舒爽感覺而甚爲理想。 實施例 以下示本發明之實施例,惟本發明並不受此等所限制 ^紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) " -68- 200300069 A7 _B7_ 五、發明説明(4 。以下質量%以單位之%表示。 (請先閲讀背面之注意事項再填寫本頁) 實施例中使用之五環性三萜烯類的古柯二醇(船越公司 製)、熊果酸(和光純藥公司製)、熊果醇(船越公司製)、樺 木酸(船越公司製)、樺木醇(船越公司製)、係做爲試藥購入 HPLC等級者係直接使用,未達該等級者係加熱至沸點、溶 解於乙醇至飽和後,經冷卻、再結晶、過濾、乾固再使用 。山楂酸係舉以下實施例說明,使用自洋橄欖植物萃取、 精製、確認純度95%者。 <製造例1> 軋碎500g日本國內產之洋橄欖(Olea europaea L.)的 乾燥果實(含種子),加入3 <已烷萃取3小時。重覆4次後 的脫脂果實中除去種子後加以粉碎,再以5倍量之己烷萃 取3小時,得229g完全除去油份之脫脂物(脫脂粕)。在此 脫脂物中加入10倍量之乙醇含量爲60質量%的含水乙醇溶 液,於室溫用力攪拌一邊萃取3小時。過濾全量後,濃縮 乾固濾液得112.7g萃取物。 經濟部智慧財產局員工消黃合作社印製 在l〇〇g此萃取物中加入2 <水,於室溫用力攪拌1小 時。以離心分離處理全量後,藉由傾析除去上澄液、乾燥 所得沈澱,得10.0g濃縮物。 其次以塡充有約40倍量(400g)矽膠之管柱的矽膠管柱 層析分餾此濃縮物。首先以凝膠之10倍量(4000ml)之己烷: 乙酸乙酯= 3:1溶離液離出多餘之成份後,再以2.5倍量( l〇〇〇ml)己烷:乙酸乙酯= 1:1溶離液溶離出多餘之不需要成 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) " -69 - 200300069 A7 B7 五、發明説明(4 份。繼而以塡充矽膠之10倍量(4000ml)的己烷:乙酸乙酯= 1:1溶離液溶離出目的山楂酸,得粗山楂酸餾份。自此餾份 (請先閲讀背面之注意事項再填寫本頁) 除去己烷及乙酸乙酯後,真空乾燥得1.96g粗山楂酸分餾物 〇 再使用塡充有約30倍量(60g)之十八烷基矽膠之管柱, 以ODS管柱層析精製此粗山楂酸分餾物。首先以10倍量( 600ml)塡充之矽膠的甲醇:水= 8:2溶離液溶離出雜質不需 要成份。繼而以30倍量( 1 800ml)塡充之矽膠的甲醇:水=8: 2溶離液溶離出目的之山楂酸,得精製之山楂酸餾份。自此 餾份除去甲醇後,真空乾燥得1.51g精製山楂酸1。 在此由NMR,MS等分析確認此精製山楂酸1係其一部 份爲鈉鹽及鉀鹽之狀態,其餘則大部份爲游離酸之狀態。 又,以GC測定此等之純度,確認做爲山楂酸之純度爲95% 以上。 <製造例2> 在lkg搾油意大利產洋橄欖(Olea europaea L.)所得搾 經濟部智慧財產局員工消资合作社印¾ 油殘渣(搾油粕)中加入10倍量之含65質量%乙醇之含水乙 醇水溶液,於室溫用力攪拌一邊萃取3小時。過濾全量後, 濃縮乾固濾液,得20.2g萃出物。 在此萃取物中加入1 ί正丁醇、1 <水、攪拌10分鐘 後,分爲正丁醇相與水相。除去正丁醇相之正丁醇後,真 空乾燥得1.33g濃縮物。 其次以塡充有約40倍量(500g)矽膠之管柱的矽膠管柱 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) ' -70- 200300069 A7 _B7 五、發明説明(蛉 (請先閱讀背面之注意事項再填寫本頁) 層析分餾此濃縮物。首先以凝膠之10倍量(50 00 ml)之己烷: 乙酸乙酯= 3:1溶離液離出多餘之成份後,再以2.5倍量( 1250 ml)己烷:乙酸乙酯=1:1溶離液溶離出多餘之不需要成 份。繼而以塡充矽膠之10倍量(5000ml)的己烷:乙酸乙酯= 1 :1溶離液溶離出目的山楂酸,得粗山楂酸餾份。自此餾份 除去己烷及乙酸乙酯後,真空乾燥得2.66g粗山楂酸分餾物 〇 再使用塡充有約30倍量(80g)之十八烷基矽膠之管柱, 以ODS管柱層析精製此粗山楂酸分餾物。首先以10倍量( 8 00 ml)塡充之矽膠的甲醇:水=8:2溶離液溶離出雜質不需 要成份。繼而以30倍量(2400 ml)塡充之矽膠的甲醇:水=8: 2溶離液溶離出目的之山楂酸,得精製之山楂酸餾份。自此 餾份除去甲醇後,真空乾燥得2.06g精製山楂酸2。 在此由NMR,MS等分析確認此精製山楂酸2係其一部 份游離酸狀態,其餘之大部份爲鈉或鉀鹽等狀態。又,以 GC測定此等之純度,確認做爲山楂酸之純度爲95%以上。 經濟部智慧財4局員工消費合作社印製 <製造例3> 在1 kg橄欖油製造步驟中所得意大利產洋橄欖萃取殘 渣(以萃取步驟再處理搾油殘渣之脫脂物)中,加入10倍量 乙醇,加熱爲55 °C用力攪拌一邊萃取3小時。過濾全量後, 濃縮乾燥濾液,得35g萃取液。 其次以塡充有約40倍量(1400g)矽膠之管柱的矽膠管柱 層析分餾此濃縮物。首先以凝膠之10倍量(14 <)之己烷: 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -71 - 200300069 A7 B7 五、發明説明(4 乙酸乙酯= 3:1溶離液離出多餘之成份後,再以2.5倍量( 3500ml)己烷:乙酸乙酯=1:1溶離液溶離出多餘之不需要成 份。繼而以塡充矽膠之10倍量(14 的己烷:乙酸乙酯=1: 1溶離液溶離出目的山楂酸,得粗山楂酸餾份。自此餾份除 去己烷及乙酸乙酯後,真空乾燥得5.90g粗山楂酸分餾物。 再使用塡充有約30倍量(180g)之十八烷基矽膠之管柱, 以ODS管柱層析精製此粗山楂酸分餾物。首先以10倍量 ( 1 800ml)塡充之矽膠的甲醇:水= 8:2溶離液溶離出雜質不需 要成份。繼而以30倍量(5 400 ml)塡充之矽膠的甲醇:水=8: 2溶離液溶離出目的之山楂酸,得精製之山楂酸餾份。自此 餾份除去甲醇後,真空乾燥得5.36g精製山楂酸3。 在此由NMR,MS等分析確認此精製山楂酸3係其一部 份爲鈉鹽及鉀鹽之狀態,其餘則大部份爲游離酸之狀態。 又,以GC測定此等之純度,確認做爲山楂酸之純度爲97% 以上。 做爲五環性三萜烯類之衍生物係如以下取得。 <合成例> 將4.5g山楂酸l.〇g三乙胺溶解於50ml氯仿、冰冷下 將l.lg亞磺醯氯溶解於l〇ml氯仿所得者滴下,一邊攪拌1 小時。繼而加入3.2g乙醇,冰冷下,將l.Og二乙胺溶解於 1 0 m 1氯仿所得者一邊滴下,一邊攪拌3小時。反應完後萃 取氯仿溶解成份,以矽膠管柱層析精製餾去氯仿後所得粗 反應物,得3.5g山楂酸乙酯。 本紙浪尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -裝-- (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部智慈財4局員工消费合作社印製 -72 - 200300069 A7 B7 五、發明説明(6¾ <合成例2>2,3-0-二乙醯基-山楂酸 (請先閲讀背面之注意事項再填寫本頁) 將2.0g山楂酸溶解於100ml吡啶,加入50ml醋酐攪拌 一晚。餾去吡啶及醋野後,將殘留物溶解於乙醚,以1N鹽 酸水溶液一次,以飽和碳酸氫鈉溶液一次,以純水三次分 別洗淨此乙醚相後,加入硫酸鎂放置一晚。經過濾除去硫 酸鎂,以矽膠管柱層析精製經餾去乙醚所得粗反應物,得 2.2g2,3-0-二乙醯基-山楂酸。 <合成例3>2,3-0-三乙矽烷基-山楂酸三乙矽烷基酯 將l.Og山楂酸溶解於200ml無水二甲基甲醯胺,於0 °C加入144.0mg咪唑及350μ1三乙矽烷基氯,密封起來攪拌 2小時。餾去二甲基甲醯胺後,將殘留物溶解於乙醚,以 1Ν鹽酸水溶液一次,以飽和碳酸氫鈉溶液一次,以純水三 次分別洗淨此乙醚相後,加入硫酸鎂放置一晚。經過濾除 去硫酸鎂,以矽膠管柱層析精製經餾去乙醚所得粗反應物, 得1.5g2,3-0-三乙矽烷基·山楂酸三乙矽烷基酯。 瞍齊郎智慧时走苟員工消費合作社印製 <合成例4>2,3-0-二·硬脂醯基-山楂酸乙酯 在50ml無水甲苯中溶解l.Og合成例1所得山楂酸乙酯 ,加入5.0g三乙胺,再於冰冷下慢慢添加6.0g硬脂酸氯, 攪拌1小時。慢慢恢復至室溫,攪拌9小時。加入適量之 1N鹽酸水溶液,以乙醚萃取,以飽和碳酸氫鈉溶液一次, 以純水三次分別洗淨此乙醚相後,加入硫酸鎂放置一晚。 本紙張尺度適用中國國家揉準(CNS ) A4規格(210X297公釐) ' ' -73 - 200300069 A7 B7 五、發明説明(7b 經過濾除去硫酸鎂,以矽膠管柱層析精製經餾去乙醚所得 粗反應物,得1.2g2,3-0-二-硬脂醯基-山楂酸乙酯。 (請先閲讀背面之注意事項再填寫本頁} <合成例5>3,28-0-二乙醯基-古柯二醇 將5.0g古柯二醇溶解於250ml吡啶,加入100ml醋酐 攪拌一晚。餾去吡啶及醋酐後,將殘留物溶解於乙醚,以 1 N鹽酸水溶液一次,以飽和碳酸氫鈉溶液一次,以純水三 次分別洗淨此乙醚相後,加入硫酸鎂放置一晚。經過濾除 去硫酸鎂,以矽膠管柱層析精製經餾去乙醚所得粗反應物, 得5.4g3,28-0-二乙醯基-古柯二醇。 <合成例6>熊果酸乙酯 經濟部智慧財凌局員工消費合作社印製 將5.0g熊果酸l.lg三乙胺溶解於50ml氯仿、冰冷下 將1.2mg亞磺醯氯溶解於10ml氯仿所得者滴下,一邊攪拌 1小時。繼而加入3.5g乙醇,冰冷下,將1. 1 g三乙胺溶解 於10ml氯仿所得者一邊滴下,一邊攪拌3小時。反應完後 萃取氯仿溶解成份,以矽膠管柱層析精製餾去氯仿後所得 粗反應物,得3.8g熊果酸乙酯◊ <合成例7>3,28-0-二乙醯基-熊果醇 將5.0g熊果醇溶解於250ml吡啶,加入100ml醋酐攪 拌一晚。餾去吡啶及醋酐後,將殘留物溶解於乙醚,以1N 鹽酸水溶液一次,以飽和碳酸氫鈉溶液一次,以純水三次 分別洗淨此乙醚相後,加入硫酸鎂放置一晚。經過濾除去 本尺度適用中國國家標準(CNS ) A4規格(210X297公釐) " '' -74 - 200300069 A7 B7 五、發明説明(7)l 硫酸鎂,以矽膠管柱層析精製經餾去乙醚所得粗反應物, 得5.4g3,28-0-二乙醯基熊果醇。 <合成例8>樺木酸乙酯 將5.0g樺木酸l.lg三乙胺溶解於50ml氯仿、冰冷下 將1.2mg亞磺醯氯溶解於l〇ml氯仿所得者滴下,一邊攪拌 1小時。繼而加入3 . 1 5g乙醇,冰冷下,將1. 1 g三乙胺溶解 於10ml氯仿所得者一邊滴下,一邊攪拌3小時。反應完後 萃取氯仿溶解成份,以矽膠管柱層析精製餾去氯仿後所得 粗反應物,得3.8g樺木酸乙酯。 <合成例9>3,28-0-二乙醯基-樺木醇 將5.0g樺木醇溶解於250ml吡啶,加入100ml醋酐攪 拌一晚。餾去吡啶及醋酐後,將殘留物溶解於乙醚,以1N 鹽酸水溶液一次,以飽和碳酸氫鈉溶液一次,以純水三次 分別洗淨此乙醚相後,加入硫酸鎂放置一晚。經過濾除去 硫酸鎂,以矽膠管柱層析精製經餾去乙醚所得粗反應物, 得5.4g3,28-0-二乙醯基-樺木醇。 試驗例1 [前驅型脂肪細胞增殖抑制功能之評估] 將來源於鼠之前驅型脂肪細胞株3T3- LI (ATCC寄存, 寄存號碼爲CL- 173),以3xl05細胞/75cm2之密度在組織 培養瓶 (Nunc公司製品)中,以含有1〇%牛胎兒血淸之 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) -裝· 經濟部智慧財產局資工消費合作社印製 -75- 200300069 A7 B7 五、發明説明(7^ DMEM培養基 (Nakaraitesq公司製品)培養之,進入對 數增殖期後半之2日後,將該細胞以lxl〇4細胞0.32 cm2 之密度移植在多孔培養盤 (Corning Costar公司製品), 以含有1%牛胎兒血淸之DMEM培養基,在按照表1所記載 濃度將各種三萜烯類加入條件下培養48小時。培養開始 後第44小時將加入Alamar藍TM (Alamar公司製品),再 培養4小時。培養終了後,將由細胞之氧化返原反應所 產生螢光物質藉螢光分光光度計測定,和對照群之螢光強 度比較而計算其細胞增殖抑制率。 (評估標準) 僅添加溶解有三萜烯類之溶劑之試驗群做爲對照群, 以對照群所得螢光強度爲100%時之被檢驗物質添加時之 螢光強度計算增殖抑制率。其計算式如下式1 ° 式1 增殖抑制率(%) =100 -(添加被檢驗物質時之螢光強度/ 對照群時之螢光強度)X 100 (請先閱讀背面之注意事項再填寫本頁) -裝_ 訂 經濟部智慧財產局員工消骨合作社印^ 匕匕 厶目 功 制 抑 殖 增 胞 細 肪 脂 型 驅 前第 估於 評示 法率 方制 述抑 上殖 照增 依以 果 結 其 中 表 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -76· 200300069 A7 B7 五、發明説明(凫 J表 < 前驅型脂肪細胞增殖抑制率 (%) > 濃度(y g / m 1) 6 12.5 25 50 100 標準品 共軛亞油 0 20 30 40 40 本發明品 精製山楂酸1 10 35 94 95 95 精製山楂酸2 10 30 90 95 95 精製山楂酸3 11 36 94 95 95 古柯二醇 11 80 95 95 95 熊果酸 18 83 94 95 95 熊果醇 • • 30 38 76 樺木酸 虐 • 30 69 92 樺木醇 • 參 28 76 94 合成例1之化合物 10 40 84 86 90 合成例2之化合物 15 30 83 89 95 合成例3之化合物 18 33 79 84 91 合成例4之化合物 12 30 77 94 94 合成例5之化合物 20 78 95 96 96 合成例6之化合物 20 80 93 95 95 合成例7之化合物 • 鱗 30 70 80 合成例8之化合物 • 30 73 95 合成例9之化合物 - - 35 71 95 (請先閲讀背面之注意事項再填寫本頁) 瞍齊郎智慧时產苟員工消費合作社印製 由第1表可知山楂酸,古柯二醇,熊果酸,熊果醇,樺 木酸,樺木醇和其生理上可容許之鹽類或其衍生物等之前 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -77 - 200300069 A7 B7 五、發明説明(7i 驅型脂肪細胞增殖抑制功能較之已知具有強力抗抗肥滿功 能物質之共軛亞油酸更爲非常強大。 (請先閱讀背面之注意事項再填寫本頁) 據此顯示山楂酸,古柯二醇,熊果酸,熊果醇,樺木 酸,樺木醇和其生理上可容許之鹽類或其衍生物對於前驅 型脂肪細胞增殖抑制功能將有優異之貢獻。 試驗例2 <前驅型脂肪細胞分化抑制功能和成熟型脂肪細胞脂肪蓄 積抑制功能之評估> 經濟部智慧財產局員工消費合作社印製 將來源於鼠之前驅型脂肪細胞株3T3- LI (ATCC寄存, 寄存號碼爲CL- 173)以3x 105細胞/75 cm2之密度在組織培 養瓶 (Nunc公司製品)中,以含有10%之牛胎兒血淸之 DMEM培養基 (Nakaraitesq公司製品)培養之。然後,按照 下述方法評估其分化抑制功能。在進入對數增殖期後半之2 日後,將該細胞以8xl03細胞/孔之密度移植在1.9cm2多孔 培養盤 (Coming Costar公司製品)中,培養4〜7日之後, 按照第2表中所記載濃度添加含有分化因子之DMEM培養基 和三萜烯類,再培養48小時。然後,在含有牛胎兒血淸和 胰島素之DMEM培養基中再培養8日。培養終了後,添加 細胞溶解用緩衝液於各培養孔中,再藉三甘油酯G-和光 測定儀(和光純藥工業公司製品)測定溶解液中之脂肪 量,而推測脂肪細胞內所攝取之三甘油酯量,和對照群比 較而計算其脂肪細胞分化抑制功能。又,脂肪蓄積抑制功 能係在分化因子共存下培養2日後,變更爲含有牛胎兒血淸 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -78 - 200300069 A7 B7 五、發明説明(7Ϊ 和胰島素之DMEM培養基而添加之際,按照第2表中所記載 濃度添加以各三萜烯類之條件下,再培養8日,培養終了後, 按照評估分化抑制功能同樣操作進行,而計算脂肪細胞脂 肪蓄積抑制功能。 (評估標準) 添加僅溶解三萜烯類之溶劑群做爲對照,由對照得三 甘油酯量做爲100%時,從添加被檢驗物質時之三甘油酯量 計算其分化,脂肪蓄積抑制率。其計算式如下式2所示。 式2 分化、脂肪蓄積抑制率(%) =100-(添加被檢驗物質時之 三甘油酯量/對照群之三甘油酯量)X 1〇〇 依據上述方法評估前驅型脂肪細胞增殖抑制功能和成 熟型脂肪細胞脂肪蓄積抑制功能,其結果以分化,脂肪胃 積抑制率示於第2表中。 (請先閲讀背面之注意事項再填寫本頁) 『裝· 訂 經濟部智慧財產局員工消贫合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -79 · 200300069 經濟部智慧財1局員工消资合作社印製 A7 B7 五、發明説明(4 岸_2表 < 前驅型脂肪細胞分化•脂肪蓄積抑制率 (%) > 濃度 (ug/ml) 分化抑制 率(%) 脂肪蓄積 抑制率 (%) 分化抑 制率 (%)S.I. 脂肪蓄積 抑制率 (%) S.I. 標準品 共軛亞油 5 11.0 21.0 本發明品 精製山楂酸1 5 82.0 83.5 7.5 4.0 精製山楂酸2 5 80.0 81.7 7.3 3.9 精製山楂酸3 5 82.5 84.0 7.5 4.0 古柯二醇 5 78.5 80.4 7.1 3.8 熊果酸 5 65.4 66.9 5.9 3.2 熊果醇 5 55.4 59.2 5.0 2.8 樺木酸 5 60.0 63.8 5.5 3.0 樺木醇 5 72.3 70.2 6.6 3.3 合成例1之化合物 5 84.3 83.9 7.7 4.0 合成例2之化合物 5 82.8 80.1 7.5 3.8 合成例3之化合物 5 81.0 78.0 7.4 3.7 合成例4之化合物 5 83.6 82.6 7.6 3.9 合成例5之化合物 5 75.0 78.0 6.8 3.7 合成例6之化合物 5 69.5 80.0 6.3 3.8 合成例7之化合物 5 60.4 63.2 5.5 3.0 合成例8之化合物 5 65.1 66.6 5.9 3.2 合成例9之化合物 5 75.5 74.1 6.9 3.5 由第2表可知山楂酸,古柯二醇,熊果酸,熊果醇,樺 ’裝-- (請先閲讀背面之注意事項再填寫本頁) 訂 本紙悵尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -80 - 200300069 A7 B7 五、發明説明(7> (請先閱讀背面之注意事項再填寫本頁) 木酸,樺木醇和其生理上可容許之鹽類或其衍生物等之前 驅型脂肪細胞分化抑制功能和成熟型脂肪細胞脂肪蓄積抑 制功能,較之已知具有強抗肥滿功能物質之共軛亞油酸更 爲非常強大。 據此顯示山楂酸,古柯二醇,熊果酸,熊果醇,樺木 酸,樺木醇和其生理上可容許之鹽類或其衍生物等對於前 驅型脂肪細胞分化抑制功能和/或成熟型脂肪細胞脂肪蓄積 抑制功能將有優異貢獻。 試驗例3 <體脂肪蓄積抑制試驗〉 經濟部智慧財凌局員工消費合作社印製 按照下述方法進行體脂肪蓄積抑制試驗。將Wister系雄 (6週齡,平均體重爲160g)以AIN-93組成之粉狀調配試料 預飼養1星期後,按照平均體重能成爲均等分成12群(每群 8隻),然後,按照第4表中所記載添加以被檢驗物質之飼料 (對照群使用黃豆油),使之自由攝取8星期。又,上述飼料 以第3表中所記載成分爲基礎,添加被檢驗物質時之多餘成 分則使用減少相同質量之玉米澱粉。8星期後解剖各群之試 驗用鼠,測定其皮下和內臟之脂肪量,計算其對於總體重 之脂肪蓄積率。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -81- 200300069 A7 B7 五、發明説明(7¾ 第3表 < 飼料組成〉 組成物 組成 (%) 玉米澱粉 52.95 酪蛋白 20.0 蔗糖 10.0 精製大豆油 7.00 纖維素 5.00 混合礦物質 (AIN- 93G) 3.50 混合維生素 (AIN- 93G) 1.00 L·胱胺酸 0.30 重酒石酸膽汁素 0.25 (請先閲讀背面之注意事項再填寫本頁) 絰濟郎智慧时凌局S工消費合作钍印製 (評估標準) 以黃豆攝取群爲對照群,對照群所得體脂肪蓄積率爲 100%時,從被檢驗物質攝取群之體脂肪蓄積率按照下式3計 算得體脂肪蓄積抑制率。 式3 體脂肪蓄積抑制率(%) =100-(被檢驗物質攝取群之體脂 肪蓄積率/對照攝取群之體脂肪蓄積率)xl00 依照上述方法評估體脂肪蓄積抑制功能,其結果以體 脂肪蓄積抑制率示於第4表中。 本紙張尺度適用中國國家標準(CNS ) A4現格(210X29*7公釐) -82 · 200300069 Α7 Β7 五、發明説明(7¾ 苐4表 < ::體脂肪畜 投與物質 投與量(g/飼料100g) 體脂肪蓄積抑制率(%) 第1群 黃豆油(對照) • - 第2群 製造例2所得萃取物 10.0 9.3 第3群 製造例2所得濃縮物 5.0 10.2 第4群 精製山椅酸1 1.0 12.5 第5群 精製山楂酸2 1.0 13.6 第6群 古柯二醇 1.0 20.9 第7群 熊果酸 1.0 19.1 第8群 熊果醇 1.0 10.3 第9群 樺木酸 1.0 9.5 第10群 樺木醇 1.0 9.8 第11群 合成例1之化合物 1.0 15.0 第12群 合成例2之化合物 1.0 18.2 第13群 精製山楂酸3 1.0 12.4 (請先閱讀背面之注意事項再填寫本頁) 瞍齊郎智慧时產笱員工消費合作社印製 由第4表可知各種五環性三結燦類和其生理上可容§午之 鹽類或其衍生物使用群較之對照群有意(即Ρ<〇·〇5)抑制 體脂肪蓄積。又,經口攝取天然萃取物(山楂酸含量爲 12.2%)和其濃縮物(山楂酸含量爲19.5%)也能顯現體脂 肪蓄積抑制功能。 據此顯示各種五環性三萜烯類和其生理上可容許之鹽 類或其衍生物對於抗肥滿功能將有優異貢獻。又,從天然 取得時,較之僅萃取褚,經濃縮和/或分離•精製,純離者 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -83 - 200300069 A7 B7 _ 五、發明説明(ώ 有顯示更高功能之傾向。 (請先閱讀背面之注意事項再填寫本頁) 試驗例4 <使用動物之安全確認試驗> 按照下述方法進行急性毒性試驗。將wister系雌鼠 (6週齡,平均體重爲160g)以AIN- 93組成之粉末調配飼 料預飼養1星期後,按照平均體重成爲均等而分成6群( 每群8隻)。分別爲山楂酸投與群,古柯二醇投與群,熊 果酸投與群,熊果醇投與群,樺木酸投與群,樺木醇投與 群◊將各檢驗物質懸濁在棉籽油中,以2〇〇〇mg/kg體重之 量藉探針強行經口投與之。繼用AIN- 93組成之粉末調配 飼料飼養,觀察投與後2星期之飼養狀況,再於2星期後解 剖檢視內臟狀態。 其結果投與後2星期所有群皆無死亡例,又,解剖之 內臟檢視也無異常現象。由此可知各種五環性三萜烯類 之LD5G値爲2000mg/kg體重以上,極爲安全而優異,可藉 飮食品等形態而經口攝取。 經濟部智慧財4局員工消費合作社印製 試驗例5 <體脂肪蓄積抑制試驗> 將SD系雄鼠(6週齡,平均體重爲160g)以固形調配飼 料(硏究MR蓄用飼料,日本製產工業公司製品)預飼養1 星期之後,按照平均體重成爲均等而分成5群(每群4隻), 使之自由攝取添加有被檢驗物質之AIN- 93組成之粉末調配 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -84 - 200300069 五、發明説明(力 飼料4星期。上述飼料之組成示於第5表中。又,所有群中 添加以7質量%之調配油(黃豆油:油菜籽油=3: 7) ° 4星期後,在禁食6小時後解剖各群之試驗用與,測定 總內臟脂肪(副睪九周圍,腸間膜和腎周圍)和皮下脂肪 量。由該測定値,從對最終體重之各部位脂肪量計算其脂 肪蓄積率。以總內臟脂肪(副睪九周圍,腸間膜和腎周圍) 和皮下脂肪量之合計做爲體脂肪量,再計算對最終體重之 體脂肪蓄積率。 再以攝取調配油群爲對照群時之脂肪蓄積率爲基準, 比較被檢驗物質之脂肪蓄積率,按照下式4所示計算脂肪蓄 積抑制率確認其脂肪蓄積抑制效果,其結果示於第6表。 (請先閲讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 第5表 < 飼料組成> 組成物 組成(%) 調配油群 96-0.1% 群 96-0.01% 群 18-0.5 群 18-0.05 群 玉米澱粉 52.9 52.8 52.9 52.4 52.9 酪蛋白 20.0 20.0 20.0 20.0 20.0 蔗糖 10.0 10.0 10·0 10.0 10.0 調配油 7.0 7.0 7.0 7.0 7.0 纖維素 5.0 5.0 5.0 5.0 5.0 混合礦物質(AIN- 93G) 3.5 3.5 3.5 3.5 3.5 混合維生素(AIN-93G) 1.0 1.0 1.0 1.0 1.0 胱胺酸 0.3 0.3 0.3 0.3 0.3 重酒石酸膽汁素 0.3 0.3 0.3 0.3 0.3 被檢驗物質 0.0 0.1 0.01 0.5 0.05 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) -85- 200300069 A7 B7 五、發明説明(4 <脂肪蓄積抑制率> 式4 各部位和體脂肪蓄積抑制率(%) = 100-(被檢驗物質攝取群 脂肪蓄積率/對照攝取群之脂肪蓄積率)x 100 (請先閱讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作社印製 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -86- 200300069 A7 B7 五、發明説明(洼 經濟部智慧財產局員工消費合作社印製 體脂肪 抑制率(%) 1 CO ON % < »—η 1 * 蓄積率(%) 13.34 13.17 12.55 12.71 11.86 i]cn 抑制率(%) a cn Ό r 'i Ο 1—^ y- 蓄積率(%) 7.36 7.34 7.17 6.99 6.62 總內臟 抑制率(%) 1 〇〇 οα 5 CN 04 oi 蓄積率(%) 5.97 5.80 5.39 g 8 山楂酸 1 0.09 0.009 0.09 0.009 W 蛔 ta、 被檢驗物質 1 wn 0.05 5 .ο ο 投與物質 調配油(對照) 製造例2所得濃縮物 製造例2所得濃縮物 精製山楂酸1 精製山楂酸1 第1群 第2群 第3群 第4群 第5群 (請先閱讀背面之注意事項再填寫本頁) C.V. Description of the invention (A (please read the precautions on the back before filling this page) and other primary alcohols, secondary alcohols such as 2-propanol, 2-butanol, and tertiary alcohols such as 2-methyl-2-propanol Alcohols can be solvents such as ethylene glycol, propylene glycol, 1,3-butanediol and other liquid polyols, and these solvents can be used alone or in combination of two or more. Lower alcohols can be C! ~ C4 well-known alcohols For example, one of the above, second, third, or liquid polyols, etc., these can be used alone or in combination of two or more. In addition, when the present invention is a glutinous food, the lower alcohol is preferably ethanol, and the content is 10 Extraction of hydrous ethanol with mass% or more is preferable. It is more preferable to use 10% to 95% by mass of water-containing ethanol, and it is best to prepare 30% to 95% by mass of water-containing ethanol. The crude extract thus obtained And / or the crude extract, and the maslinic acid and / or physiologically acceptable salts thereof in the present invention can be obtained by removing the solvent and water. The solvent and water can be removed by vacuum distillation, vacuum, and vacuum. Known methods such as drying, freeze-drying, spray-drying, etc. It is not particularly limited including water. Since the extract obtained from the degreased product does not contain oil-soluble components such as triglycerides or fatty alcohols, tocopherols, it is not necessary to remove and refine these, so it is better. It is printed by the bone-eliminating cooperative of the staff of the property bureau. Since the fat-removing material contains residues after pressing, the pressing residues (pressing residues) and extraction residues (extracting residues) of olive oil can be used. The effective utilization method is usually used by those who are discarded or used in feed, so it is also an excellent method in terms of production cost. In addition, to enhance the maslinic acid and / or its physiologically acceptable extract from the olive plant The anti-fullness effect of the permitted salt is preferably maslinic acid such as concentrated scent and / or its physiologically acceptable salt is included in the anti-fullness of the present invention. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) -58-200300069 A7 B7 V. Description of the invention (々 用 飮 食品. (Please read the notes on the back before filling out this page) The concentration conditions are not particularly limited, but you can use them Method for the solubility of water. The maslinic acid and / or physiologically acceptable salts thereof contained in the anti-plumid foods of the present invention have low polarity and are insoluble compounds. Using this property, they will be derived from olives. The crude extract obtained from plants is divided into a water-insoluble component and / or a water-insoluble component, that is, it is divided into a water-insoluble component and the water-soluble component, thereby being more concentrated. The crude extract of the plant contains insoluble water and other components that are superior in anti-fatness effect compared with the whole olive olive plant extract, so it can be confirmed that maslinic acid and / or its physiological tolerance is allowed The salt has been concentrated. Water-insoluble ingredients can be obtained by adding water to the crude olive olive extract, stirring it, filtering out the precipitated part, etc., and then simply obtaining the staff of the Ministry of Economic Affairs, Smart Finance 1 Bureau Consumption cooperatives ¾ In addition, the maslinic acid and / or physiologically acceptable salts thereof contained in the anti-fattiness food of the present invention can be concentrated by liquid-liquid separation by combining ordinary solvents as required. The combination of solvents is difficult to specify at one stroke, but it can be combined with water-hydrophobic organic solvents, for example, hexane, carbon tetrachloride, chloroform, dichloromethane, 1,2-dichloroethane, and Well-known solvents such as diethyl ether, ethyl acetate, n-butanol, benzene, and toluene. Among them, hexane, ethyl acetate, and n-butanol are suitable. The maslinic acid and / or physiologically acceptable salts are those which are poorly water-soluble, and the water-soluble components that are not used can be removed when the hydrophobic organic solvent is separated from the phase. Removal of the solvent makes it extremely easy to concentrate maslinic acid and / or its physiologically acceptable salts. This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) -59- 200300069 A7 B7 V. Description of the invention (5¾ (Please read the notes on the back before filling this page) In addition, the invention is suitable for anti-fullness山 The maslinic acid and / or physiologically acceptable salts thereof contained in the food are preferably fractionated and refined from the above-mentioned extracts and / or concentrates, so that they can be concentrated and separated from the intended ingredients. The advantages of fractionation and refining are that in addition to increasing the melanin production inhibitor, impurities can also be removed. That is, when fractionating and refining, it can be used as white crystals to obtain maslinic acid and / or physiologically acceptable salts thereof. Therefore, it will not add unused colors to the food when it is used, which is very suitable for coordination. It is its advantage and it is ideal. The method of printing, fractionating and refining processing by the employee consumer cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs is difficult.槪 stipulated, but for example, the recrystallization method, ion precipitation method, chromatography method, etc. can be used. In particular, the method using liquid chromatography in chromatography is not to decompose the anti-fatness of the present invention.山 The maslinic acid and / or physiologically acceptable salts contained in the food are ideally fractionated and refined in excellent yield. Liquid chromatography is specifically cis-phase liquid chromatography and reverse-phase liquid Chromatography, thin-layer chromatography, paper chromatography, high-speed liquid chromatography (HPLC), etc., fractionate and purify the maslinic acid and / or physiologically acceptable salts thereof contained in the anti-fattiness food of the present invention Any of these methods can be used. In particular, in consideration of separation capacity, throughput, and number of steps, it is preferable to use reverse phase chromatography and high-speed liquid chromatography (HPLC). This means, for example, the following methods: that is, for example, using silica gel as a stationary phase, a hexane-ethyl acetate mixed solution, a chloroform-methanol mixed solution, and the like as a mobile phase column, and the supply rate is 0.1 to 5% (mass / volume). The crude extract from maslinic acid or its concentrate is subjected to continuous dissolution by a single mobile phase or stepwise dissolution method of sequentially increasing the polarity of the solvent, so that the predetermined fraction is dissolved in accordance with Chinese national standards. (CNS) A4 size (210X297 mm) -60-200300069 A7 __B7__ 5. Description of the invention (Separation method. (Please read the precautions on the back before filling out this page) Reverse phase liquid chromatography refers to the following methods, for example, to produce octadecylsilane-bound silica (ODS ) Is a stationary phase, and a water-methanol mixed solution, a water-acetonitrile mixed solution, and a water-acetone mixed solution are used as a mobile phase column, and a crude extract from maslinic acid is supplied at a concentration of 0.1 to 50% ((mass / volume)). Or its concentrate, a method of continuous dissolution of a single solvent or a stepwise dissolution method of sequentially reducing the polarity of the solvent to dissolve a predetermined fraction. High-speed liquid chromatography (HPLC) is in principle the same as the above-mentioned cis-phase liquid layer Those who have the same analytical or reverse-phase liquid chromatography, and perform fractionation and purification with faster and higher separation ability. One or a combination of two or more of the above methods can significantly concentrate maslinic acid and / or physiologically acceptable salts thereof, and obtain them in a state where impurities are removed, so it is highly desirable. In addition, the purity of maslinic acid and / or physiologically acceptable salts thereof can be adjusted by one method or a combination of two methods, and the strength and characteristics of melanin production inhibitory effect can be designed as required. Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ The above-mentioned concentration treatment is preferably repeated concentration treatment, and different concentration treatments can be combined. Similarly, the fractionation and refining treatments are preferably repeated fractionation and refining treatments, and different fractionation and refining treatments can be combined. After the concentration treatment is applied, fractionation, refining treatment, or fractionation, refining treatment, and fractionation, refining treatment may be applied, and after concentration treatment, fractionation, refining treatment, and concentration treatment may be performed. Of course, combinations other than the above combinations can also be used. 〇 The extraction treatment, concentration treatment, and fractionation described above in various combinations ^ The paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) -61-200300069 A7 B7 V. Description of the invention (Β (please read the notes on the back before filling this page) and / or refined treatment, which is very suitable for obtaining maslinic acid and / or physiologically acceptable salts. The combination is not particularly limited, only A specific example of the treatment may be the following method. For example, after extracting and treating the olive plant with water and / or a hydrophilic organic solvent, a part or all of the hydrophilic organic solvent is removed from the obtained extract, and water is added as required to stir. The insoluble water component precipitated in the recovered water layer portion is concentrated. The precipitated insoluble water component can be recovered by filtration or centrifugation. In order to improve the recovery efficiency, water is added to the aqueous solution and stirred as needed. The water-extracted and / or hydrophilic organic solvent-extracted dry extract obtained may be added with water and stirred in the same manner as described above. After the treatment, the insoluble water component can be recovered by filtration and concentrated. This concentration method is a treatment under the water system, so it is safer than using a solvent to concentrate, and the range of machines that can be used is also wider. Also, Because it contains almost no oil, the efficiency of concentration and refining is also excellent and ideal. It is printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs for fractional distillation and refining during cis-phase and / or reverse-phase chromatography and / or recrystallization When these concentrates are processed, they can be purified very smoothly into high-purity maslinic acid and / or physiologically acceptable salts thereof, and even more isolated. Here, the amount of water added during liquid-liquid separation The amount is not particularly limited as long as it is a separable amount, but in terms of the mass of the dried extract per unit, the amount is preferably 1 to 100 times, more preferably 5 to 50 times, and the best is 10 to The amount is about 30 times. In the liquid-liquid separation of water-hydrophobic organic solvents, water and hydrophobic organic solvents are preferably water: hydrophobic organic solvents of 1 to 1: 9 (volume ratio). This paper Standards apply to Chinese National Standard (CNS) Α4 regulations (210X297 mm) -62- 200300069 A7 B7 V. Description of the invention (8: 2 ~ 2: 8 for the better). (Please read the precautions on the back before filling out this page). The total content of maslinic acid and / or physiologically tolerable salt in a mixture of maslinic acid and physiologically tolerable salt obtained from the product obtained from the olive oil production step is preferably 95% or more, and more preferably 95% to 99.99%. This content can be measured, for example, by chromatography. In addition, the hydrophilic organic solvent is removed from the extract obtained from the olive oil, and the remaining aqueous solution is optionally added with water, and then a hydrophobic organic solvent can be added. Liquid-liquid separation of water-hydrophobic organic solvents is concentrated. In addition, water can also be added to the extracts in the dry solid state, and then hydrophobic organic solvents can be added to borrow water-hydrophobic organic solvents. Separated and concentrated. Fractionation and purification by cis-phase and / or reverse-phase chromatography and / or recrystallization can obtain crude maslinic acid and / or physiologically acceptable salts thereof. Printed by the Consumers' Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs of the present invention, the anti-plumbing foods containing maslinic acid and / or physiologically acceptable salts thereof, but containing maslinic acid and / or physiologically acceptable salts thereof Salts can also be obtained by using the above-mentioned extracts, concentrates, separation / refined products, pure isolates, etc., for the anti-fat foods of the present invention. In addition, by adjusting the degree of concentration, separation, and refining, the concentration of maslinic acid and / or physiologically acceptable salts thereof can be adjusted, and it can be adjusted and blended in the food. In addition, other anti-fertilizing substances can be blended and used to design the anti-fertilizing function in detail, and the anti-fertilizing function can be greatly enhanced by the synergistic effect with other anti-fertilizing substances. Since olive oil contains maslinic acid, using the olive oil as an oily ingredient in the anti-fattiness food of the present invention can obtain a very suitable paper size applicable to the Chinese National Standard (CNS) A4 specification (210X297 1-63-200300069 mm Α7 Β7 V. Description of the invention (βί) Anti-fatness effect is extremely ideal. (Please read the precautions on the back before filling this page) Also, extract maslinic acid from olive and / Or its physiologically acceptable salt is also extracted with oleic acid and / or its physiologically acceptable salt, but oleic acid and / or its physiologically acceptable salt is related to hawthorn The acid has good mutual solubility, so these mixtures can be directly used in the anti-plump foods of the present invention. By this, it can be expected that the physiological effects of the synergistic effects will be multiplied, especially the maslinic acid and / or its physiology The salt that can be tolerated in the present invention exerts a multiplying effect on the effect of anti-puffiness, so it is very ideal. It can be adjusted when it is extracted from the olive plant and isolated and refined maslinic acid and / or its physiologically tolerable salt. The conditions are sufficient Mixtures with oleic acid and / or physiologically acceptable salts thereof, and oleic acid and / or physiologically acceptable salts thereof may be isolated from olives, respectively. Permissible salts can be obtained by mixing. It can also be maslinic acid and / or physiologically acceptable salts thereof obtained from different raw materials, and oleic acid and / or physiologically acceptable salts thereof. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs. Also, cratalic acid and / or physiologically acceptable salts of pentacyclic triterpenes other than the physiologically acceptable salts of the subject of the present invention can also be based on maslinic acid and / or The raw materials and methods described in physiologically acceptable salts are separated from natural materials. The anti-fertilization foods of the present invention can provide anti-hypertrophy and / or anti-overfilling foods However, as mentioned above, the pentacyclic triterpenes of the present invention and physiologically acceptable salts or derivatives thereof have a precursor-type adipocyte proliferation inhibiting function, a precursor-type adipocyte differentiation inhibiting function, or a mature type of fat. cell Fat accumulation inhibition function, according to this function, this paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) " -64-200300069 A7 B7 V. Description of the invention (β) ι (Please read the precautions on the back before (Fill in this page) and have anti-hypertrophic hypertrophy and / or anti-hypertrophic hypertrophy function. In other words, it is believed that anti-hypertrophy can be obtained mainly by the function of inhibiting the proliferation of precursor adipocytes or inhibiting the differentiation of precursor adipocytes. The function of sexual fullness, so it has the effect of anti-hypertrophic fullness and / or the formation of excessive hypertrophy. Printed by the Ministry of Health Intellectual Property Bureau® Industry and Consumer Cooperatives ¾ The anti-fullness food of the present invention can provide anti-fullness and And / or plump therapeutic tincture. In other words, the present invention contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. It is related to the prevention of plumpness and / or the treatment of plump foods. Use for the purpose of preventing fullness refers to the situation where you start to worry about fullness or when you are concerned about fullness in the long-term or middle-aged period, and use it in advance to prevent fullness. In this case, the loquat food of the present invention is a loquat food containing an anti-hypertrophic substance, such as pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. Therefore, excessive restriction or Reduced dieting is ideal for achieving the goal of healthy plumpness. In addition, the use for the purpose of treating plumpness means being plumped, especially when it is necessary to treat plumpness in terms of health, to improve the condition of plumpness. In this case, the anti-fattiness food of the present invention is a food containing anti-fattiness function such as pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof, so it will require Excessive dieting or changing lifestyle habits can minimize the burden on the body, and can be used to treat fullness through a more moderate diet, etc., which is ideal. In addition, the anti-puffiness foods of the present invention can also be used as foods for weight loss. In other words, the present invention contains one or two selected from the group consisting of pentacyclic triterpenes and their physiologically acceptable salts or their derivatives. The Chinese National Standard (CNS) A4 specification applies to this paper standard ( 210X297 mm) -65-200300069 A7 _B7_ V. The invention description (Seven (please read the precautions on the back before filling out this page) is related to the diet food for weight loss. The purpose of weight loss is to Those who are overweight naturally include those who are not particularly overweight, but need to lose weight when it is necessary to lose weight due to health or beauty. In this case, the food for preventing obesity in the present invention contains five rings Triterpenes and their physiologically tolerable salts or their derivatives have functions such as anti-puffiness, so they do not need to go on an excessive diet with pain or malnutrition, and live in a full diet and It is ideal to effectively lose weight under the nutritional supply. Printed by the Consumer Cooperative of the 1st Bureau of Wisdom and Finance of the Ministry of Economic Affairs ¾ Furthermore, the anti-obesity foods of the present invention can also be used to improve the foods that are not easily full In other words, the present invention is used for improving one's physical fitness by selecting one or two or more types from a group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof.飮 Food related. The so-called use for the purpose of improving the body is not easy to plump, refers to the fundamental and long-term plump countermeasures to improve the physique of the body itself and cause the body to become plump. In this case, the present invention Anti-plump foods are foods containing pentacyclic triterpenes and physiologically acceptable salts or derivatives that have anti-plumping properties, so they do not accompany long-term dieting. And other pains, and it is ideal to improve the physical fitness without getting enough nutrition and food. In a specific embodiment of the present invention, for example, the defatted residue obtained by the olive oil manufacturing process can be extracted with ethanol solution to obtain The dried and concentrated concentrate is an example of edible oils and fats containing 0.1 to 5% by mass of the above-obtained concentrate as maslinic acid obtained by GC analysis. Also, another aspect of the present invention is: Specific implementation forms, for example, can use the Chinese olive ^ paper size to apply Chinese National Standards (CNS) A4 specifications (210X297 mm) " -66-200300069 A7 B7 V. Description of the invention (6 ^ degreasing or residue obtained from the oil manufacturing process to For ethanol solution extraction, take 1 ~ 30% by mass of the lettuce seasoning containing the extract obtained above as an example. (Please read the precautions on the back before filling this page) Another embodiment of the present invention Form, for example, the degreased residue obtained by the manufacturing process of olive oil can be extracted with ethanol solution, and the obtained extract can be dried to be concentrated into a concentrate. The content of the concentrate containing maslinic acid fraction by GC analysis is 0.1 to 5% by mass. Lettuce for lettuce is taken as an example. In another specific embodiment of the present invention, for example, the residue of the pressed oil obtained by the olive oil manufacturing process can be extracted with an ethanol solution, and the obtained extract can be dried to be concentrated into a concentrate. An example of the material containing the concentrate is 0.1 to 5% by mass. In another specific embodiment of the present invention, for example, the degreased residue obtained by the manufacturing process of foreign olive oil can be subjected to extraction treatment with an ethanol solution, and the obtained extract can be dried and concentrated to calculate the content of maslinic acid obtained by GC analysis of the concentrate. As an example, a tablet containing 0.5 to 25% by mass can be used as an example. Printed by the Consumers ’Cooperative of the 1st Bureau of the Ministry of Economic Affairs, another specific embodiment of the present invention. For example, the residue of the pressed oil obtained by the manufacturing process of foreign olive oil can be extracted with ethanol solution, and the resulting extract can be dried and concentrated. For example, a cracker containing 0.1 to 5% by mass of maslinic acid, which is obtained by GC analysis of the concentrate, may be used as an example. In another specific embodiment of the present invention, for example, the degreased residue obtained by the manufacturing process of foreign olive oil can be subjected to extraction treatment with an ethanol solution, and the obtained extract can be dried and concentrated to calculate the content of maslinic acid obtained by GC analysis of the concentrate. For example, a clothing liquid containing 0.5 to 5% by mass and a frying conditioner (frozen food) are exemplified. In addition, in another specific embodiment of the present invention, for example, the Chinese National Standard (CNS) A4 specification (210X297 mm) can be applied based on the size of the foreign paper I " -67-200300069 A7 _ _ B7_ __ V. Description of the invention (Take (please read the precautions on the reverse side and fill in this page) Extraction residues from olive oil manufacturing process are extracted with ethanol solution, and the resulting extracts are dried and concentrated to include the maslinic acid obtained by GC analysis of the concentrate. 0.05 to 2.5% by mass of sauce can be exemplified. In addition, another specific embodiment of the present invention, for example, the degreased residue obtained by the manufacturing process of foreign olive oil can be extracted with an ethanol solution, and the obtained extract can be concentrated by drying and The content of maslinic acid obtained by GC analysis containing the concentrate can be exemplified by containing 0.1 to 5% by mass of beauty milk. In addition, in another specific embodiment of the present invention, for example, the pressed oil residue obtained by the manufacturing process of foreign olive oil can be used to Extraction treatment with ethanol solution. The obtained extract is dried and concentrated. Based on the maslinic acid containing the concentrate obtained by GC analysis, it contains 0.1 to 5% by mass of margarine. For example, printed by the Consumer Cooperatives of the 1st Bureau of Wisdom and Finance of the Ministry of Economic Affairs, the present invention contains one or two or more selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. These are related to anti-hypertrophy foods. These pentacyclic triterpenes have a particularly excellent anti-fertilizer function of precursor-type adipocyte proliferation inhibition function, precursor-type adipocyte differentiation inhibition function, and mature adipocyte fat accumulation inhibition function. Full-featured. The fermented foods for anti-fullness of the present invention do not require a special burden in terms of time or labor, and it is ideal to simply and continue to enjoy the anti-fullness function. Moreover, the pentacyclic triterpenes of the present invention may be It is obtained from natural plants and can be used safely in daily use, especially when it is derived from olives. It is ideal for users to give a feeling of spiritual comfort. Examples Examples of the present invention are shown below, but The present invention is not limited by these ^ The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) " -68- 200300069 A7 _B7_ V. Description of the invention (4). The following mass percentages are expressed in% of units. (Please read the precautions on the back before filling this page.) Pentacyclic triterpene cocadiols (manufactured by Funakoshi), ursolic acid (and (Manufactured by Kwangjon Pharmaceutical Co., Ltd.), arbutanol (manufactured by Funakoshi Corporation), betulinic acid (manufactured by Funakoshi Corporation), betulin (manufactured by Funakoshi) After heating to boiling point and dissolving in ethanol to saturation, it is cooled, recrystallized, filtered, dried, and reused. Hawthorn acid is described in the following examples, which are extracted from the olive plant, purified, and confirmed to have a purity of 95%. < Manufacturing example 1 > 500g of dried fruits (including seeds) of domestic olives (Olea europaea L.) produced in Japan were crushed, and 3 was added < Hexane extraction for 3 hours. The seeds were removed from the defatted fruits after repeated four times, the seeds were pulverized, and then extracted with 5 times the amount of hexane for 3 hours to obtain 229 g of defatted matter (defatted meal) from which oil was completely removed. A 10-fold amount of an aqueous ethanol solution having an ethanol content of 60% by mass was added to the degreased material, and the mixture was extracted with vigorous stirring at room temperature for 3 hours. After filtering the entire amount, the filtrate was concentrated to dryness to obtain 112.7 g of extract. Printed by the Xiaohuang Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs Add 100 g of this extract to 2 < Water, vigorously stirred at room temperature for 1 hour. After the entire amount was centrifuged, the supernatant was removed by decantation and the resulting precipitate was dried to obtain 10.0 g of a concentrate. Next, the concentrate was fractionated by silica gel column chromatography with a column filled with about 40 times (400 g) of silica gel. First, 10 times the amount of gel (4000ml) of hexane: ethyl acetate = 3: 1 eluate to remove excess components, and then 2.5 times (100ml) of hexane: ethyl acetate = 1: 1 dissolving solution dissolves excess and does not need cost. Paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) " -69-200300069 A7 B7 V. Description of the invention (4 copies. 10 times the amount (4000ml) of hexane: ethyl acetate = 1: 1 eluent to dissolve the target maslinic acid to obtain the crude maslinic acid fraction. From this fraction (please read the precautions on the back before filling this page) Remove After hexane and ethyl acetate, vacuum drying to obtain 1.96 g of crude maslinic acid fraction. The crude column was filled with about 30 times the amount (60 g) of octadecyl silicone gel, and the crude product was purified by ODS column chromatography. Fraction of maslinic acid. First, the silica gel filled with 10 times the amount (600ml) is filled with methanol: water = 8: 2 eluent to dissolve the impurities which are not needed. Then, the methanol filled with the silica gel with 30 times the amount (1 800ml) is filled with: Water = 8: 2 dissolves the maslinic acid from the target to obtain the refined maslinic acid fraction. After removing methanol from this fraction, It was dried to obtain 1.51 g of refined maslinic acid 1. Here, analysis by NMR, MS and the like confirmed that this refined maslinic acid 1 was in a state of a part of sodium salt and potassium salt, and the rest was mostly in a state of free acid. The purity was measured by GC, and it was confirmed that the purity of maslinic acid was 95% or more. < Manufacturing Example 2 > 10 kg of 65% by mass of ethanol was added to oil residue (pressed oil meal) to the oil residue (pressed oil meal) of the Intellectual Property Office of the Intellectual Property Bureau of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs of the Ministry of Economic Affairs. The aqueous ethanol solution was extracted with vigorous stirring at room temperature for 3 hours. After filtering the whole amount, the solid filtrate was concentrated to obtain 20.2 g of an extract. Add 1 ί n-butanol, 1 to this extract < Water, stirred for 10 minutes, and then separated into an n-butanol phase and an aqueous phase. After the n-butanol phase of the n-butanol phase was removed, it was vacuum dried to obtain 1.33 g of a concentrate. Secondly, the silica gel column filled with about 40 times the quantity (500g) of silica gel. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) '-70- 200300069 A7 _B7 V. Description of the invention (蛉(Please read the precautions on the back before filling this page) Chromatographically fractionate this concentrate. First, use 10 times the amount of gel (50 00 ml) of hexane: ethyl acetate = 3: 1 eluate to remove excess After the ingredients, 2.5 times (1250 ml) hexane: ethyl acetate = 1: 1 eluent is used to dissolve excess unnecessary components. Then fill 10 times (5000ml) of hexane: ethyl acetate with silica gel. Ester = 1: 1 eluate dissolves the target maslinic acid to obtain the crude maslinic acid fraction. After removing hexane and ethyl acetate from this fraction, it is dried under vacuum to obtain 2.66 g of crude maslinic acid fraction. The column of octadecylsilicone with 30 times the amount (80g) was purified by ODS column chromatography. Firstly, 10 times the amount (800 ml) of silica gel filled with methanol: water = 8 : 2 dissolving liquid to dissolve out impurities without the need of ingredients. Then 30 times the amount (2400 ml) of silica gel filled with methanol: water = 8: 2 dissolving liquid dissolving The purified maslinic acid fraction is obtained from the maslinic acid which is obtained. After removing the methanol from this fraction, vacuum drying is performed to obtain 2.06 g of refined maslinic acid 2. Here, it is confirmed by NMR, MS analysis that the refined maslinic acid 2 is a part of it Part of the free acid state, most of the rest are in the state of sodium or potassium salt. Also, the purity was measured by GC to confirm that the purity of maslinic acid is above 95%. System < Manufacturing Example 3 > In a 1 kg olive oil production step obtained from the extraction residue of Italian olives (re-processed the degreased oil residues in the extraction step), 10 times the amount of ethanol was added, and the mixture was heated to 55 ° C and vigorously stirred while extraction. 3 hours. After filtering the entire amount, the filtrate was concentrated and dried to obtain 35 g of an extract. This concentrate was then fractionated by silica gel column chromatography filled with about 40 times (1400 g) silica gel column. First 10 times the amount of gel (14 <) Hexane: This paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) -71-200300069 A7 B7 V. Description of the invention (4 Ethyl acetate = 3: 1 The dissolving liquid leaves the excess After the ingredients, 2.5 times the amount (3500ml) of hexane: ethyl acetate = 1: 1 eluent to dissolve excess unnecessary components. Then fill 10 times the amount of silica gel (14 hexane: ethyl acetate = The 1: 1 dissolution solution dissolves the target maslinic acid to obtain a crude maslinic acid fraction. After removing hexane and ethyl acetate from this fraction, vacuum drying is performed to obtain 5.90 g of a crude maslinic acid fraction. It is filled with about 30 times more A quantity (180g) of octadecyl silica gel column, and the crude maslinic acid fraction was purified by ODS column chromatography. First, the silica gel was filled with 10 times (1 800ml) methanol: water = 8: 2 to dissolve The liquid dissolves out impurities without the need of ingredients. Then, 30 times the amount (5 400 ml) of silica gel filled with methanol: water = 8: 2 dissolves the target maslinic acid to dissolve the purified maslinic acid fraction. From this distillation After the methanol was removed, 5.36 g of refined maslinic acid 3 was obtained by vacuum drying. Here, NMR, MS and other analysis confirmed that this refined maslinic acid 3 was one of the first. Parts are in the state of sodium salt and potassium salt, and the rest are mostly in the state of free acid. In addition, the purity of these was measured by GC to confirm that the purity of maslinic acid was 97% or more. As pentacyclic triterpenes The olefin derivatives are obtained as follows. < Synthesis example > A solution obtained by dissolving 4.5 g of maslinic acid and 1.0 g of triethylamine in 50 ml of chloroform and dissolving 1.1 g of sulfenyl chloride in 10 ml of chloroform was dropped, and stirred for 1 hour. Subsequently, 3.2 g of ethanol was added, and 1.0 g of diethylamine was dissolved in 10 m of chloroform under ice-cooling, followed by stirring for 3 hours. After completion of the reaction, the chloroform dissolved component was extracted, and the crude reaction product obtained by distilling off chloroform was purified by silica gel column chromatography to obtain 3.5 g of ethyl maslinate. This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm)-Packing-(Please read the precautions on the back before filling this page) Order printed by the Ministry of Economic Affairs and the Intellectual Property Cooperative 4th Bureau-72- 200300069 A7 B7 V. Description of the invention (6¾ < Synthesis Example 2 > 2,3-0-diethylfluorenyl-maslinic acid (please read the precautions on the back before filling this page). Dissolve 2.0 g of maslinic acid in 100 ml of pyridine and add 50 ml of acetic anhydride and stir overnight. After distilling off the pyridine and vinegar, the residue was dissolved in ether, washed once with a 1N aqueous hydrochloric acid solution, once with a saturated sodium bicarbonate solution, and washed with pure water three times, and then added magnesium sulfate and left overnight. The magnesium sulfate was removed by filtration, and the crude reaction product obtained by distilling off the ether was purified by silica gel column chromatography to obtain 2.2 g of 2,3-0-diethylfluorenyl-maslinic acid. < Synthesis Example 3 > 2,3-0-triethylsilyl-massyl triethylsilyl ester 1.0 g of maslinic acid was dissolved in 200 ml of anhydrous dimethylformamide, and 144.0 mg of imidazole and 04.0 C were added at 0 ° C. 350 μ1 triethylsilyl chloride, sealed and stirred for 2 hours. After distilling off dimethylformamide, the residue was dissolved in ether, and the ether phase was washed once with 1N aqueous hydrochloric acid solution, once with saturated sodium bicarbonate solution, and three times with pure water, and then magnesium sulfate was added to stand overnight. The magnesium sulfate was removed by filtration, and the crude reaction product obtained by distilling off the ether was purified by silica gel column chromatography to obtain 1.5 g of 2,3-0-triethylsilyl · massate triethylsilyl ester. Qi Qilang Printed by Employee Consumer Cooperatives < Synthesis Example 4 > 2,3-0-Distearyl-ethyl maslinate was dissolved in 50 ml of anhydrous toluene with 1.0 g of ethyl maslinate obtained in Synthesis Example 1, and 5.0 g of triethylamine was added thereto. Under ice cooling, 6.0 g of chlorine stearate was slowly added and stirred for 1 hour. Slowly return to room temperature and stir for 9 hours. Add an appropriate amount of 1N hydrochloric acid aqueous solution, extract with ether, once with saturated sodium bicarbonate solution, wash the ether phase with pure water three times, and then add magnesium sulfate and leave it overnight. This paper size is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) '-73-200300069 A7 B7 V. Description of the invention (7b Magnesium sulfate is removed by filtration and purified by silica gel column chromatography. The crude reaction product yielded 1.2g of 2,3-0-di-stearylyl-maslinate. (Please read the precautions on the back before filling in this page} < Synthesis example 5 > 3,28-0-diethylfluorenyl-cocadiol 5.0 g of cocadiol was dissolved in 250 ml of pyridine, and 100 ml of acetic anhydride was added and stirred overnight. After distilling off the pyridine and acetic anhydride, the residue was dissolved in ether, washed once with a 1 N aqueous hydrochloric acid solution, once with a saturated sodium bicarbonate solution, and three times with pure water, and then added magnesium sulfate and left overnight. The magnesium sulfate was removed by filtration, and the crude reaction product obtained by distilling off the ether was purified by silica gel column chromatography to obtain 5.4 g of 3,28-0-diethylfluorenyl-cocadiol. < Synthesis Example 6 > Printed by the Consumer Cooperatives of the Wisdom Finance Bureau of the Ministry of Economic Affairs, Ethyl Ursolic Acid, 5.0 g of ursolic acid 1.lg triethylamine was dissolved in 50 ml of chloroform, and 1.2 mg of sulfinyl chloride was dissolved in ice-cold solution. 10 ml of the obtained chloroform was dropped and stirred for 1 hour. Subsequently, 3.5 g of ethanol was added, and 1.1 g of triethylamine was dissolved in 10 ml of chloroform under ice-cooling, followed by stirring for 3 hours. After the reaction was completed, the chloroform dissolved component was extracted, and the crude reaction product obtained by distilling off chloroform was purified by silica gel column chromatography to obtain 3.8 g of ethyl ursolic acid. < Synthesis Example 7 > 3,28-0-diethylfluorenyl-arsanol 5.0 g of arsitol was dissolved in 250 ml of pyridine, and 100 ml of acetic anhydride was added and stirred overnight. After distilling off the pyridine and acetic anhydride, the residue was dissolved in ether, and the ether phase was washed once with 1N aqueous hydrochloric acid solution, once with saturated sodium bicarbonate solution, and three times with pure water, and then magnesium sulfate was added to stand overnight. Filtered to remove the standard applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) " '' -74-200300069 A7 B7 V. Description of the invention (7) l Magnesium sulfate, purified by silica gel column chromatography and distilled away The crude reaction product obtained from diethyl ether gave 5.4 g of 3,28-0-diethylamidoarsanol. < Synthesis example 8 > Ethyl betulinate 5.0 g of betulinic acid 1.1 g of triethylamine was dissolved in 50 ml of chloroform and ice-cooled. The solution obtained by dissolving 1.2 mg of sulfenyl chloride in 10 ml of chloroform was dropped and stirred for 1 hour. Next, 3.15 g of ethanol was added, and 1.1 g of triethylamine was dissolved in 10 ml of chloroform under ice-cooling, and the mixture was stirred for 3 hours while being dropped. After the reaction, the chloroform dissolved component was extracted, and the crude reaction product obtained by distilling off chloroform was purified by silica gel column chromatography to obtain 3.8 g of ethyl betulinate. < Synthesis Example 9 > 3,28-0-diethylfluorenyl-birulinol 5.0 g of betulin was dissolved in 250 ml of pyridine, and 100 ml of acetic anhydride was added and stirred overnight. After distilling off the pyridine and acetic anhydride, the residue was dissolved in ether, and the ether phase was washed once with 1N aqueous hydrochloric acid solution, once with saturated sodium bicarbonate solution, and three times with pure water, and then magnesium sulfate was added to stand overnight. The magnesium sulfate was removed by filtration, and the crude reaction product obtained by distilling off the ether was purified by silica gel column chromatography to obtain 5.4 g of 3,28-0-diethylfluorenyl-betulin. Test Example 1 [Evaluation of Proliferation-Inhibiting Function of Precursor Adipocytes] A mouse precursor-producing adipocyte cell line 3T3-LI (ATCC deposit, deposit number CL-173) was used in a tissue culture bottle at a density of 3xl05 cells / 75cm2. (Product made by Nunc), the paper size containing 10% bovine fetal blood pupa is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)-Packing · Printed by the Intellectual Property Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs-75- 200300069 A7 B7 V. Description of the invention (7 ^ DMEM medium (manufactured by Nakaraitesq)). After entering the second half of the logarithmic growth period, the cells were treated with lx104. Cells were transplanted at a density of 0.32 cm2 into a multi-well culture plate (product of Corning Costar), and cultured for 48 hours in a DMEM medium containing 1% bovine fetal blood pupa with various triterpenes added at the concentrations described in Table 1. At the 44th hour after the start, Alamar BlueTM (manufactured by Alamar) will be added and cultured for another 4 hours. After the end of the culture, the fluorescent substance produced by the oxidation-reversion reaction of the cells will be fluoresced. Measured with a photometer, and compared with the fluorescence intensity of the control group to calculate the cell proliferation inhibition rate. (Evaluation criteria) Only the test group in which a triterpene solvent was dissolved was used as the control group, and the fluorescence intensity obtained by the control group was Calculate the proliferation inhibition rate with the fluorescence intensity when the test substance is added at 100%. The calculation formula is as follows: 1 ° Equation 1 Proliferation inhibition rate (%) = 100-(Fluorescence intensity when the test substance is added / When the control group is added Fluorescence intensity) X 100 (Please read the precautions on the back before filling out this page)-Equipment _ Ordered by the Bone Cooperative Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs The previous evaluation was based on the evaluation method, and the increase in the yield was based on the results. The paper size of the surface is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -76 · 200300069 A7 B7. 5. Description of the invention (凫 J table < Proliferation-inhibiting rate of precursor type adipocytes (%) > Concentration (yg / m 1) 6 12.5 25 50 100 Standard conjugated linoleum 0 20 30 40 40 Purified maslinic acid of the present invention 1 10 35 94 95 95 Refined Cratalic acid 2 10 30 90 95 95 Refined Cratalic acid 3 11 36 94 95 95 Cocadiol 11 80 95 95 95 Ursolic acid 18 83 94 95 95 Ursanol • • 30 38 76 Birch acid abuse • 30 69 92 Birch Alcohol • See 28 76 94 Compound of Synthesis Example 1 40 40 84 86 90 Compound of Synthesis Example 15 30 83 89 95 95 Compound of Synthesis Example 3 33 33 79 84 91 Compound of Synthesis Example 12 30 77 94 94 Synthesis of 5 Compound 20 78 95 96 96 Compound of Synthesis Example 6 80 80 93 95 95 Compound of Synthesis Example 7 • Scale 30 70 80 Compound of Synthesis Example 8 • 30 73 95 Compound of Synthesis Example 9--35 71 95 (Please read the back first Please note this page and fill in this page again.) Qi Qilang Zhishigou employee consumer cooperative printed from Table 1 shows that maslinic acid, cocadiol, ursolic acid, ursolic alcohol, betulinic acid, betulin and its physiologically acceptable Permissible salts or their derivatives, etc. Use Chinese National Standard (CNS) A4 specification (210X297 mm) -77-200300069 A7 B7 V. Description of the invention (7i drive type fat cell proliferation inhibiting function compared with conjugated linoleum known to have a strong anti-hypertrophic function substance Acid is more powerful. (Please read the notes on the back before filling out this page) According to this, maslinic acid, cocadiol, ursolic acid, ursitol, betulinic acid, betulin and its physiologically acceptable salts Or their derivatives will have an outstanding contribution to the proliferative inhibition function of precursor adipocytes. Test Example 2 < Evaluation of the function of inhibiting the differentiation of precursor adipocytes and the function of inhibiting fat accumulation in mature adipocytes > Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs, will be derived from the rat precursor adipocyte cell line 3T3- LI (ATCC deposit, deposit CL-173) was cultured in a tissue culture flask (manufactured by Nunc) at a density of 3 x 105 cells / 75 cm2 in DMEM medium (manufactured by Nakaraitesq) containing 10% bovine fetal blood pupa. Then, the differentiation-inhibitory function was evaluated by the following method. After entering the logarithmic growth phase two days later, the cells were transplanted into a 1.9 cm2 multi-well culture plate (coming Costar) at a density of 8 x 103 cells / well, and cultured for 4 to 7 days according to the concentrations described in Table 2 DMEM medium and triterpenes containing differentiation factors were added and cultured for another 48 hours. Then, it was cultured in DMEM medium containing bovine fetal blood pupa and insulin for another 8 days. After the end of the culture, a lysis buffer was added to each culture well, and the amount of fat in the lysate was measured by a triglyceride G-wako tester (manufactured by Wako Pure Chemical Industries, Ltd.) to estimate the amount of fat taken up by the adipocytes. The amount of triglyceride was compared with the control group to calculate its adipocyte differentiation inhibitory function. In addition, the fat accumulation inhibiting function was cultured for 2 days under the coexistence of differentiation factors, and the paper was changed to contain bovine fetal blood. The paper size was adapted to the Chinese National Standard (CNS) A4 (210X297 mm) -78-200300069 A7 B7 V. Invention Note (When adding 7 胰岛素 and insulin in DMEM medium, add each triterpene at the concentration described in Table 2 and incubate for another 8 days. After the end of the culture, follow the same procedure to evaluate the differentiation inhibition function. The function of inhibiting fat accumulation in adipocytes is calculated. (Evaluation criteria) When a solvent group that dissolves only triterpenes is added as a control, when the amount of triglyceride obtained from the control is 100%, the triglyceride when the test substance is added Calculate the differentiation and fat accumulation inhibition rate based on the amount. The calculation formula is shown in the following formula 2. Formula 2 Inhibition rate of differentiation and fat accumulation (%) = 100- (the amount of triglyceride when the test substance is added / the triglyceride of the control group Ester amount) X 100 The proliferative fat cell proliferation inhibition function and mature adipocyte fat accumulation inhibition function were evaluated according to the above method. The production rate is shown in Table 2. (Please read the precautions on the back before filling out this page) "Binding and ordering printed on paper standards of the Ministry of Economic Affairs Intellectual Property Bureau staff poverty alleviation cooperatives The paper standards are applicable to China National Standard (CNS) A4 specifications ( 210X297 mm) -79 · 200300069 A7 B7 printed by the Consumers' Cooperative of the 1st Bureau of Wisdom and Finance of the Ministry of Economic Affairs < Precursor type adipocyte differentiation and inhibition rate of fat accumulation (%) > Concentration (ug / ml) Inhibition rate of differentiation (%) Inhibition rate of fat accumulation (%) Inhibition rate of differentiation (%) SI Inhibition rate of fat accumulation (%) SI Standard Conjugated Linoleum 5 11.0 21.0 Refined maslinic acid of this invention 1 5 82.0 83.5 7.5 4.0 Refined maslinic acid 2 5 80.0 81.7 7.3 3.9 Refined maslinic acid 3 5 82.5 84.0 7.5 4.0 Cocadiol 5 78.5 80.4 7.1 3.8 Bear Fruit acid 5 65.4 66.9 5.9 3.2 Ursolic alcohol 5 55.4 59.2 5.0 2.8 Betulinic acid 5 60.0 63.8 5.5 3.0 Betulin 5 72.3 70.2 6.6 3.3 Compound of Synthesis Example 5 84.3 83.9 7.7 4.0 Compound of Synthesis Example 5 82.8 80.1 7.5 3.8 Synthesis Compound 5 in Example 3 81.0 78.0 7.4 3.7 Compound 5 in Synthesis Example 4 83.6 82.6 7.6 3.9 Compound 5 in Synthesis Example 5 75.0 78.0 6.8 3.7 Compound 5 in Synthesis Example 6 69.5 80.0 6.3 3.8 Compound 5 in Synthesis Example 7 60.4 63.2 5.5 3.0 Synthesis Compound 5 of Example 8 65.1 66.6 5.9 3.2 Synthesis of Compound 5 of Example 9 75.5 74.1 6.9 3.5 Table 2 shows that maslinic acid, cocadiol, ursolic acid, ursitol, 'Package-(Please read the notes on the back before filling this page) The size of the bound paper is applicable to the Chinese National Standard (CNS) A4 (210X297 mm) -80-200300069 A7 B7 V. Description of the invention (7 > (Please Read the precautions on the back before filling in this page.) Compared with the pre-cursor type adipocyte differentiation inhibition function and mature adipocyte fat accumulation inhibition function, lignan, betulin and physiologically acceptable salts or derivatives thereof It is known that conjugated linoleic acid with a strong anti-pigmenting function is more powerful. According to this, maslinic acid, cocadiol, ursolic acid, ursitol, betulinic acid, betulin and its physiologically acceptable salts Or their derivatives, etc., will contribute significantly to the function of inhibiting precursor adipocyte differentiation and / or inhibiting fat accumulation in mature adipocytes. Test Example 3 < Body Fat Accumulation Inhibition Test> Printed by the Consumer Cooperatives of the Smart Finance Bureau of the Ministry of Economic Affairs The body fat accumulation inhibition test was performed as follows. Wister males (6 weeks old, average weight 160g) were pre-breeded with AIN-93 powder for one week, and then divided into 12 groups (8 animals per group) according to the average body weight. The feed added with the test substance described in Table 4 (soybean oil for the control group) was allowed to be freely ingested for 8 weeks. In addition, the above-mentioned feed is based on the ingredients described in Table 3, and corn starch reduced by the same quality is used for the extra components when the test substance is added. After 8 weeks, the test mice of each group were dissected, and the subcutaneous and visceral fat mass was measured, and the fat accumulation rate for the total weight was calculated. This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) -81- 200300069 A7 B7 V. Description of invention (7¾ Table 3 < Feed composition> Composition composition (%) Corn starch 52.95 Casein 20.0 Sucrose 10.0 Refined soybean oil 7.00 Cellulose 5.00 Mixed minerals (AIN- 93G) 3.50 Mixed vitamins (AIN- 93G) 1.00 L · Cysteine 0.30 weight Biletan tartrate 0.25 (Please read the precautions on the back before filling out this page) 钍 Printed by Suji Consumers ’Co-operation and Consumption Coordination (Evaluation Criteria) Soybean intake group as the control group, the body fat accumulation rate obtained by the control group When it is 100%, the body fat accumulation rate from the test substance ingestion group is calculated according to the following formula 3 to calculate the body fat accumulation inhibition rate. Formula 3 Inhibition rate of body fat accumulation (%) = 100- (Body fat accumulation rate of test substance intake group / Body fat accumulation rate of control intake group) x 100 The body fat accumulation inhibition function is evaluated according to the above method, and the result is body fat The accumulation suppression rate is shown in Table 4. This paper size is applicable to Chinese National Standard (CNS) A4 (210X29 * 7mm) -82 · 200300069 Α7 Β7 V. Description of the invention (7¾ 苐 4 <: body fat animal administration amount (g / feed 100g) body fat accumulation inhibition rate (%) Group 1 soybean oil (control) •-Extract from Group 2 Manufacturing Example 2 10.0 9.3 3 Concentrate obtained from group production example 5.0 10.2 Group 4 refined mangoic acid 1 1.0 12.5 Group 5 refined mangoic acid 2 1.0 13.6 Group 6 cocadiol 1.0 20.9 Group 7 ursolic acid 1.0 19.1 Group 8 ursula Alcohol 1.0 10.3 Group 9 betulinic acid 1.0 9.5 Group 10 betulin 1.0 1.0 Group 11 Compound 1 Synthesis Example 1.0 1.0 15.0 Group 12 Synthesis Example 2 Compound 1.0 18.2 Group 13 Refined Mangolic Acid 3 1.0 12.4 (Please read first Note on the back, please fill out this page again.) 瞍 Qilang Wisdom Hours 消费 Printed by Employee Consumer Cooperatives. Table 4 shows that various pentacyclic triads and their physiologically tolerable § noon salts or their derivatives can be used. The group is intentional than the control group (ie P <0.05; Inhibition of body fat accumulation. In addition, oral intake of natural extracts (maslinic acid content of 12.2%) and its concentrates (maslinic acid content of 19.5%) can also show the function of inhibiting body fat accumulation. Accordingly, it has been shown that various pentacyclic triterpenes and their physiologically acceptable salts or their derivatives will have an excellent contribution to the anti-puffiness function. In addition, when obtained from nature, it is concentrated and / or separated / refined compared to extracting only Chu. The paper size of pure paper is applicable to China National Standard (CNS) A4 (210 × 297 mm) -83-200300069 A7 B7 _ 5 、 Instructions of invention (there is a tendency to display higher functions. (Please read the precautions on the back before filling this page) Test Example 4 < Safety confirmation test for animals > An acute toxicity test was performed according to the following method. Wister female rats (6 weeks old, average weight: 160g) were pre-bred with powdered feed consisting of AIN-93 for one week, and then divided into 6 groups (eight in each group) based on the average body weight becoming equal. The maslinic acid administration group, the cocadiol administration group, the ursolic acid administration group, the ursolic alcohol administration group, the betulinic acid administration group, and the betulin alcohol administration group respectively suspended the test substances in cottonseed. In the oil, 2,000 mg / kg of body weight was forcibly administered orally by a probe. Continue to use AIN-93 powder to prepare feed, observe the feeding status 2 weeks after administration, and then dissect and examine the internal organs status 2 weeks later. As a result, there were no deaths in all groups 2 weeks after administration, and no abnormalities were found in the visceral examination of the anatomy. From this, it can be known that LD5G of various pentacyclic triterpenes is more than 2000 mg / kg body weight, is extremely safe and excellent, and can be ingested orally in the form of food. Printed by the Consumer Finance Cooperative of the 4th Bureau of Smart Finance, Ministry of Economic Affairs, Test Example 5 < Body fat accumulation inhibition test > SD male rats (6 weeks old, average weight: 160g) were pre-breeded in solid form (researched MR storage feed, manufactured by Nippon Kogyo Co., Ltd.) for one week, and then The average weight becomes equal and is divided into 5 groups (4 in each group), so that they can freely ingest the powder composed of AIN-93 added with the test substance. The paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm)- 84-200300069 V. Description of the invention (Power feed for 4 weeks. The composition of the above feed is shown in Table 5. In addition, all groups are added with 7% by mass of blended oil (soybean oil: rapeseed oil = 3: 7) ° After 4 weeks, the test group was dissected for 6 hours after fasting, and the total visceral fat (peripheral entrapment, mesenteric and perirenal) and subcutaneous fat were measured. From this measurement, the weight of the final body weight was measured. Calculate the fat accumulation rate of the fat mass of each part. Use the total of visceral fat (peripheral parasomnia, mesenteric and renal) and subcutaneous fat mass as the body fat mass, and then calculate the body fat accumulation rate for the final weight. Then ingest The fat accumulation rate when the oil distribution group is the control group is compared with the fat accumulation rate of the test substance, and the fat accumulation inhibition rate is calculated according to the following formula 4 to confirm the fat accumulation inhibition effect. The results are shown in Table 6. (Please read the notes on the back before filling out this page.) Form 5 printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs < Feed composition > Composition composition (%) Blend oil group 96-0.1% group 96-0.01% group 18-0.5 group 18-0.05 group corn starch 52.9 52.8 52.9 52.4 52.9 casein 20.0 20.0 20.0 20.0 20.0 sucrose 10.0 10.0 10.0 10.0 10.0 Blended oil 7.0 7.0 7.0 7.0 7.0 Cellulose 5.0 5.0 5.0 5.0 5.0 Mixed minerals (AIN-93G) 3.5 3.5 3.5 3.5 3.5 Mixed vitamins (AIN-93G) 1.0 1.0 1.0 1.0 1.0 Cysteine 0.3 0.3 0.3 0.3 0.3 Bile Tartrate 0.3 0.3 0.3 0.3 0.3 Tested Substance 0.0 0.1 0.01 0.5 0.05 This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297 mm) -85- 200300069 A7 B7 V. Description of the invention (4 < Inhibition rate of fat accumulation > Formula 4 Inhibition rate of fat accumulation in each part and body (%) = 100- (fat accumulation rate of the test substance intake group / fat accumulation rate of the control intake group) x 100 (please read the back Note: Please fill in this page again.) Printed by the Employees' Cooperatives of the Intellectual Property Bureau of the Ministry of Economy. The paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) -86- 200300069 A7 B7. Inhibition rate of body fat printed by employees' cooperative of property bureau (%) 1 CO ON% < »—η 1 * accumulation rate (%) 13.34 13.17 12.55 12.71 11.86 i] cn inhibition rate (%) a cn Ό r 'i Ο 1— ^ y- accumulation rate (%) 7.36 7.34 7.17 6.99 6.62 total visceral inhibition Rate (%) 1 〇〇οα 5 CN 04 oi accumulation rate (%) 5.97 5.80 5.39 g 8 maslinic acid 1 0.09 0.009 0.09 0.009 W 蛔 ta, test substance 1 wn 0.05 5 .ο ο dosing substance preparation oil (control ) Concentrate obtained in Production Example 2 Concentrate obtained in Production Example 2 Purified maslinic acid 1 Purified maslinic acid 1 Group 1 Group 2 Group 3 Group 4 Group 5 (Please read the precautions on the back before filling out this page) C .

,1T .加 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -87 - 200300069 A7 B7 五、發明説明(ώ (請先閱讀背面之注意事項再填寫本頁) 由第6表可知攝取添加山楂酸飼料群較之對照群能確知 體脂肪之減低效果。其趨勢在低用量調配飼料攝取群較之 高用量調配飼料攝取群爲顯明,可知很少量就能有優異之 抗肥滿功能。又,從一日攝取量也能看到少量就有效之結 果。 上述顯示爲獲得本發明之抗肥滿效果,不必要攝取高 濃度,多量,相反地,在低含量範圍之一定範圍,也能發揮 優異之抗肥滿效果。 又,發現調配洋橄欖萃取物也能發揮抗肥滿功能,但 也知道經濃縮,精製,純離者較能獲得更優異之效果。 另外,將洋橄欖萃取物和其經濃縮,精製(純離)而 得山楂酸比較抗肥滿功能時,經濃縮,精製(純離)而得 山楂酸能使內臟脂肪和皮下脂肪均衡地減少。僅注意皮下 脂肪時,經濃縮,精製(純離)而得山楂酸較能減低皮下 脂肪。 實施例1食用油脂 經濟部智慧財產局員工消費合作社印製 精製山楂酸1 10.Og EXV,洋橄欖油 1000.Og 以上述調配比率,將精製山楂酸1添加在EX V (Extravigin)洋橄欖油,保持60°C下藉攪拌機充分混合到整 體呈淸澄狀,進行溶解而製造食用油脂。 本紙伕尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) ' --- -88 - 200300069 A7 B7 五、發明説明(8& 實施例2生菜沙拉用佐料 (請先閲讀背面之注意事項再填寫本頁) 製造例1中所得萃取物 30.0g 水 46.6g 蒼耳烷樹膠 O.lg 果糖葡甸糖液糖 5.0g 食鹽 5 . Og MSG 0.3g 釀米醋(酸度10%) 10.〇g 胡椒 適量 黃豆沙拉油 3 0.0 g 經濟部智慧財凌局員工消費合作社印¾ 按照上述調配比率,首先,將黃豆沙拉油以外之材料 投入備有攪拌機可加熱之容器中,使用螺旋漿攪拌機以 lOOrpm速度攪拌下加熱至9〇°C,保持品溫在90°C下攪拌25 分鐘。然後冷卻至品溫爲20°C,再混合黃豆沙拉油而製成 生菜沙拉用佐料。所得生菜沙拉用佐料乃具有洋橄欖風 味而品質良好之製品。 實施例3生菜沙拉用佐料 製造例1中所得粗製山楂酸餾分 3.0g 水 46.6g 蒼耳烷樹膠 O.lg 果糖葡萄糖液糖 5.0g 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -89- 200300069 經濟部智慧財產局員工消費合作社印製 A7 B7 、發明説明(4 MSG 0.3g 釀米醋(酸度10%) 10.〇g 胡椒 適量 黃豆沙拉油 32.0g 按照上述調配比率, 首先將黃豆沙拉油以外之材料, 投入備有攪拌機而可加溫之容器中,使用螺旋漿攪拌機以 lOOrpm速度攪拌下加熱至90°C。保持品溫在90°C下攪拌25分 鐘。然後冷卻品溫至20°C, 混合以黃豆沙拉油而製成生菜 沙拉用佐料。 實施例4飮料 製造例2中所得濃縮物 3.0g 蜂蜜 15.0g 枸櫞酸 O.lg dl-蘋果酸 O.lg D-山梨糖醇液(70%) 10.Og 苯甲酸鈉 O.lg 香料 適量 精製水 使總量成爲lOOg之餘量 將上述成分混合均一而製得健康飮料β 實施例5飮料 本纸張尺度適用中國國家操準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) -90- 200300069 A7 B7 五、發明説明(分 經濟部智慧財產局員工消費合作社印製 古柯二醇 3.0g 蜂蜜 15.Og 枸櫞酸 0.1 g dl-蘋果酸 〇· lg D-山梨糖醇液(70%) 10.Og 苯甲酸鈉 o.lg 香料 適量 精製水 使總i 將上述成分混合均 一而製得健1 實施例6錠狀食品 熊果酸 22.5g 顆粒糖 4.5g L-抗坯血酸 2_lg 糊料 適量 香料 適量 色素 適量 按照上述調配比率混合各材料,該混合物直接藉粉末 壓縮法製成錠狀而得每粒重250mg之錠狀食品。 實施例7軟膠囊狀食品 樺木酸 2.0g (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -91 - 200300069 A7 B7 五、發明説明(以 蜜臘 14.0g 番紅花油 84.0g (請先閱讀背面之注意事項存填寫本頁) 將蜜臘和番紅花油加熱溶解混合均一後,慢慢冷卻下 添加樺木酸,攪拌,恢復常溫時,以明膠之軟膠囊包裝,_ 乾燥而得軟膠囊狀食品。 實施例8殼類食品 熊果醇 0.15g 小麥粉 30. 脫脂黃豆 18.5g 小麥麩皮 15.0g 小麥胚芽 11.5 g 顆粒糖 10.0g 按照上述調配比率混合後,加水成型,以烤箱加熱乾 燥而得球狀榖類食品。 經濟部智慧財產局貸工消費合作社印製 實施例9錠狀甜點 枸椽酸 l.Og 脫脂奶粉 15.5g 蔗糖脂肪酸酯 l.Og 香料 適量 精製山楂酸1 2.5g 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX297公釐) -92 - 200300069 五、發明説明(以 顆粒糖 乳糖 A7 B7 20.0g 60.0g 將上述原料均一混合, 造粒,S 之錠狀甜點。 實施例10脆餅乾 人造奶油 70.0g 砂糖 40.0g 食鹽 〇.7g 全卵 20.0g 低筋麵粉 100.Og 精製山楂酸2 2.0g (請先閱讀背面之注意事項再填寫本頁) 按照上述調配原料,混合後分割爲每塊10g重量,在 180°C烘焙15分鐘而製成脆餅乾。 經濟部智慧財產局員工消費合作社印¾ 實施例11冷凍食品 60.0g X 10 1.5g 2.5g 5.0g 1.0g 2.0g 猪黑肌肉切片 蒼耳烷樹膠 卵白粉 麥芽糊精 調味料 精製山楂酸1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -93- 200300069 A7 B7 五、發明説明(士 水 50.0g 麵包粉 適量 (請先閲讀背面之注意事項再填寫本頁) 將蒼耳烷樹膠,卵白粉,麥芽糊精,調味料,山楂酸 在水中混合攪拌調製成爲衣液,塗布在猪肉切片周圍,再 附著以麵包粉,再於180 °C之黃豆油炸3分鐘而得炸製食品 。使用上述全部原料製成1 0片炸製食品,然後,冷卻至-30 °C而成冷凍食品。 實施例12殺菌袋包裝食品 經濟部智慧財凌局員工消費合作社印製 (肉部分) 攪碎猪肉 21.0g 植物性油 5.0g 蔬菜糊 3.0g 豆瓣醬 l.Og (醬部分) 蒼耳烷樹膠 0.2g 醬油 10.Og 味酣 8.0g 砂糖 6.0g 食鹽 4.0g 萃取調味料 0.8g 植物性調味料 0.8g 精製山楂酸2 0.8g 豆瓣醬粉末 O.lg 水 使總里成爲70g之餘量 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -94 - 200300069 A7 B7 五、發明説明(9)| (請先閱讀背面之注意事項再填寫本頁) 將肉部分和醬部分分別調製後,按肉部分30g和醬部分 70g合計爲100g,塡裝在鋁箔殺菌袋中,經加熱殺菌(120°C ,25分鐘)而製成殺菌袋包裝食品。 實施例13人造奶油 油菜籽油 42.0g 硬化油菜籽油 42.Og 水 14.0g 食鹽 0.5g 卵磷脂 〇.5g 單甘油酯 〇.4g 精製山楂酸1 0.6g 香料 適量 胡蘿葡素 微量 經濟部智慧財/i局員工消費合作社印¾ 將上述原料按照一般方法混合,使用調配機急冷混合 處理而製成人造奶油。 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) -95- 200300069 A7 B7 五、發明説明(4 實施例14美奶滋 黃豆沙拉油 74.〇g 水 8.4g 砂糖 l.Og 麩胺酸鈉 〇.3g 芥辣粉末 0.3g 食鹽 l.Og 釀米醋 4.0g 精製山楂酸2 l.Og 加鹽蛋黃 10.Og (請先閲讀背面之注意事項再填寫本頁) 經濟部智慧財產局員工消費合作钍印¾ 按照上述調配比率,首先,將黃豆沙拉油,加鹽蛋黃 以外之原料混合攪拌下加熱至90t,保持在90°C下攪拌25分 鐘。冷卻至2(TC之後,混合以黃豆沙拉油,加鹽蛋黃,在減 壓下攪拌而製得美奶滋。 使用本發明之抗肥滿用飮食品,可以不需要時間或勞 力等之負擔,簡單且繼續地攝取五環性三萜烯類和其生理 上可容許之鹽類或其衍生物,其結果能獲得其抗肥滿效果 。又,本發明中之五環性三te烯類可由天然物取得,因此 ,使用上有安全感。 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -96 -, 1T. The size of this paper applies Chinese National Standard (CNS) A4 (210X297mm) -87-200300069 A7 B7 V. Description of invention (please read the precautions on the back before filling this page) Form 6 It can be seen that the intake of added maslinic acid feed groups can confirm the effect of reducing body fat compared with the control group. The trend is obvious in the low-dose feed intake group compared with the high-dose feed intake group, and it can be seen that a small amount can have excellent anti-fertility Full function. In addition, a small amount of effective results can be seen from the daily intake. The above shows that in order to obtain the anti-puffiness effect of the present invention, it is unnecessary to ingest high concentrations and large amounts. On the contrary, it is within a certain range of low content range. Can also play an excellent anti- plump effect. Also, it is found that the blended European olive extract can also play an anti- plump function, but it is also known that after concentrating, refining, pure people can obtain more excellent effects. In addition, Olive extract and its concentrated, refined (purified) to obtain maslinic acid. Compared with the anti-puffiness function, concentrated and refined (purified) to obtain maslinic acid can make visceral fat and subcutaneous fat. Homogeneous reduction. When only paying attention to the subcutaneous fat, it can be concentrated and refined (purely separated) to obtain maslinic acid which can reduce the subcutaneous fat. EXV, 1000.Og of olive oil At the above blending ratio, add refined maslinic acid 1 to EX V (Extravigin) olive oil, and keep it mixed with a blender at 60 ° C until the whole is smooth and dissolve to produce food. Grease. The paper scale is applicable to Chinese National Standard (CNS) A4 (210X29 * 7mm) '----88-200300069 A7 B7 V. Description of the invention (8 & Example 2 Seasoning for lettuce salad (please read first Note on the back side, please fill in this page again.) 30.0g of the extract obtained in Manufacturing Example 1 46.6g water Xanthan gum O.lg fructose glucose glucose 5.0g table salt 5. Og MSG 0.3g rice vinegar (acidity 10%) 10.〇g Pepper Soybean Salad Oil 3 0.0 g Printed by the Consumers ’Cooperative of the Ministry of Economic Affairs and Intelligent Finance Bureau ¾ According to the above-mentioned blending ratio, first, put materials other than soy bean salad oil into a container that can be heated by a blender and use The propeller stirrer is heated to 90 ° C with stirring at 100 rpm, and the product temperature is stirred at 90 ° C for 25 minutes. Then it is cooled to 20 ° C and mixed with soybean salad oil to make a lettuce salad dressing The obtained seasoning for lettuce salad is a product with a European olive flavor and good quality. Example 3 The crude hawthorn acid fraction obtained in Production Example 1 for lettuce salad 3.0 g of water 46.6 g of xanthan gum O.lg fructose glucose solution Sugar 5.0g This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) -89- 200300069 Printed A7 B7 by the Consumer Cooperative of Intellectual Property Bureau of the Ministry of Economic Affairs, A7 B7, invention description (4 MSG 0.3g rice vinegar (acidity 10% acidity) ) 10.0g pepper soy bean salad oil 32.0g According to the above blending ratio, first put materials other than soy bean salad oil into a container equipped with a stirrer for heating, and use a propeller stirrer to stir at 100 rpm and heat to 90 ° C. Stir the product at 90 ° C for 25 minutes. Let it cool to 20 ° C and mix it with soy salad oil to make lettuce. Salad dressing. Example 4 Concentrate obtained in Production Example 2 3.0g honey 15.0g citrate O.lg dl-malic acid O.lg D-sorbitol solution (70%) 10.Og sodium benzoate O.lg perfume refined Water makes the total amount to 100g. The above ingredients are mixed uniformly to produce a healthy material. Example 5: The paper size is applicable to China National Standards (CNS) A4 size (210X297 mm) (Please read the note on the back first) Please fill in this page again for matters) -90- 200300069 A7 B7 V. Description of the invention (cocadiol 3.0g printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economy 3.0g honey 15.Og citrate 0.1 g dl-malic acid lg D-Sorbitol solution (70%) 10.Og Sodium benzoate o.lg A suitable amount of purified water to make the total i mixed the above ingredients uniformly to obtain health 1 Example 6 22.5g ursolic acid in pellet food granules 4.5g L-anti-blood acid 2_lg paste, appropriate amount of fragrance, appropriate amount of pigment, appropriate amount of the materials are mixed according to the above-mentioned blending ratio, and the mixture is directly made into a tablet shape by powder compression method to obtain a tablet-shaped food weighing 250 mg per capsule. Example 7 Soft capsule shape Food Betulinic Acid 2.0g ( Please read the notes on the back before filling this page) This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297mm) -91-200300069 A7 B7 V. Description of the invention (14.0g honey wax saffron oil 84.0g ( (Please read the precautions on the back and fill in this page first) After heating and dissolving the honey wax and saffron oil and mixing uniformly, slowly add betulinic acid under cooling, stir, and return to normal temperature. Packed in gelatin soft capsules, _ dried to obtain Soft capsule-like food. Example 8 Shell food 0.15g wheat flour 30. Defatted soybeans 18.5g wheat bran 15.0g wheat germ 11.5 g granulated sugar 10.0g After mixing according to the above-mentioned mixing ratio, add water to form and heat in an oven The dried glutinous glutinous food was obtained. Example 9: Dessert citrate l.Og skim milk powder 15.5g sucrose fatty acid ester l.Og spice refined refined mangoic acid 1 2.5 g This paper size applies the Chinese National Standard (CNS) A4 specification (21 OX297 mm) -92-200300069 V. Description of the invention (with granulated sugar lactose A7 B7 20.0g 60.0g Mix uniformly, granulate, and tablet-like dessert of S. Example 10 Crispy Biscuits Margarine 70.0g Granulated Sugar 40.0g Table Salt 0.7g Whole Egg 20.0g Low Gluten Flour 100.Og Refined Hawthorn Acid 2 2.0g (Please read the back Please fill in this page again.) Prepare the ingredients according to the above, mix them and divide them into 10g pieces, then bake them at 180 ° C for 15 minutes to make crackers. Printed by the Consumer Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs ¾ Example 11 Frozen food 60.0g X 10 1.5g 2.5g 5.0g 1.0g 2.0g Pig black muscle slice Xanthan gum gum white powder maltodextrin seasoning refined mangoic acid 1 unit Paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) -93- 200300069 A7 B7 V. Description of invention (50.0g of bread water, appropriate amount of bread flour (please read the precautions on the back before filling this page) Alkane gum, egg white powder, maltodextrin, seasoning, and maslinic acid are mixed in water to prepare a coating liquid, which is coated around pork slices, then adhered with bread flour, and fried in soybeans at 180 ° C for 3 minutes. Fried food. Use all the above ingredients to make 10 pieces of fried food, and then cool to -30 ° C to make frozen food. Example 12 Packed food in sterilized bags Printed by the Consumer Cooperative of the Smart Finance Bureau of the Ministry of Economic Affairs (meat Part) Crushed pork 21.0g Vegetable oil 5.0g Vegetable paste 3.0g Watercress l.Og (Sauce part) Xanthan gum 0.2g Soy sauce 10.Og Miso 8.0g Sugar 6.0g Salt 4.0g Extract seasoning 0.8gPlant-based seasoning 0.8g Refined maslinic acid 2 0.8g Douban paste powder O.lg water makes the total li become 70g The paper size is applicable to Chinese National Standard (CNS) A4 (210X297 mm) -94-200300069 A7 B7 V. Description of the invention (9) | (Please read the notes on the back before filling in this page) After preparing the meat part and sauce part separately, add the meat part 30g and sauce part 70g together to 100g, and pack it in an aluminum foil sterilization bag After being sterilized by heating (120 ° C, 25 minutes), it was made into sterilization bag packaging food. Example 13 Margarine rapeseed oil 42.0g hardened rapeseed oil 42.0g water 14.0g table salt 0.5g lecithin 0.5g monoglycerin Esters 0.4 g refined maslinic acid 1 0.6 g Flavor appropriate amount of carotene glucosin trace amount Ministry of Economic Affairs, Intellectual Property Office / i Bureau Consumer Cooperatives Co. ¾ The above raw materials are mixed in accordance with a general method, and the blender is used for rapid cold mixing to prepare margarine. Paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) -95- 200300069 A7 B7 V. Description of the invention (4 Example 14 US Milk Nourishing Soybean Salad Oil 74.0 g water 8.4 g granulated sugar l.Og bran Sodium 0.3g mustard powder 0.3g table salt l.Og brewed rice vinegar 4.0g refined hawthorn acid 2 l.Og salted egg yolk 10.Og (Please read the precautions on the back before filling this page) Staff of the Intellectual Property Bureau of the Ministry of Economic Affairs Consumption cooperation seal ¾ According to the above blending ratio, first, soy bean salad oil and raw materials other than salted egg yolk are mixed and heated to 90t, and kept at 90 ° C for 25 minutes. After cooling to 2 ° C, mix soy bean salad oil, add salted egg yolks, and stir under reduced pressure to obtain beautiful milk. Using the anti-fat food for foods of the present invention does not require the burden of time or labor. The pentacyclic triterpenes and their physiologically acceptable salts or their derivatives are simply and continuously ingested, and as a result, their anti-puffiness effect can be obtained. In addition, the pentacyclic triterpenes in the present invention can be obtained by Made of natural materials, so it feels safe to use. This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) -96-

Claims (1)

200300069 A8 B8 C8 D8 六、申請專利範圍 1 (請先閲讀背面之注意事項再填寫本頁) 1 ·一種抗肥滿用飮食品,其特徵爲含有五環性三萜烯類 ,和其生理上容許之鹽類或其衍生物所構成群中選擇之化 合物而成。 2 . —種前驅型脂肪細胞增殖抑制用飮食品,其特徵爲 含有五環性三萜烯類,和其生理上容許之鹽類或其衍生物 所構成群中選擇之化合物而成。 3 . —種前驅型脂肪細胞分化抑制用飮食品,其特徵爲 •含有五環性三萜烯類,和其生理上容許之鹽類或其衍生物 所構成群中選擇之化合物而成。 4. 一種成熟型脂肪細胞脂肪蓄積抑制用飮食品,其特 徵爲含有五環性三萜烯類,和其生理上容許之鹽類或其衍 生物所構成群中選擇之化合物而成。 5. 如申請專利範圍第1項之抗肥滿用飮食品,其中五環 性三萜烯類係齊墩果烷系三萜烯類,熊果烷系三萜烯類, 羽扇烷系三萜烯類所構成群中選擇而成。 經濟部智慧財產局員工消黄合作社印製 6. 如申請專利範圍第1項之抗肥滿用飮食品,其中五環 性三萜烯類係山楂酸,古柯二醇,熊果酸,熊果醇,樺木酸 或樺木醇。 7. 如申請專利範圍第6項之抗肥滿用飮食品,其中含 有山楂酸和/或其生理上容許之鹽類.而成。 8·如申請專利範圍第1項之抗肥滿用飮食品,其中由五 環性三萜烯類,其生理上容許之鹽類和其衍生物所構成群 中選擇之化合物係從天然原料中萃取而得。 9.如申請專利範圍第1項之抗肥滿用飮食品,其中由五 本纸張尺度逍用中國國家梂準(CNS ) A4規格(210X297公釐) -97 - 200300069 A8 B8 C8 D8 _ 六、申請專利範圍 2 (請先閲讀背面之注意事項再填寫本頁) 環性三萜烯類,其生理上容許之鹽類和其衍生物所構成群 中選擇之化合物係從.天然原料中萃取,濃縮和/或分離,精 製而得。 10·如申請專利範圍第丨項之抗肥滿用飮食品,其中由 五環性三萜烯類,其生理上容許之鹽類和其衍生物所構成 群中選擇之化合物係從天然原料中萃取處理,自所得萃取 物中純離而得。 Π · —種抗肥滿用飮食品,其特徵爲含有洋橄欖植物之 脫脂物,洋橄欖萃取物或洋橄欖萃取油爲有效成分者。 1 2.如申請專利範圍第11項之抗肥滿用飮食品,其中 洋橄欖植萃取物係洋橄欖油之製造工程中所得脫脂物用水 和/或有機溶劑萃取而得之萃取物。 13. 如申請專利範圍第1項之抗肥滿用飮食品,其中該 飮食品係水系飮食品者。 經濟部智慧財產局員工消費合作社印製 14. 如申請專利範圍第1項之抗肥滿用飮食品,其中, 五環性三萜烯類,其生理上容許之鹽類和其衍生物所構成 群中選擇之化合物之含有率係對於飮食品之總質量計, 0.00001〜90質量%者。 15. —種調配油脂或調配油脂加工品,其特徵爲含有五 環性三萜烯類,其生理上容許之鹽·類和其衍生物所構成群 中選擇之化合物。 16. 如申請專利範圍第1 5項之調配油脂或調配油脂加 工品,其中製品l〇〇g中所含五環性三萜烯類,其生理上容 許之鹽類和其衍生物而成化合物之含量係0·001〜1〇g者。 本紙張尺度適用中國國家標準(CNS ) A4规格(210X 297公釐) -98- 200300069 B8 C8 D8 六、申請專利範圍 3 1 7. —種抗肥滿用飮食品,其特徵爲使用如申請專利範 圍第15項之調配油脂和/或調配油脂加工品而成。 (請先閲讀背面之注意事項再填寫本頁) 18. —種抗肥大性肥滿用和/或抗形成過大性肥滿用飮食 品,其特徵爲含有五環性三萜烯類,其生理上容許之鹽類 和其衍生物所構成群中選擇之化合物而成。 19. 一種預防肥滿和/或治療肥滿用飮食品,其特徵爲含 有五環性三萜烯類,其生理上容許之鹽類和其衍生物所構 成群中選擇之化合物而成。 20. —種減肥用飮食品,其特徵爲含有由五環性三萜烯 類,其生理上容許之鹽類和其衍生物所構成群中選擇之化 合物而成。 21. —種改善成不易肥滿體質用飮食品,其特徵爲含有 由五環性三萜烯類,其生理上容許之鹽類和其衍生物所構 成群中選擇之化合物而成。 本紙張尺度逋用中國國家標準(CNS ) A4规格(210X297公釐) -99- 200300069 (一) 、本案指定代表圖爲: (二) 、本代表圖之元件代表符號簡單說明:200300069 A8 B8 C8 D8 6. Scope of patent application 1 (Please read the precautions on the back before filling out this page) 1 · A kind of anti-plump food, which is characterized by containing pentacyclic triterpenes, and its physiological characteristics Permissible salts or derivatives of selected compounds. 2. A kind of proliferative food for suppressing proliferative adipocytes, which comprises pentacyclic triterpenes, and compounds selected from the group consisting of physiologically acceptable salts or derivatives thereof. 3. —A kind of proliferative food for inhibiting the differentiation of precursor adipocytes, which is characterized by containing a compound selected from the group consisting of pentacyclic triterpenes and physiologically acceptable salts or derivatives thereof. 4. A gluten-containing food for inhibiting fat accumulation in mature adipocytes, which is characterized by containing pentacyclic triterpenes and a compound selected from the group consisting of physiologically acceptable salts or derivatives thereof. 5. For example, the gluten-resistant food for plumpness in item 1 of the scope of patent application, in which pentacyclic triterpenes are oleanolane triterpenes, ursane triterpenes, and lupinane triterpenes It is selected from the group consisting of olefins. Printed by the Yellow Property Cooperative of the Intellectual Property Bureau of the Ministry of Economic Affairs 6. For example, in the case of applying for patent No. 1, the penetrating triterpenes are maslinic acid, cocadiol, ursolic acid, and bear Fruit alcohol, betulin or betulin. 7. For example, the anti-fertilization food for gluten-free foods in the scope of patent application No. 6, which contains maslinic acid and / or physiologically acceptable salts thereof. 8. The fertility-resistant glutinous food according to item 1 of the scope of patent application, wherein the compound selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts and derivatives thereof is selected from natural raw materials. Extracted. 9. For example, the anti-fattiness food for food in item 1 of the scope of patent application, in which five paper sizes are used in accordance with China National Standard (CNS) A4 (210X297 mm) -97-200300069 A8 B8 C8 D8 _ 6 2. Scope of patent application 2 (Please read the notes on the back before filling out this page) Cyclotriterpenes, the compounds selected from the group of physiologically acceptable salts and their derivatives are extracted from natural raw materials. , Concentrated and / or separated and refined. 10. The fertility-resistant gluten-free food according to item 丨 of the application, wherein the compound selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts and derivatives thereof is selected from natural raw materials. Extraction treatment, purely obtained from the obtained extract. Π · —A kind of anti-fattiness food for glutinous rice, which is characterized in that it contains defatted substances from olive olive plants, and olive olive extract or olive olive oil is the active ingredient. 1 2. The fermented food for preventing fullness as claimed in item 11 of the scope of patent application, wherein the olive oil plant extract is an extract obtained by extracting the defatted product obtained in the manufacturing process of olive oil with water and / or an organic solvent. 13. For example, the anti-plumbing foods for which the scope of the patent application is item 1, wherein the foods are water-based foods. Printed by the Consumer Cooperatives of the Intellectual Property Bureau of the Ministry of Economic Affairs. 14. For example, the anti-fertilization food for gluten-free foods in the scope of patent application No. 1 consists of pentacyclic triterpenes, physiologically acceptable salts and derivatives thereof. The content rate of the compound selected in the group is 0.00001 to 90% by mass based on the total mass of the yam food. 15. —A compound prepared from processed oils or processed fats and oils, which contains pentacyclic triterpenes, physiologically acceptable salts, and compounds selected from the group consisting of derivatives thereof. 16. For example, the compounded fats or oils or processed fats and oils processed according to item 15 of the scope of patent application, wherein 100 g of the product contains pentacyclic triterpenes, physiologically acceptable salts and derivatives thereof. The content is from 0.001 to 10 g. This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) -98- 200300069 B8 C8 D8 VI. Application for patent scope 3 1 7. —A kind of anti-fattiness foods, which are characterized by the use of such as patent application It is prepared by blending fats and oils and / or processed fats and oils in the scope of item 15. (Please read the precautions on the back before filling this page) 18. —A kind of glutinous food for anti-hypertrophy and / or over-hypertrophy, which is characterized by containing pentacyclic triterpenes and its physiological It is a compound selected from the group consisting of salts and derivatives thereof. 19. A food for preventing obesity and / or treating obesity, characterized by containing pentacyclic triterpenes, physiologically acceptable salts and compounds selected from the group consisting of derivatives thereof. 20. A gluten-free food for weight loss, which is characterized by containing a compound selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts thereof, and derivatives thereof. 21. A kind of gluten-free food for improving body mass, which is characterized by containing compounds selected from the group consisting of pentacyclic triterpenes, physiologically acceptable salts and derivatives thereof. This paper uses the Chinese National Standard (CNS) A4 specification (210X297 mm) -99- 200300069 (1). The representative representative of the case is: (2) The component representative symbols of the representative diagram are simply explained: 本案若有化學式時,請揭示最能顯示發明特徵的化學式:If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: 一 3 —One 3 —
TW091132788A 2001-11-08 2002-11-07 Anti-obesity foods and drinks TW200300069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001343917 2001-11-08

Publications (1)

Publication Number Publication Date
TW200300069A true TW200300069A (en) 2003-05-16

Family

ID=19157516

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091132788A TW200300069A (en) 2001-11-08 2002-11-07 Anti-obesity foods and drinks

Country Status (3)

Country Link
JP (1) JPWO2003039270A1 (en)
TW (1) TW200300069A (en)
WO (1) WO2003039270A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772195B2 (en) * 2004-07-29 2010-08-10 Board Of Trustees Of Michigan State University Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
CA2663697C (en) * 2006-09-18 2015-11-24 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body
ES2328999B1 (en) 2008-04-03 2010-10-27 Biomaslinic S.L. USE OF MASLINIC ACID FOR THE TREATMENT OF PATHOLOGIES AND ITS SYMPTOMS THROUGH THE COH-2 INHIBITION.
JP2010202558A (en) * 2009-03-02 2010-09-16 Nihon Univ Antiobestic agent and diabetes-ameliorating agent
JP5459710B2 (en) * 2010-05-10 2014-04-02 日本製粉株式会社 Pharmaceutical composition for suppressing type I allergy comprising maslinic acid as an active ingredient
JP2015003877A (en) * 2013-06-20 2015-01-08 国立大学法人 筑波大学 Composition comprising hydroxytyrosol or salt thereof
WO2018051471A1 (en) * 2016-09-15 2018-03-22 日本農産工業株式会社 Fat accumulation inhibitor, preadipocyte differentiation inhibitor, visceral-fat-reducing agent, and food or beverage for visceral-fat reduction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3984310B2 (en) * 1995-06-22 2007-10-03 日本製粉株式会社 Glycerophosphate dehydrogenase inhibitor
JP2000044478A (en) * 1998-07-28 2000-02-15 Pola Chem Ind Inc Acat-inhibitor and composition containing the same for preventing and curing arteriosclerosis
JP2000136130A (en) * 1998-10-30 2000-05-16 Coral Biotech Kk Suppressant for liberation of histamine
JP2001252054A (en) * 2000-01-07 2001-09-18 Kanebo Ltd Food composition
JP3597437B2 (en) * 2000-02-10 2004-12-08 日清オイリオグループ株式会社 Edible fats and oils with blood lipid improving function

Also Published As

Publication number Publication date
WO2003039270A1 (en) 2003-05-15
JPWO2003039270A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
JP4398147B2 (en) Food and drink for whitening and oral whitening agent
JP4644787B2 (en) Anti-obesity agent having lipase inhibitory activity and antioxidant properties
JP6802256B2 (en) GLP-1 secretion promoting composition and method for producing the same
WO2011077800A1 (en) Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages
JP4358957B2 (en) Agent for scavenging or reducing free radicals or active oxygen
JP2007016013A (en) Oral composition for ameliorating climacteric skin
JP2009001515A (en) Isoflavone derivative having estrogen-adjusting action, food preparation, cosmetic, and endometriosis remedy each comprising the same
JPH0353866A (en) Lignans-containing food and drink
JP2007084504A (en) Composition containing fermentation product of barley as active ingredient and having neovascularization inhibitory action
JP5027361B2 (en) Hyaluronic acid production promoter
JP5309292B2 (en) Lipase inhibitor
TW200300069A (en) Anti-obesity foods and drinks
JP2006225312A (en) Leptin secretion-inhibiting composition
JP5175442B2 (en) Yacon-derived anticancer agent
JPWO2002078468A1 (en) Food and drink for vascular disorders
JP6893210B2 (en) Metabolic syndrome inhibitor
JPWO2002052956A1 (en) Food and drink for antitumor
JP2011012005A (en) Hyperlipidemia-ameliorating agent
JP4672304B2 (en) Lipolysis accelerator
KR101344564B1 (en) Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia
JP2007204447A (en) Carnitine derivative having excellent neutral-fat reducing effect, anti-obesity drug, food preparation, and cosmetic having cellulite reducing effect, each comprising the derivative
JP5167462B2 (en) Novel compounds and osteoclast differentiation / proliferation inhibitors
WO2007034958A1 (en) Anti-angiogenic composition comprising grain-derived component as active ingredient
JP2010155787A (en) Anti-inflammatory, anti-aging agent, antiobestic agent, hair restorer, cosmetic and food and drink for beautification
JP2004161678A (en) Anti-inflammatory agent and cyclic amp phosphodiesterase inhibitor